New N-heterocyclic carbene ligands and their applications in homogenous catalysis by Luan, Xinjun
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2010
New N-heterocyclic carbene ligands and their applications in homogenous
catalysis
Luan, Xinjun
Abstract: Die Entwicklung von N-heterozyklischen Carbenen (NHCs) als Liganden für Übergangsmet-
allkatalysatoren hat zu vielen neuen Errungenschaften in der homogenen Katalyse beigetragen. Um
die Familie von unterschiedlichen NHC Liganden zu erweitern, werden in der vorliegenden Disserta-
tion folgende Ergebnisse präsentiert: (1) Eine Klasse von gesättigten NHC Liganden mit Naphthyl-
basierten Seitenketten und ihre gute Performenz in drei unterschiedlichen katalytischen Reaktionen, und
(2) eine Reihe von chiralen NHC Liganden, welche aus C2-symmetrischen Diaminen mit Naphthylseit-
enketten dargestellt wurden, sowie die erfolgreiche Anwendung der entsprechenden Palladiumkomplexe
in der asymmetrischen Synthese von Oxindolen mit quaternären Kohlenstoffzentren. Das zweite Kapi-
tel beschreibt die Synthese und Charakterisierung von leicht zugänglichen und stabilen NHCs, die mit
Naphthyl in der Seitenkette substituiert sind. Bei der Anwendung in der Katalyse wurden exzellente
Resultate in Palladium- basierten Kupplungsreaktionen, in der Ruthenium-basierten Metathese sowie in
der organokatalytischen Ringöffnungsalkylierung von Epoxiden erhalten. Im dritten Kapitel wurde die
Untersuchung der NHCs zum entsprechenden chiralen Gegenstück ausgeweitet indem die Chiralität von
C2-symmetrischen Diaminen für das heterozyklische Rückgrat genutzt wurde. Die zugehörigen Palladi-
umkomplexe mit diastereomerenreinen NHC Liganden wurden aufgetrennt und in der asymmetrischen
Synthese von 3-Aryl-3-methyl-oxindolen getestet. Hierbei zeigten die katalytischen Daten einen drastis-
chen Einfluss auf die Enantioselektivität je nach der Orientierung der Seitenkette. Das vierte Kapitel
befasst sich mit einem anderen ähnlichen NHC Liganden, der die asymmetrische Synthese von 3-Allyl-
3-aryl-oxindolen mit einer hohen Chemo- und Enantioselektivität begünstigen konnte. The recent de-
velopment of N-heterocyclic carbenes (NHCs) as ligands for transition metal catalysts has proved to
be very fruitful in the field of homogeneous catalysis. In order to expand the family of versatile NHC
systems for catalysis, this dissertation presents: (1) a class of saturated NHC ligands with naphthyl-
derived side chains and their good performance in three different types of catalysis, and (2) a series of
chiral NHC ligands derived from C2-symmetric diamines with naphthyl side chains and the successful
applications of their palladium complexes in the asymmetric synthesis of oxindoles bearing quaternary
carbon centers. Chapter 2 describes the synthesis and characterization of a new class of easily accessible
and stable NHCs which incorporate substituted naphthyl side chains. In catalysis, excellent catalytic
results are obtained in palladium-based coupling reactions, in ruthenium-based metathesis, and in the
organocatalytic ring-opening alkylation of epoxide. In Chapter 3, the NHC study was expanded to their
chiral counterparts by introducing the chiral regime of C2-symmetric diamines into their heterocyclic
backbone. Palladium complexes bearing diastereomerically pure NHC ligand were separated and tested
in the asymmetric synthesis of 3-aryl-3-methyl- oxindoles. The catalytic data demonstrates the dramatic
effects on enantioselectivity according to the orientation of the side chains. Chapter 4 addresses another
similar chiral NHC ligand which could promote the asymmetric synthesis of 3-allyl-3-aryl- oxindoles with
high chemo- and enantioselectivity.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-163891
Dissertation
Published Version
Originally published at:
Luan, Xinjun. New N-heterocyclic carbene ligands and their applications in homogenous catalysis. 2010,
University of Zurich, Faculty of Science.
2
 New N-Heterocyclic Carbene Ligands and Their 
Applications in Homogenous Catalysis 
 
 
 
Dissertation  
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.) 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät der 
Universität Zürich 
 
von 
Xinjun Luan 
aus China 
 
 
Promotionskomitee 
 
Prof. Dr. Reto Dorta (Vorsitz und Leitung) 
Prof. Dr. Jay S. Siegel 
Prof. Dr. Cristina Nevado 
 
Zürich, 2010 
 
 
 II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2010 
Xinjun Luan 
All Rights Reserved 
 
 III 
 
 
 
 
 
 
 
 
 
For my Family, for their love and support. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 IV 
 
Acknowledgements 
 
I deeply appreciate many people for their assistance and contributions to the 
work in this dissertation and for helping me enjoy life as a graduate student. 
I want to begin by acknowledging Prof. Dr. Reto Dorta for being a wonderful 
advisor. He has been very patient with me and provided me with a unique 
environment to do chemistry. He guided me to approach problems in the right 
direction at some critical points, and the freedom which Reto provided allowed me to 
pursue some interesting challenges for myself and participate in research projects 
beyond a mere student. Yet at the same time, he is also a very good friend. Therefore, 
I am very honored to have had the great opportunity to work in his group. 
I thank my committee members Prof. Dr. Jay S. Siegel and Prof. Dr. Cristina 
Nevado for their support in my career development as well as for their helpful 
suggestions on my research and proposals. I thank PD. Dr. Nathaniel Finney for 
reading my dissertation and all his kindness for my life and study. I thank PD. Dr. 
Anthony Linden for his work on the crystal structures. 
All the members of the Dorta group are wonderful. I wish to thank them for 
their help and support: Dr. Natalie M. Scott, Dr. Chirara Costabile, Dr. Ludovic 
Vieille-Petit, Ronaldo Mariz, Michele Gatti, Emma Drinkel, Linglin Wu, Carine 
Robert and Justus Bürgi. 
 
 V 
Zusammenfassung 
 
Die Entwicklung von N-heterozyklischen Carbenen (NHCs) als Liganden für 
Übergangsmetallkatalysatoren hat zu vielen neuen Errungenschaften in der homogenen 
Katalyse beigetragen. Um die Familie von unterschiedlichen NHC Liganden zu 
erweitern, werden in der vorliegenden Dissertation folgende Ergebnisse präsentiert: (1) 
Eine Klasse von gesättigten NHC Liganden mit Naphthyl-basierten Seitenketten und 
ihre gute Performenz in drei unterschiedlichen katalytischen Reaktionen, und (2) eine 
Reihe von chiralen NHC Liganden, welche aus C2-symmetrischen Diaminen mit 
Naphthylseitenketten dargestellt wurden, sowie die erfolgreiche Anwendung der 
entsprechenden Palladiumkomplexe in der asymmetrischen Synthese von Oxindolen 
mit quaternären Kohlenstoffzentren. 
Das zweite Kapitel beschreibt die Synthese und Charakterisierung von leicht 
zugänglichen und stabilen NHCs, die mit Naphthyl in der Seitenkette substituiert 
sind. Bei der Anwendung in der Katalyse wurden exzellente Resultate in Palladium-
basierten Kupplungsreaktionen, in der Ruthenium-basierten Metathese sowie in der 
organokatalytischen Ringöffnungsalkylierung von Epoxiden erhalten. Im dritten 
Kapitel wurde die Untersuchung der NHCs zum entsprechenden chiralen Gegenstück 
ausgeweitet indem die Chiralität von C2-symmetrischen Diaminen für das 
heterozyklische Rückgrat genutzt wurde. Die zugehörigen Palladiumkomplexe mit 
diastereomerenreinen NHC Liganden wurden aufgetrennt und in der asymmetrischen 
Synthese von 3-Aryl-3-methyl-oxindolen getestet. Hierbei zeigten die katalytischen 
Daten einen drastischen Einfluss auf die Enantioselektivität je nach der Orientierung 
der Seitenkette. Das vierte Kapitel befasst sich mit einem anderen ähnlichen NHC 
Liganden, der die asymmetrische Synthese von 3-Allyl-3-aryl-oxindolen mit einer 
hohen Chemo- und Enantioselektivität begünstigen konnte. 
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Abstract 
 
The recent development of N-heterocyclic carbenes (NHCs) as ligands for 
transition metal catalysts has proved to be very fruitful in the field of homogeneous 
catalysis. In order to expand the family of versatile NHC systems for catalysis, this 
dissertation presents: (1) a class of saturated NHC ligands with naphthyl-derived side 
chains and their good performance in three different types of catalysis, and (2) a series 
of chiral NHC ligands derived from C2-symmetric diamines with naphthyl side chains 
and the successful applications of their palladium complexes in the asymmetric 
synthesis of oxindoles bearing quaternary carbon centers. 
Chapter 2 describes the synthesis and characterization of a new class of easily 
accessible and stable NHCs which incorporate substituted naphthyl side chains. In 
catalysis, excellent catalytic results are obtained in palladium-based coupling 
reactions, in ruthenium-based metathesis, and in the organocatalytic ring-opening 
alkylation of epoxide. In Chapter 3, the NHC study was expanded to their chiral 
counterparts by introducing the chiral regime of C2-symmetric diamines into their 
heterocyclic backbone. Palladium complexes bearing diastereomerically pure NHC 
ligand were separated and tested in the asymmetric synthesis of 3-aryl-3-methyl-
oxindoles. The catalytic data demonstrates the dramatic effects on enantioselectivity 
according to the orientation of the side chains. Chapter 4 addresses another similar 
chiral NHC ligand which could promote the asymmetric synthesis of 3-allyl-3-aryl-
oxindoles with high chemo- and enantioselectivity. 
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Chapter 1 
 
Introduction 
 
What is a carbene? A carbene is an electron-deficient two-coordinate carbon 
compound with two non-bonding electrons. There are two states of carbenes 
according to the alignment of the two electrons: 1) ground state—the two unshared 
electrons are in the same orbital with antiparallel spins, also called singlet carbene; 2) 
excited state—the two electrons are in two different orbitals with parallel spins, also 
called triplet carbene) (Figure 1). 
 
R'
R
R'
R
singlet triplet
Figure 1. Singlet and triplet carbenes. 
 
For a long time, carbenes were considered to be too reactive to be isolated, 
and the majority of carbene research was focused on transition metal carbene 
complexes. Metal carbene complexes are often classified into two types. The "Fischer 
carbenes", named after Ernst Otto Fischer, feature strong !-acceptors at the metal and 
are electrophilic at the carbene carbon atom.1 "Schrock carbenes," named after 
Richard R. Schrock, are characterized by a more nucleophilic carbene carbon center; 
this species typically feature higher valent metals.2 (Figure 2) 
 
Figure 2. Fischer and Schrock carbenes.
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Fischer carbene metal complexes have proven to be very efficient and 
extraordinarily versatile starting materials for carrying out a wide range of 
cycloaddition reactions, which give rise to a great array of aromatic and heterocyclic 
ring systems with a high degree of selectivity in most cases. For example, the Wulff-
Dötz reaction is the chemical reaction of an aromatic or vinylic alkoxy pentacarbonyl 
chromium carbene complex with an alkyne and carbon monoxide to give a Cr(CO)3-
coordinated substituted phenol (Scheme 1).3 The need to employ stoichiometric 
amounts of a Fischer carbene complex is, perhaps, the major drawback of these 
synthetically useful molecules and this has, most likely, been hampering their 
practical application in organic synthesis. Nevertheless, efforts to perform the 
chemistry of Fischer carbene complexes using catalytic amount of the metal are under 
way and some limited success has been achieved.4 
 
Scheme 1. Wulff-Dötz reaction.
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In contrast, Schrock carbene metal complexes have had a major impact in the 
field of catalysis. Especially valuable was the use of several Schrock carbene metal 
complexes for olefin metathesis, which opened up a new era of olefin metathesis and 
resulted in the 2005 Nobel Prize in Chemistry. Two research groups have mainly 
invented these catalysts: Schrock introduced tungsten and molybdenum alkylidene 
catalysts, which are commonly called “Schrock catalysts”; 5  Grubbs developed 
ruthenium benzylidene catalysts, which are named as “Grubbs catalysts”6 (Figure 3). 
These discoveries have triggered extensive follow-up work, and these achievements 
definitely represent a great treasure for the chemical community. 
 
Schrock catalyst Grubbs catalyst
Figure 3. Typical Schrock catalyst and Grubbs catalyst.
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Despite those advances in metal-carbene chemistry, it was not until 1991 that 
Arduengo et al. were able to isolate the first free carbene.7 The free carbene unit was 
part of an N-heterocycle hence its name N-heterocyclic carbene (NHC). The free 
NHC IAd shown in Figure 4 is stable in the absence of oxygen and moisture, and 
could be handled easily being a crystalline, singlet, and electron-rich carbene. In 
comparison to a typical Fischer carbene, NHC–metal complexes contain the chemical 
bonding based on electron "-type donation group of the filled methylene lone pair 
orbital to an empty metal d-orbital but no ! electron back bonding of a filled metal d-
orbital to the empty p-orbital on carbon, leaving a p orbital vacant. The lone electron 
pairs at the two adjacent nitrogen atoms could contribute to stabilizing the vacant 
orbital of the carbene center by formation of a three-center four-electron ! system. 
Hence, a combination of !-donor for the metal center and a !-acceptor for the two 
nitrogen atoms preserves the electron neutrality of the carbene center by an electronic 
push-pull mechanism. As a result, the bond between the metal and the NHC is usually 
presented as a single bond, which is quite unlike the double bond description in the 
Fischer and Schrock carbene metal complexes. This type of carbenes is stabilized 
both electronically and sterically, and offers great opportunity for other variations. 
N N
N
N
N
N
R
R R
R
N
N
R
R
IAd
Figure 4. The first stable free carbene.  
 
Indeed, the last decade has unimpeachably witnessed the fruitful use of N-
heterocyclic carbenes (NHCs) as spectator or active ligands for transition-metal 
catalysts and as organic catalysts on their own (Figure 5).8 Owing to their strong !-
donor and weak !-acceptor properties, NHCs have appeared as attractive and versatile 
alternatives to the ubiquitous tertiary phosphine ligands in many metal-catalyzed 
processes. In contrast to the extensively used phosphine complexes, most of the 
complexes formed with these ligands are stable towards heat, air, and moisture.9 
Indeed, N-heterocyclic carbenes are tightly bound to the meal, thereby avoiding 
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decomposition pathways or deposition of free (and inactive) metal under catalytic 
conditions. 10  These compounds were shown by infrared spectroscopy of their 
carbonyl derivatives to be very powerful !-donors, even better than the most basic 
tertiary phosphines.11 This, along with their easy steric modification, has resulted in 
intense research over the last decade. Nevertheless, truly viable and versatile NHCs 
are limited to monodentate aryl-substituted imidazol-2-ylidenes (2,4,6-mesityl-
substituted IMes and 2,6-isopropylphenyl-substituted IPr) and their saturated 
imidazolin-2-ylidene counterparts (SIMes and SIPr) (Figure 6). 
NN
iPriPr
iPr iPr
Ru
PCy3Cl
Cl
Ph
NN
Pd
Cl
Ph
NN
Cu
Cl
NN
iPriPr
iPr iPr
Au
Cl
NN
iPriPr
iPr iPr
Figure 5. Examples of some successful catalysts using NHCs. 
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NN NN
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iPr iPr
NN
iPriPr
iPr iPr
IMes IPr
SIMes SIPr
Figure 6. The most common NHCs.  
 
To improve the understanding of chemical bonding in these metal complexes 
containing N-heterocyclic carbene ligands, the principle of isolobal analogy was 
incorporated. 
The isolobal analogy in organometallic chemistry proposed by Roald 
Hoffmann is recognized by half of the 1981 Nobel Prize in Chemistry,12 and it aims to 
build bridges between the MLn fragments from the inorganic world and the AHn 
fragments in the organic world. Two fragments are deemed to be isolobal if the 
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number, symmetry properties, approximate energy and shape of the frontier orbitals 
and the number of electrons in them are similar. The isolobal relationship is 
symbolized by a double-headed arrow with half an orbital below. 
MLn AHn
 
If two fragments are isolobal then they should have quite similar bonding 
capabilities. If molecules are isolobal then they should have very similar electronic 
structures. The isolobal analogy is helpful to provide simple ways to classify 
molecules and a short-cut to understand their electronic structures, to predict new 
hopefully stable molecules, and to offer clues about reactivity and reaction 
mechanisms. 
The generation of isolobal fragments starts with saturated (molecules where 
all bonding and nonbonding MOs are filled and the antibonding MOs are empty) 
molecules of any sort. For example, main group fragments can be generated by 
starting from methane or any molecule obeying the octet rule; the transition metal 
fragments are generated in an analogous way, from the starting point of any molecule 
obeying the eighteen electron rule. A representative isolobal scheme generated by this 
approach is shown below (Scheme 2). 
C
H
H
H
H Cr
L
LL
L
L L Mn
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Fe
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L = Neutral ligand
Scheme 2. Isolobal fragments.  
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The number of starting points is nearly infinite! One can also go up or down in 
the Periodic Table: 
CH2 SiH2 Fe(CO)4 Ru(CO)4
CH3 BH3 Fe(CO)5 Mo(CO)5
 
Furthermore, the number of electrons in the frontier orbitals can be adjusted to 
form other relationships: 
CH3 BH3 Cr(CO)5 Mn(CO)Cl
CH CpCo Ni(PR3)Fe(CO)3
 
Due to Hoffmann’s great contribution, the fundamentals of the isolobal 
analogy have now been exposed. Just how far reaching the relationships are, is shown 
below: 
Table 1. Isolobal Analogies 
Transition Metal Coordination Number on which Analogy is Based Organic 
Fragment 9 8 7 6 5 
CH3 d1ML8 d3ML7 d5ML6 d7ML5 d9ML4 
CH2 d2ML7 d4ML6 d6ML5 d8ML4 d10ML3 
CH d3ML6 d5ML5 d7ML4 d9ML3  
 L = neutral two electron ligand 
Based on the similar electronic structures of phosphine ligands (PR3) and 
NHC ligands, they could be said to be isolobal. Therefore, they should possess very 
similar bonding capabilities towards metal centers, and NHC–metal bonds could be 
defined as single bonds in comparison with the well-accepted P–metal single bonds. 
Moreover, the parent metal complexes containing phosphine ligands and NHC ligands 
are also isolobal. Some examples are shown as follows: 
NN
SIMes
P
PCy3  
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Ru
PCy3Cl
Cl
Ph
NN
Grubbs II
Ru
PCy3
PCy3Cl
Cl
Ph
Grubbs I  
Development of new valuable NHC ligand architectures is a logical extension 
in this field. We therefore decided to target a new class of saturated, five-membered 
NHCs that bear two identical, modified naphthyl substituents at the two nitrogen 
positions. Due to the hindered rotation about the C–N bond, the incorporation of two 
naphthyl moieties should in principle give rise to two atropisomers with chiral C2-
symmetric (anti) and achiral Cs-symmetric (syn) conformations (eq 1). We reasoned 
that the fluxionality of the resulting ligands might be tunable by adjusting the size of 
the substituents at the 2- and 7-positions of the naphthyls. Once the barrier to rotation 
is high enough, the atropisomers would offer the potential for separation and 
resolution and could subsequently be used in catalytic enantioselective 
transformations. We also anticipated that complexation of NHCs to a metal center 
should increase the barrier to rotation in the atropoisomeric unit so that the isomers 
would, in principle, be separable at that stage. 
NN
R1
R2
R1
R2
NN
R1R
1
R2 R2
anti syn
?23
4
5
6 7
8
 
The objective of the work described in this dissertation is to develop this new 
family of promising NHC ligands for homogeneous catalysis, especially for 
asymmetric catalysis. 
In chapter 2, we outline the synthetic efforts that led to the development of this 
new class of NHC ligands together with an in depth analysis of their fluxional 
behavior. We also report rare examples of crystallographically characterized, 
saturated NHC compounds. Furthermore, we discuss their stability as monomers both 
experimentally and by using a newly developed computational method that allows 
one to predict monomer-dimer equilibria of NHCs.13 Finally, we demonstrated the 
versatility of the new NHC ligands in metal-catalyzed reactions and as 
organocatalysts. Whereas palladium based systems investigated show comparable 
activity to Nolan’s catalysts for C–C and C–N coupling reactions, all NHC ligands 
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studied outperform both SIPr•HBF4 and phosphines in the base-catalyzed alkylation 
of internal epoxides. Excellent activity in ring-closing metathesis indicates that the 
naphthyl-based NHC architectures might indeed represent a good compromise 
between high reactivity with possibly better stability in metathesis reactions involving 
ruthenium complexes. 
In chapter 3 and 4, we focus on expanding the new NHC family to chiral NHC 
ligands for asymmetric catalysis. Based on the chiral regime of C2-symmetric starting 
diamines, the naphthyl-based chiral NHC ligands were readily prepared. Careful 
analysis of the NHC precursors showed the existence of three different isomers in 
such NHC structures. The NHC ligands were then transferred onto palladium while 
maintaining the isomeric ratio, which enabled us to separate these diastereomeric 
compounds via flash chromatography. Palladium complexes bearing diastereomerically 
pure NHC ligands were then tested in the asymmetric synthesis of 3-aryl-3-methyl-
oxindoles and 3-allyl-3-aryl-oxindoles containing chiral quaternary carbon centers. The 
catalytic data demonstrate a dramatic effect on enantioselectivity depending on the 
orientation of the side chains. Satisfactorily, the biologically important oxindoles 
could be obtained with high enatioselectivity (up to 94% ee) when using these new 
NHC-Pd complexes. 
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Chapter 2 
 
Identification and Characterization of a New Family of 
Catalytically Highly Active Imidazolin-2-ylidenes 
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2.1 Abstract 
A new class of easily accessible and stable imidazolin-2-ylidenes has been 
synthesized where the side chains are comprised of substituted naphthyl units. 
Introduction of the naphthyl groups generates C2-symmetric (rac) and Cs-symmetric 
(meso) atropisomers and interconversion between the isomers is studied in detail both 
experimentally and computationally. Complete characterization of the carbenes 
includes rare examples of crystallographically characterized saturated NHC 
structures. Steric properties of the ligands and an investigation of their stability are 
also presented. In catalysis, the new ligands show versatility comparable to the most 
widely used NHCs IMes/SIMes or IPr/SIPr. Excellent catalytic results are obtained 
when either the NHC salts (ring-opening alkylation of epoxides), NHC-modified 
Palladium compounds (C–C and C–N cross-couplings), or NHC–Ruthenium 
complexes (ring-closing metathesis) are employed. In several cases, this new ligand 
family provides catalytic systems of higher reactivity than observed with previously 
reported NHC compounds. 
 
2.2 Introduction 
The introduction of N-heterocyclic carbenes as ligands for transition metal 
catalysts and as organic catalysts on their own has put this class of compounds at the 
forefront of current research efforts.1 Whereas hundreds of NHCs with various 
structural motifs have been synthesized and tested in catalysis, bulky, monodentate 
aryl-substituted imidazol-2-ylidenes (2,4,6-mesityl-substituted IMes and 2,6-
isopropylphenyl-substituted IPr) and their saturated imidazolin-2-ylidene counterparts 
(SIMes and SIPr) still remain the only ligands that represent a truly viable alternative 
to phosphines, both in terms of versatility and reactivity. Presumably, the 
perpendicular arrangement of the aryl side chains, combined with the steric bulk on 
the aromatic rings, leads to a situation where these ligands confer stability to 
unsaturated and reactive metal centers during catalysis and where decomposition of 
the catalyst through unwanted metal–ligand interactions is rarely observed. Equally 
important for their widespread use and success is the simple fact that IMes/SIMes and 
IPr/SIPr are stable as free carbenes, making them easy to handle and manipulate. In 
this context, it is of note that most structures based on saturated imidazolin-2-ylidenes 
dimerize readily to give enetetramines. This renders saturated NHCs considerably less 
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amenable to catalysis and restricts access to stable modifications of this ligand class. 
In fact, the tendency of saturated NHCs towards dimerization is so pronounced that 
very few stable imidazolin-2-ylidenes are known in the literature.2,3 
Herein, we describe the synthesis of a series of saturated NHCs that 
incorporate substituted naphthyl side chains. In order to extend the family of versatile 
NHC systems for catalysis, we reasoned that 2-substituted naphthyl side chains would 
be ideally suited for mimicking the successful architectures of the SIMes and SIPr 
ligand systems (Chart 1). Unexpectedly, the introduction of alkyl-substituents on the 
naphthyl moieties generates atropisomeric ligands with C2-symmetric (rac) and Cs-
symmetric (meso) conformations and we present an in depth study on the 
interconversion of these conformers. Whereas the parent naphthyl-substituted NHC 
ligand proved to be unstable as a free carbene, dimerizing rapidly to form the 
enetetramine, free carbenes of the other structures were generated in high yield and 
were characterized by X-ray crystallography. 
To test the potential and versatility of our imidazolin-2-ylidenes in catalysis, 
we selected applications that include Palladium and Ruthenium catalyzed reactions 
and an example pertinent to their use in organocatalysis. Throughout, the new ligand 
systems show excellent catalytic activities and in a number of cases studied, they 
outperform the existing systems. 
 
N N
C2
N N
Cs
R1
R2
R2
R1
R2
R1
R2
R1
1
23
4
5
6 7
8
R1 = Methyl; SIMes analogue
R1 = Isopropyl; SIPr analogue
(1)N N
R1
C2
R1
R1
SIMes: R1, R2 = Methyl 
SIPr: R1 = Isopropyl; R2 = H
R2R2
R1
 
Chart 1. Imidazolin-2-ylidenes with phenyl (left) and naphthyl (right) side chains. 
 
2.3 Results and Discussion 
2.3.1 Synthesis and Characterization of Naphthyl-based Ligands: The 
synthesis of the imidazolinium salts 3a-3d is summarized in Scheme 1. For both 2,7-
dimethyl- and 2,7-isopropylnaphthalene, we first devised a bromination protocol to 
obtain 1c and 1d. Bromination in dichloromethane with slight cooling and without 
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addition of any catalyst/initiator provided the best results. Under these optimized 
reaction conditions, the initial bromination of the naphthyl derivatives turned out to be 
extremely selective and after workup, 1c and 1d were obtained in quantitative yield. 
Taking 1a-d,4 and following known synthetic procedures,5 gave the saturated NHC 
salts 3a-3d in good overall yield and high purity. Elucidation of SINap·HBF4 [3a; 1,3-
Bis(naphthalen-1-yl)-imidazolin-2-ylidene], SI2MeNap·HBF4 [3b; 1,3-Bis(2-
methylnaphthalen-1-yl)-imidazolin-2-ylidene], SIMeNap·HX [3c (X = BF4)/3c!  (X = 
Cl); 1,3-Bis(2,7-dimethylnaphthalen-1-yl)-imidazolin-2-ylidene; 3c] and SIPrNap·HX 
[3d (X = BF4)/3d! (X = Cl); 1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-imidazolin-2-
ylidene] by 1H and 13C NMR spectroscopy showed that SINap·HBF4 (3a) adopts one 
conformation, while 3b-3d and 3c! /3d!  gave rise to both meso (Cs-symmetric) and 
racemic (C2-symmetric) isomers at room temperature (see discussion below for 
details). Full characterization of these new imidazolinium salts includes single crystal 
X-ray diffraction studies for 3b and 3d!. In both cases, the crystals measured 
correspond to the Cs-symmetric (meso) species and thermal ellipsoid drawings of the 
molecules can be found in Figure 1. 
 
Br
1b
Br
Br
1c
1d
CH2Cl2
Br2
X
SINap.HX (3a, X = BF4)
SI2MeNap.HX (3b, X = BF4)
SIMeNap.HX (3c, X = BF4; 3c', X = Cl)
i), ii)
0°C
N N
R1
R2
R2
R1
C2/Cs-symmetry
Br
1a
SIPrNap.HX (3d, X = BF4; 3d', X = Cl)
 
Scheme 1. Synthesis of imidazolinium salts. Reaction conditions; i) ethylenediamine, 
Pd2(dba)3/2(±)-BINAP (cat.), NaOtBu, Toluene, 100°C; ii) Method A: NH4BF4, 
HCO2H (cat.), HC(OEt)3; Method B: HCl, THF; then HC(OEt)3, MW. 
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Figure 1. Thermal ellipsoid drawings of imidazolinium salts 3b (left) and 3d!  (right). 
The anions and the hydrogen atoms except for the backbone and imidazolinium 
protons are omitted for clarity. 
 
Deprotonation of 3b-3d with NaH and catalytic amounts of potassium tert-
butoxide led to clean formation of the free, monomeric carbenes 4b-4d in high yields 
(Scheme 2). However, attempts to deprotonate SINap·HBF4 (3a) (or SINap·HCl,6) 
with NaH/KOtBu, KH/DMSO or KHMDS invariably led to immediate formation of a 
bright orange solution containing the dimer SINap=SINap (4a) as the sole observable 
product.7 To test the purely qualitative observation that the instability of 4a might be 
due to the lack of the second ortho-substituent found in 4b-4d (the first one being 
represented by the fused aromatic ring), we synthesized and fully characterized 
SIAnt·HBF4 (3e; 1,3-Bis(anthracen-9-yl)-imidazolinium tetrafluoroborate, see 
experimental section). Indeed, deprotonation of this species, with both ortho positions 
‘protected’ by fused aromatic rings, leads to clean formation of monomeric SIAnt 
(4e).8 
According to the 1H NMR and 13C NMR spectra, the deprotonated products 
4a-4c adopt one conformation at 300 K. In the case of dimer 4a, this implies that only 
one of the possible regioisomers is formed. For monomers SI2MeNap (4b) and 
SIMeNap (4c), the results suggest that deprotonation of the imidazolinium salt leads 
to a situation where the naphthyl sidechains are able to freely rotate due to the 
removal of the NHC-H bond. Finally, examination of the free N-heterocyclic carbene 
SIPrNap (4d) by 1H NMR and 13C NMR spectroscopy at 300 K shows two sets of 
signals corresponding to the presence of two isomers in an approximately 5:6 ratio 
(see VT experiments below). Thus, removal of the hydrogen does not seem to alter 
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the initial rac/meso ratio and we can therefore assume that in this case, a high enough 
barrier to rotation between the C2- and Cs-conformations is maintained and no 
interconversion occurs during deprotonation. 
N
N
Ar
Ar
BF4
SINap.HBF4 (3a)
SI2MeNap.HBF4 (3b)
SIMeNap.HBF4 (3c)
SIPrNap.HBF4 (3d)
N
N
Ar
Ar
SINap (transient)
SI2MeNap (4b)
SIMeNap (4c)
SIPrNap (4d)
NaH/cat. KOtBu
THF N
N
Ar
Ar
N
N
Ar
Ar
SINap=SINap (4a)
SIAnt.HBF4 (3e) SIAnt (4e)
or
 
Scheme 2. Deprotonation of imidazolinium salts 3a-e. 
 
The identities of carbene dimer 4a and of the free N-heterocyclic carbenes 4c 
and 4d were unambiguously established by single-crystal X-ray crystallography 
(Figure 2). Crystals of 4a were obtained by slow evaporation of a saturated THF/Et2O 
solution. The solid state structure of 4a shows a strongly distorted carbene dimer, 
consistent with the structure of N,N',N'',N'''-tetraphenyl-bis(1,3-imidazolidin-2-
ylidene).9 The side view of the molecule reveals a small tetrahedral distortion at the 
nitrogen positions and non-planar 5-membered N-heterocycles. Similar distortions in 
related enetetramines have been documented in the literature and render the nitrogen 
atoms reactive and accessible, for example, to ready protonation of this type of 
molecule.10 Crystals of 4c suitable for X-ray analysis were obtained by slow 
evaporation of a saturated Et2O solution, and crystals of 4d were grown from 
saturated pentane/Et2O solutions. In the solid state, SIMeNap (4c) shows its meso 
form, while the measured SIPrNap (4d) crystal corresponds to the racemic C2-
symmetric conformer. A comparison of bond lengths and angles with the only two 
other crystallographically characterized saturated NHCs, namely Arduengo’s 
SIMes,2a and Denk’s SItBu,3a reveals a similar bonding situation for 4c and 4d. The 
N(1)–C(2)–N(3) angles [104.8(2)°; 4c and 104.5(2)°; 4d] are identical to SIMes 
[104.7(3)°], but slightly smaller than in SItBu [106.44(9)°]. A clear difference can be 
seen in the planarity of the N-heterocycle. Whereas the backbone carbon atoms in 
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SIMes and SItBu deviate measurably from the plane of the other three ring atoms, the 
N-heterocycles in 4c and 4d are almost perfectly planar. 
 
 
Figure 2. Thermal ellipsoid views of the SINap=SINap (4a, left), meso-SIMeNap (4c, 
middle) and rac-SIPrNap (4d, right). Hydrogen atoms on the side chains are omitted 
for clarity. 
 
2.3.2 Variable-Temperature 1H NMR Studies: VT 1H NMR studies were 
performed in order to obtain more information on the dynamic behavior of the 
imidazolinium salts and the free imidazolin-2-ylidenes. Figure 3 schematically 
represents the rotation about the C–N bonds and color codes show the hydrogen 
atoms likely to be affected by the rotation. 
 
N N
R1
R2
R2
R1
H HHH
H8
H8
N N
R1
R2
R2
R1
H HHH
H8
H8
Him
 
Figure 3. Schematic representation of the interconversion between the atropisomers. 
 
Imidazolinium salts: VT 1H NMR spectra of SINap·HBF4 (3a) were measured 
in acetone-d6 in the temperature range of 183-303 K. Only one set of signals was 
observed for the whole temperature range, meaning that the naphthyl substituents are 
rotating freely even at low temperature (183 K).  
VT 1H NMR spectra of SI2MeNap·HBF4 (3b) show coalescence of the 
carbenic proton signals [" 8.17 (Him-C2) and 8.36 (Him-Cs) ppm] at 370 K (DMSO-
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d6), and above 380 K the protons of H8 (green) and the NHC backbone protons (red) 
appear as broad singlets, indicating fast interconversion. 
 
Figure 4. VT 1H NMR spectra (500 MHz) of SIMeNap·HBF4 (3c, left) and 
SIMeNap·HCl (3c! , right) in C2D2Cl4. 
 
VT 1H NMR studies with different solvents (DMSO-d6 and C2D2Cl4) have 
been carried out for SIMeNap·HBF4 (3c) and its chloride analogue, SIMeNap·HCl 
(3c!). In this case, the 1H NMR spectrum of the imidazolinium chloride salt 3c!  is 
identical to that of its corresponding tetrafluoroborate salt 3c in DMSO-d6. However, 
significant differences between the spectra of 3c and 3c!  in C2D2Cl4 at 303K were 
observed (Figure 4). The signals of the imidazolinium proton in 3c!  shift to 
significantly lower magnetic field (ca. 1.0 ppm) with respect to the value for 3c, 
presumably reflecting an increased contribution of hydrogen bonding between the 
Him-proton and the chloride anion. When raising the temperature to the coalescence 
temperature, we find that both the nature of the counteranion (BF4- resp. Cl-) as well 
as the choice of the solvent (DMSO-d6 or C2D2Cl4) do not affect the ease of 
interconversion for 3c and 3c! . Furthermore, the process is almost not affected by the 
introduction of the 7-methyl group and coalescence temperatures for 
SI2MeNap·HBF4 (3b) and SIMeNap·HBF4 (3c) are practically identical. 
The VT 1H NMR spectra in DMSO-d6 of 3d and 3d!  showed a static behavior, 
with no detectable line-shape modifications up to 420 K. Undoubtedly, the decrease 
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in fluxional behavior is caused by the increased size of the ortho-substituents on the 
naphthyl moieties (isopropyl vs methyl). 
Free NHCs: VT 1H NMR experiments were also performed on solutions of 
4b-4d. In the case of 4b and 4c, interconversion of the two atropisomeric 
conformations at room temperature leads to the observation of a single signal for the 
H8 protons (" = 8.18 ppm for 4b and " = 8.02 ppm for 4c in toluene-d8). Lowering the 
temperature showed gradual broadening of these signals with decoalescene at 273 K 
(4b) and 293 K (4c). The formation of two sets of 1H NMR signals in the slow-
exchange regime is again consistent with the dynamic interconversion between meso- 
and rac-conformers. With SIPrNap (4d), two sets of signals were observed at room 
temperature and fully attributed to the rac and meso forms. By raising the 
temperature, coalescence of the resonance signals at " 8.00 and 8.10 ppm (H8 proton) 
was achieved at 350 K, and above 360 K the signal appeared as a sharp singlet at " 
8.02 ppm (Figure 5). 
 
 
Figure 5. VT 1H NMR spectra (400 MHz) of free carbenes 4c (left) and 4d (right) in 
toluene-d8. 
Activation free Energies: From the VT analyses performed above, we 
calculated activation free energies !G‡ at the coalescence temperature (Tc) for the 
interconversion, using complete line-shape analysis,11 which gave the corresponding 
!G‡ (kJ mol-1) values (Table 1). It is evident from the data that the rotational barriers 
decrease in the order (3d = 3d!) > (3c = 3c!) " 3b > 3a for the salts, and 4d > 4c > 4b 
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for the free NHCs. These trends can be clearly associated with the steric demand of 
the naphthyl side chains. More specifically, substituents at both the 2- and 7-positions 
of the naphthyl moieties affect !G‡, with the 2-position playing a crucial factor 
limiting the rotation about the C–N bond between the side chains and the five-
membered central ring. Moreover, !G‡ decreases by about 20 kJ mol-1 when 
removing the carbenic proton, that is when going from the imidazolinium salts to the 
free carbenes. 
 
Table 1. Values of Tc, the corresponding !G‡’s and DFT values for !G‡. 
Entry Compound Solvent Tc (K) !G‡ (kJ mol-1) DFT !G‡ (kJ mol-1) 
1 3a acetone-d6 < 183 <44.1 30 
2 3b DMSO-d6 370 (H8) 74.6 75 
3 3c C2D2Cl4 353 (Him) 75.5 74 
4 3c!  C2D2Cl4 373 (Him) 75.5 - 
5 3c or 3c!  DMSO-d6 350 (Him) 75.6 - 
6 3d or 3d!  DMSO-d6 > 410 >89.9 80 
7 4b toluene-d8 273 (H8) 56.9 54 
8 4c toluene-d8 293 (H8) 59.8 54 
9 4d toluene-d8 350 (H8) 74.4 70 
 
2.3.3 Calculations on the Chemical/Conformational Stability and Steric 
Characterization of the Ligands: DFT calculations in the solvent phase confirm that 
the rac and meso isomers of 4b-d are of substantially the same energy (within 3 kJ 
mol-1), and this difference is scarcely dependent on the solvent, since calculations in 
THF or toluene resulted in very similar values (within 1-2 kJ mol-1). In excellent 
agreement with the experimental !G‡’s, the DFT barrier in toluene for the 
interconversion of the rac isomer into the meso isomer is quite similar in 4b and 4c 
(around 54 kJ mol-1), and increases to 70 kJ mol-1 in 4d. Rotation in the monomeric 
species SINap, instead, presents the negligible barrier of 3 kJ mol-1. With regards to 
the dimerization of the free NHCs to the corresponding enetetramines, we calculated 
that dimerization of SINap in THF is favored by 15 kJ mol-1, whereas 4b-d were 
calculated to be thermodynamically stable as monomers. However, while 4b and 4c 
are slightly more stable than the dimer (by 10 and 29 kJ mol-1, respectively), 
dimerization of 4d is remarkably unfavored (by 106 kJ mol-1). Similar excellent 
agreement between the DFT and the experimental values is obtained for the rotational 
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barriers in the 3a-3d salts. In all cases, the salts present a barrier to rotation roughly 
20 kJ mol-1 higher than in the corresponding free NHC. 
These results clearly support the idea that the behavior of SINap and 4b-4d is 
determined by the nature of the group in position 2 of the binaphthyl framework. With 
a hydrogen atom in this position, such as in SINap, rotation around the N–naphthyl 
bond is completely free, and dimerization to the enetetramine SINap=SINap (4a) is 
favored. With a methyl group in this position, such as in 4b and 4c, rotation around 
the N–naphthyl bond presents a moderate barrier, and dimerization is moderately 
disfavored. Finally, with a bulky isopropyl group in this position, such as in 4d, 
rotation around the N–Ar bond is frozen at room temperature, and dimerization is 
clearly unfavored. 
Table 2. Steric parameter %VBur corresponding to SINap and 4b-4d. 
%VBur 
Entry NHC 
rac-isomer meso-isomer 
1 SINap 26 26 
2 SI2MeNap (4b) 28 27 
3 SIMeNap (4c) 29 28 
4 SIPrNap (4d) 31 31 
5 IMes 
6 SIMes 
7 IPr 
8 SIPr 
26[a] 
27[a] 
29[a] 
30[a] 
[a] Values taken from ref. 13.  
 
To further characterize this new ligand family, we calculated the percent of 
buried volume %VBur, a molecular descriptor that can be considered as an analogue of 
Tolman’s cone angle for tertiary phosphines,12 and that can be successfully used to 
classify the steric properties of NHC ligands.13,14 Table 2 shows that the %VBur of 
SINap is smaller than the value previously calculated for SIMes (%VBur = 27), while 
%VBur of 4b and 4c indicate a slightly bulkier nature than their mesityl-substituted 
counterparts. It is of interest to note that the %VBur of the meso isomer is usually 
smaller than that of the rac isomer. Finally, the %VBur of SIPrNap (4d) is somewhat 
larger than the %VBur of the SIPr ligand (%VBur = 30). In short, this analysis confirms 
the starting hypothesis that 4b and 4c should substantially mimick the IMes/SIMes 
ligands, while the steric requirements of 4d are best compared to the SIPr ligand. 
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2.3.4 Catalytic Applications: Palladium Catalysis. Pioneering work by 
Nolan et al. has shown that NHC–modified Pd–allyl catalysts are extremely active 
systems in various cross-coupling reaction protocols.15 By following their 
experimental procedure, addition of [Pd(allyl)Cl]2 to free carbenes 4b-d gave high 
yields of rac/meso mixtures of our compounds with general formula 
(NHC)Pd(allyl)Cl (5b-d). Attempts to separate these rac/meso mixtures via column 
chromatography using a variety of different eluents were unsuccessful and the 
compound mixtures were recovered unchanged. In contrast, repeated crystallization 
from CH2Cl2/hexane and ethyl acetate/hexane (see Experimental  Section) enabled the 
separation of both 5c and 5d into meso-5c, rac-5c, and meso-5d, rac-5d respectively. 
NMR analyses gave distinct signals for the rac and meso complexes and to assign 
their conformation unambiguously, the crystal structures of all four compounds were 
determined (Figure 6). As could be anticipated from the studies on our NHC salts, the 
formation of the NHC–metal bond efficiently freezes the rotation around the C–N 
bonds of the NHC side chains. 
 
 
Figure 6. Crystal structures of (meso-SIMeNap)Pd(allyl)Cl (meso-5c, top left), rac-
SIMeNapPd(allyl)Cl (rac-5c, top right), (meso-SIPrNap)Pd(allyl)Cl (meso-5d, bottom 
left), and rac-SIPrNapPd(allyl)Cl (rac-5d, bottom right). 
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Considering the excellent performance of DFT in reproducing the 
experimental rotational barrier between the rac and meso isomers in the free NHCs, 
we used the same approach to predict the rac to meso rotational barrier in the 
catalytically active compounds, presumed to have the formula (NHC)Pd(0). Even for 
the less encumbered (SI2MeNap)Pd(0) and (SIMeNap)Pd(0) intermediates we found 
a high barrier for rotation (102 and 103 kJ mol-1 in toluene), which suggests that the 
respective symmetry of the ligands (rac or meso) should be retained during catalysis. 
 
Initial catalytic studies with our palladium complexes indicated that the 
reactivity of meso-5c (meso-5d) is essentially the same as the reactivity seen for rac-
5c (rac-5d) (see Supporting Information). For convenience, all of the following 
catalytic applications were therefore run with rac/meso mixtures of the precatalysts. 
Rather bulky substrates were chosen in the Suzuki-Miyaura cross-coupling reactions 
of aryl chlorides (Table 3, entries 1-20). Especially when both coupling partners are 
ortho-substituted (entries 1-10), our naphthyl-based catalysts perform better than the 
corresponding (SIMes)Pd(allyl)Cl [SIMes-Nolan] and (SIPr)Pd(allyl)Cl [SIPr-
Nolan] systems and display high activity at 80°C.16 Significant reactivity differences 
between 5b-5d can only be seen when the reactions are run at room temperature, 
where SIPrNap-modified 5d gives better conversions than the catalysts derived from 
methyl-substituted 5b and 5c. In contrast, activity differences are dramatic in the 
Hartwig-Buchwald amination with difficult aryl-chloride substrates (entries 21-31), 
where we see an enormous drop in catalyst performance when moving from the 
SIPr/SIPrNap systems (excellent reactivity) to SIMes-, SI2MeNap- and SIMeNap-
modified palladium complexes, which are rather poor catalysts for the substrates 
studied. In these amination protocols, small changes in the sterics of the NHC ligand 
system seem to have a big impact on the activity of the catalysts and the bulkiest 
systems (SIPr-Nolan and 5d) become the catalysts of choice for these 
transformations.  
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Table 3. Selected Pd-catalyzed C-C and C-N couplings with 5b-d. 
Entry Ar-Cl Amine or B-acid Product
 [c] 
Catalyst  
(1 mol%) 
Time Temp. Yield[a] 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
 
 
 
 
 
 SIMes-Nolan 5b  
5c  
SIPr-Nolan 
5d  
SIMes-Nolan 
5b  
5c  
SIPr-Nolan 
5d  
1h 
1h 
1h 
1h 
1h 
16h 
16h 
16h 
16h 
16h 
80°C 
80°C 
80°C 
80°C 
80°C 
RT 
RT 
RT 
RT 
RT 
<5% 
98% 
98% 
59% 
99% 
<5% 
43% 
58% 
57% 
75% 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
 
 
 
 
 
 
SIMes-Nolan 
5b  
5c  
SIPr-Nolan 
5d  
SIMes-Nolan 
5b  
5c  
SIPr-Nolan 
5d  
1h 
1h 
1h 
15min 
15min 
16h 
16h 
16h 
3h 
3h 
80°C 
80°C 
80°C 
80°C 
80°C 
RT 
RT 
RT 
RT 
RT 
82% 
95% 
97% 
86% 
99% 
79% 
75% 
81% 
83% 
98% 
21 
22 
23 
24 
25 
26 
   SIMes-Nolan 
5b  
5c  
SIPr-Nolan 
5d  
5d (0.1 mol%) 
24h 
24h 
96h 
1min 
1min 
6h 
RT 
RT 
RT 
RT 
RT 
RT 
88% 
95% 
89% 
99% 
99% 
95% 
27 
28 
29 
30 
31 
 
 
 
 
 
 
SIMes-Nolan  
5b  
5c  
SIPr-Nolan 
5d  
20h 
20h 
20h 
10min 
10min 
80°C 
80°C 
80°C 
80°C 
80°C 
11% 
23% 
4% 
99% 
99% 
[a] Yields determined by GC against internal standard. Reaction times and conditions of the reference 
systems (SIMes)Pd(allyl)Cl [SIMes-Nolan] and (SIPr)Pd(allyl)Cl [SIPr-Nolan] were chosen 
according to the results for 5b/5c and 5d respectively. 
 
 
 
 
Cl (HO)2B
MeO MeO
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N
Cl HN O N
N
O
Cl HN
N
Chapter 2 
 24 
 
 
2.3.5 Ruthenium Catalysis. One of the most important applications of NHCs 
in metal catalysis is undoubtedly their use as ligands in Ru-catalyzed metathesis 
reactions.17 The general interest in these transformations compelled us to examine 
analogues of Grubbs’ second generation catalyst [RuCl2(SIMes)(=CHPh)(PCy3)],17c 
incorporating ligand systems 4b-d. Synthesis was achieved by simple exchange of 
one phosphine ligand with NHCs 4b-d in toluene.17b Appropriate workup gave 
[RuCl2(SI2MeNap)(=CHPh)(PCy3)] (6b), [RuCl2(SIMeNap)(=CHPh)(PCy3)]  (6c) 
and [RuCl2(SIPrNap)(=CHPh)(PCy3)] (6d) in good yields. We then employed 
catalysts 6b-6d in the ring-closing metathesis of three standard substrates (Table 4, 
entries 1-14). Except for a slightly lower reaction temperature (27°C instead of 30°C), 
standard reaction conditions were used,18 and the conversions were monitored by 1H 
NMR spectroscopy. While the reactivities of 6b and 6c closely resemble that seen 
with SIMes-modified Grubbs II, catalyst 6d gave markedly superior results. In fact, 
6d outperforms Grubbs II by an order of magnitude and RCM of all three substrates 
runs to completion in less than one hour with only 0.1 mol% of 6d, corresponding to 
turnover frequencies for complete conversion at 27°C of up to 2’400 TOF (entry 10). 
Even trisubstituted diolefin linalool reacts readily under these conditions, at the same 
time showing a pronounced induction period that is absent for the other two substrates 
or at 1 mol% catalyst loading (Figure 7). Interestingly, the introduction of alkylated 
naphthyl side chains renders catalysts 6b-d more active towards RCM of 
diethyldimethallyl malonate (entries 15-18).19 In recent years, enhancement of 
reactivities by fine-tuning [RuCl2(SIMes)(=CHPh)(PCy3)] (Grubbs II) have been 
observed and have by and large been achieved by modifying every other entity of the 
precatalyst.20,21,22,23 Unfortunately, such approaches often involve additional synthetic 
steps and are normally exclusive and limited to ruthenium metathesis. On the other 
hand, successful modifications to the NHC structure as presented here with SIPrNap 
may prove valuable in a plethora of other catalytic applications and certainly highlight 
the pivotal role played by the NHC ligand architecture in these systems.24 
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Table 4. RCM of standard dienes employing catalysts 6b-d. 
Entry Diene Product Catalyst Loading (mol%) Temp. t (min) Conv.
[a] 
1 
2 
3 
4 
5 
 
 
Grubbs II 
6b 
6c 
6d 
6d 
1 
1 
1 
1 
0.1 
30°C 
27°C 
27°C 
27°C 
27°C 
42 
70 
65 
17 
52 
98%[b] 
98% 
98% 
98% 
98% 
6 
7 
8 
9 
10 
  Grubbs II 
6b 
6c 
6d 
6d 
1 
1 
1 
1 
0.1 
25°C 
27°C 
27°C 
27°C 
27°C 
90 
54 
28 
10 
25 
98%[c] 
98% 
98% 
100% 
100% 
11 
12 
13 
14 
  6b 
6c 
6d 
6d 
1 
1 
1 
0.1 
27°C 
27°C 
27°C 
27°C 
18 
19 
7 
35 
100% 
100% 
100% 
100% 
15 
16 
17 
18 
 
 Grubbs II 
6b 
6c 
6d 
5 
5 
5 
5 
30°C 
27°C 
27°C 
27°C 
96 h 
72 h 
72 h 
72 h 
17%[b] 
30% 
40% 
31% 
[a] Conversions determined by 1H NMR spectroscopy. For better comparison, a fixed conversion of 
98% was used for entries 1-8. [b] Taken from ref. 18. [c] Taken from ref. 21a. 
 
 
Figure 7. Conversion to product at 27°C with 1 mol% (left) and 0.1 mol% (right) of 
catalyst 6d. Abbreviations used: Mal (Diethyldiallyl malonate), Ts-N (N,N-Diallyl-4-
methyl-benzenesulfonamide), and Lin (Linalool). 
2.3.6 Alkylation of Epoxides. With the excellent catalytic results obtained 
above in both palladium and ruthenium mediated reactions, we finally wanted to see 
whether our systems could also be used as catalytic Lewis bases for the ring-opening 
alkylation of epoxides by alkylaluminum reagents. Initial studies by Schneider et al. 
CO2EtEtO2C CO2EtEtO2C
Ts
N
Ts
N
OH
OH
CO2EtEtO2C
CO2EtEtO2C
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on the use of phosphine and arsine bases in these transformations,25 have more 
recently been followed by Nguyen’s finding that bulky NHC salts could also be 
employed.26 The best NHC-derived catalyst turned out to be a substructure of 
SIPr·HBF4 with two additional methyl groups on the backbone of the N-heterocycle 
(for simplicity, we call this ligand DMSIPr·HBF4), whereas Schneider et al. have 
identified AsPh3 as the best base in their studies. The reactivity of SI2MeNap·HBF4 
(3b), SIMeNap·HBF4 (3c) SIPrNap·HBF4 (3d) is superior to the benchmark catalysts 
reported in the literature (Table 5). In fact, catalytic ring-opening of cyclohexene oxide 
could be easily run with only 1 mol% of catalyst (versus 5 mol% for the reference 
systems) and resulted in products of equal or higher yields (entries 1-6). Even better 
results were obtained with more challenging substrates cyclopentene oxide and 2,3-
butene oxide (entries 7-16). Furthermore, build-up of side products as observed by 
Nguyen et al. with SIPr·HBF4 and DMSIPr·HBF4 was not observed with our catalysts. 
Within our ligand family, we again identify SIPrNap·HBF4 (3d) as the most 
competent substructure, giving almost quantitative yields with all products.  
Table 5. NHC-catalyzed ring-opening alkylation of epoxides. 
O
R R
+
Catalyst
RT, 12-24h
OHEt
R R
AlEt3
toluene
  
Entry Epoxide Product Catalyst 
Loading 
(mol%) 
t (h) Yield[a] 
1 
2 
3 
4 
5 
6 
 
 
 
AsPh3 
SIPr·HBF4 
DMSIPr·HBF4 
3b 
3c 
3d 
5 
5 
5 
1 
1 
1 
24 
12 
12 
12 
12 
12 
94%[b] 
71%[c] 
93%[c] 
98% 
95% 
93% 
7 
8 
9 
10 
11 
  AsPh3 
DMSIPr·HBF4 
3b 
3c 
3d 
5 
5 
1 
1 
1 
24 
12 
24 
24 
24 
75%[b],[d] 
77%[c] 
90% 
91% 
97% 
12 
13 
14 
15 
16 
  AsPh3 
DMSIPr·HBF4 
3b 
3c 
3d 
5 
5 
1 
1 
1 
24 
12 
20 
20 
20 
62%[b] 
53%[c] 
61% 
78% 
96% 
[a] Yields after workup, determined by GC against internal standard. [b] Taken from ref. 25. 
[c] Taken from ref. 26. [d] Reaction conducted at 50°C. 
O
OH
Et
O
OH
Et
O
OH
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2.4 Conclusions 
We have presented a new class of saturated NHC ligands with naphthyl-
derived side chains. An initial, highly selective bromination protocol was devised for 
some of the substituted naphthyl moieties and renders the synthetic pathway to all of 
the imidazolinium salts easy and straightforward. Deprotonation of the salts yielded a 
dimer in the case of SINap, whereas with substituted naphthyl as well as with 
anthracenyl side chains, high yields of the free carbenes and rare examples of 
crystallographically characterized imidazolin-2-ylidenes were obtained. The stability 
of the monomers is explained by using computational methods. In both the NHC salts 
and the free carbenes, introduction of substituted naphthyl side chains gives rise to 
C2-symmetric (rac) and Cs-symmetric (meso) atropisomers. In depth experimental 
and computational analyses for the interconversion between the two isomers showed 
that as soon as the NHC carbon atom is bound to either a hydrogen (for the NHC salt) 
or a metal (NHC-Pd), the rotation around the C-N bonds becomes highly unfavorable. 
At the outset of the present study, we sought the identification of viable N-
heterocyclic carbene alternatives to the widely used and versatile IMes/SIMes and 
IPr/SIPr architectures. The preliminary catalytic results presented here exceeded our 
expectations. Not only were we able to demonstrate that this new naphthyl-based 
NHC ligand family presents similar versatility to the reference systems and can (at 
least) be employed in palladium-based coupling reactions, in ruthenium-based 
metathesis and in the organocatalytic ring-opening alkylation of epoxide, but more 
importantly, we were able to show that catalytic activities were at least as high or 
higher than in the reference systems. In the palladium-catalyzed reactions, generally 
better reactivities than with the corresponding SIMes- and SIPr-modified Nolan 
catalysts were obtained, with SIPrNap outperforming the methyl-substituted ligands. 
Better still, the naphthyl-substituted NHCs described here are the catalysts of choice 
for the organocatalytic ring-opening alkylation of epoxides, giving higher yields of 
products at lower catalyst loadings than the reference systems described in the 
literature. Of possibly even greater significance is the identification of precatalyst 
[RuCl2(SIPrNap)(=CHPh)(PCy3)] (6d) as a rapidly initiating species in metathesis. In 
fact, the preliminary results here show that 6d outperforms Grubbs II in the ring-
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closing metathesis by an order of magnitude, making it a very appealing alternative to 
existing catalyst systems. 
One of our long-term goals is the identification of a family of broadly 
applicable chiral NHC ligands and we believe that the unique architecture of the 
naphthyl-based N-heterocyclic carbenes we describe here presents an ideal starting 
point for such a study.  
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2.5 Computational Part 
The density functional calculations were performed on all the systems at the 
GGA level with the Gaussian03 set of programs.27 For the BP86 calculations, gradient 
corrections were taken from the work of Becke and Perdew.28 The electronic 
configuration of the molecular systems was described by the triple-# basis set with 
polarization functions of Ahlrichs and co-workers (TZVP basis set in gaussian03).29 
Solvent effects including contributions of non electrostatic terms have been estimated 
in single point calculations on the gas-phase optimized structures, based on the 
polarizable continuous solvation model PCM, default keyword SCRF = (Solv = X) 
with X = THF, toluene, acetone or methanol, in gaussian03.30 Transition states for the 
rac/meso isomerization were approached by rotating the R1 group around the N-R1 
bond in 10° steps. Full transition state searches were started from the maximum of 
this curve, and frequency calculations were performed on the final geometries to 
confirm the presence of only one negative value. The free energy barrier in solution 
was obtained as the free energy in the gas-phase corrected by the free-energy of 
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solvation through single-point calculations with the PCM approach, on the rac isomer 
and on the transition state geometry. 
The dimerization energies have been calculated as the energy difference 
between the optimized geometries of the dimer NHC=CHN and of two monomers 
NHC, as shown in eq. S1. 
                                       2 NHC:  ! NHC=CHN + –Edim.                     (S1) 
Calculations have been performed with the gaussian03 package at the BP86 level of 
theory together with the TZVP basis set. Solvent effects were estimated through 
single-point calculations with the PCM approach on both the monomer and the dimer. 
To validate this approach we calculated the dimerization energy of the NHC S1, 
whose free energy of dimerization, about 5 kcal/mol in diglyme at 298 K, has been 
determined experimentally.31 
N
N
Et
Et
S1  
With our approach in THF, we calculate an Edim = 7.3 kcal/mol for S1, which 
is rather close to the experimental value, and substantially validate our strategy for the 
calculation of the dimerization energy. 
 
2.6 Experimental Part 
General Information. All reactions were carried out under a nitrogen 
atmosphere using Standard Schlenk-lines or gloveboxes (Mecaplex or Innovative 
Technology). All reagents were used as received unless otherwise noted. Solvents 
were purchased in the best quality available, degassed by purging thoroughly with 
nitrogen and dried over activated molecular sieves of appropriate size. Alternatively, 
they were purged with argon and passed through alumina columns in a solvent 
purification system (Innovative Technology). Solvents for NMR spectroscopy were 
degassed with nitrogen and dried over molecular sieves. NMR spectra were recorded 
on AV2 400 or AV2 500 MHz Bruker spectrometers. Multiplicities are abbreviated as 
follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet (dd), quintet 
(quint), septet (sept), multiplet (m), and broad (br). High-resolution mass spectra 
(HRMS) were performed on a Finnigan MAT 95 (Finnigan MAT95, San Jose, CA; 
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USA) double-focusing magnetic sector mass spectrometer (geometry BE). ESI mass 
spectra were performed on a triple stage quadrupole instrument (Finnigan TSQ 700, 
San Jose, CA; USA), equipped with a combined Finnigan Atmospheric Pressure Ion 
(API) source. GC-MS analysis was done on a Finnigan Voyager GC8000 Top. GC 
analyses of reaction mixtures were carried out on a Trace GC 2000 equipped with an 
FID detector. The column used was a 30-m ZB-5 capillary column with 0.25-mm 
inner diameter and 0.25-µm film thickness. Flow rate = 1.5 mL/min for He carrier 
gas. GC yields were determined through integration of the product peak against 
internal standard using pre-established response factors. Retention times for various 
components of the reaction mixture were assigned by injection of a pure sample of 
each component. X-ray crystallography was performed on a Nonius Kappa CCD area-
detector diffractometer using graphite-monochromated Mo K! radiation (# = 0.71073 
Å) and an Oxford Cryosystems Cryostream 700 cooler. N,N-Diallyl-4-
methylbenzenesulfonamide was prepared according to a literature procedure.32  
 
N,N!-Bis(naphthalen-1-yl)ethane-1,2-diamine (2a). A 100 mL two necked flask 
was charged with Pd2(dba)3 (65 mg, 0.07 mmol), (±)-BINAP (88 mg, 0.14 mmol), 
NaOtBu (410 mg, 4.26 mmol) and toluene (25 mL) in the glovebox. 1-
bromonaphthalene (1a) (417 $L, 2.98 mmol) and ethylenediamine (95 $L, 1.42 
mmol)) were added by syringe outside the glovebox. The reaction mixture was stirred 
at 100°C for 17 h under nitrogen. After cooling to room temperature, it was filtered 
through a silica gel filter, washed with 300 mL hexane and the product was collected 
by washing with 400 mL CH2Cl2. The CH2Cl2 fraction was dried by rotavapor to give 
421 mg (95%) of 2a as a yellow oil. 1H NMR (CDCl3, 400 MHz): " 7.82-7.77 (m, 
4H), 7.47-7.37 (m, 4H), 7.36 (d, J = 7.8 Hz, 2H), 7.28 (d, J = 7.3 Hz, 2H), 6.74 (d, J = 
7.8 Hz, 2H), 4.64 (br s, 2H), 3.72 (s, 4H); 13C NMR (CDCl3, 100 MHz): " 142.87, 
134.56, 128.90, 126.65, 126.13, 125.31, 124.02, 120.24, 118.83, 105.74, 43.93. 
HRMS (EI) m/z calculated for C22H20N2 [M]+ 312.1626, observed 312.1622. 
1,3-Bis(naphthalen-1-yl)-imidazolinium tetrafluoroborate (SINap·HBF4) (3a). 
Triethyl orthoformate (18 mL) was added to the diamine (2a) (470 mg, 1.50 mmol) in 
a 50 mL Schlenk flask equipped with a distillation head. To this solution were added 
NH4BF4 (157 mg, 1.50 mmol) and 2 drops of formic acid. The reaction was heated to 
100 °C and stirred for 12 h. Upon cooling to room temperature, the white precipitate 
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was collected by filtration, washed with Et2O and pentane and dried in vacuo to yield 
449 mg (73%) of the title product. 1H NMR (DMSO-d6, 400 MHz): " 9.53 (s, 1H), 
8.41 (d, J = 8.3 Hz, 2H), 8.18-8.13 (m, 4H), 7.98 (d, J = 7.0 Hz, 2H), 7.82-7.78 (m, 
2H), 7.75-7.71 (m, 4H), 4.78 (s, 4H). 13C NMR (DMSO-d6, 100 MHz): " 159.76, 
133.92, 132.43, 130.15, 128.60, 128.14, 127.85, 127.27, 125.72, 124.62, 122.38, 
53.65. 19F NMR (DMSO-d6, 376.4 MHz): -148.28, -148.33. HRMS (ESI) m/z 
calculated for C23H19N2 [M-BF4]+ 323.1548, observed 323.1547. 
2-(1,3-Di-1-naphthalenyl-2-imidazolidinylidene)-1,3-di-1-naphthalenyl-
imidazolidine (4a). A suspension of NaH (26 mg, 1.10 mmol) and KOtBu (6 mg, 
5.00 $ 10-2 mmol) in 10 mL THF was added to a suspension of SINap%HBF4 (3a) (410 
mg, 1.00 mmol) in 10 mL THF. The reaction was stirred for 2 h at rt in the glovebox, 
filtered through celite and dried in vacuo to yield 200 mg (62%) of a red solid. 
Crystals suitable for an X-ray diffraction study were grown from a THF/Et2O 
solution. 1H NMR (THF-d8, 400 MHz): " 7.71-6.82 (m, 28H), 3.90 (br, 4H), 3.15 (br, 
4H); 13C NMR (THF-d8, 100 MHz): " 145.38, 135.43, 130.47, 127.88, 125.87, 
125.26, 124.77, 124.64, 123.93, 120.35, 112.88, 55.20.  
N,N!-Bis(2-methylnaphthalen-1-yl)ethane-1,2-diamine (2b). In the glovebox a 100 
mL two necked flask was charged with Pd2(dba)3 (114 mg, 0.12 mmol), (±)-BINAP 
(156 mg, 0.25 mmol), NaOtBu (720 mg, 7.50 mmol), 1-bromo-2-methylnaphthalene 
(1b) (1.16 g, 5.25 mmol) and toluene (50 mL). Ethylenediamine (167 $L, 2.50 mmol) 
was added by syringe outside the glovebox. The reaction mixture was stirred at 100°C 
for 16 h under nitrogen. It was then plugged through a silica gel filter, washed with 
CH2Cl2, concentrated in vacuo, and the residue was purified by flash chromatography 
using CH2Cl2 as eluent to yield 760 mg (89%) of 2b as a yellow oil. 1H NMR (CDCl3, 
400 MHz): " 8.18 (d, J = 7.9 Hz, 2H), 7.81 (d, J = 7.9 Hz, 2H), 7.51 (d, J = 8.4 Hz, 
2H), 7.49-7.40 (m, 4H), 7.31 (d, J = 8.4 Hz, 2H), 3.92 (br s, 2H), 3.48 (s, 4H), 2.49 (s, 
6H). 13C NMR (CDCl3, 100 MHz): " 142.02, 133.57, 129.41, 128.67, 128.39, 125.85, 
125.57, 124.93, 122.92, 122.57, 50.51, 18.29. HRMS (EI) m/z calculated for 
C24H24N2 [M]+ 340.1939, observed 340.1943. 
1,3-Bis(2-methylnaphthalen-1-yl)-imidazolinium tetrafluoroborate 
[SI2MeNap·HBF4] (3b). Triethyl orthoformate (25 mL) was added to the diamine 
(2b) (760 mg, 2.23 mmol) in a 50 mL schlenk flask equipped with a distillation head. 
To this solution were added NH4BF4 (234 mg, 2.23 mmol) and 2 drops of formic acid. 
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The reaction was heated to 100  °C and stirred for 12 h. Upon cooling to room 
temperature, the white precipitate was collected by filtration, washed copious 
amounts of Et2O and dried in vacuo to yield 858 mg (88%) of the title product. 1H 
NMR (DMSO-d6, 400 MHz): " 9.47 (s, 1H), 8.36 (d, J = 8.4 Hz, 1H), 8.17 (d, J = 8.2 
Hz, 1H), 8.12-8.08 (m, 4H), 7.86-7.77 (m, 2H), 7.70-7.61 (m, 4H), 4.90-4.65 (m, 4H), 
2.70 (s, 3H), 2.67 (s, 3H). 13C NMR (DMSO-d6, 100 MHz) (due to the existence of 
two atropisomers, the 13C NMR spectrum is complex): " 164.38, 161.72, 161.60, 
134.20, 134.08, 132.47, 130.28, 130.27, 129.28, 129.27, 129.24, 129.15, 128.97, 
128.93, 128.54, 128.44, 128.30, 128.25, 126.46,121.89, 121.45, 52.44, 52.41, 17.68, 
17.59. 19F NMR (CDCl3 282.4 MHz): -154.03, -154.08. HRMS (ESI) m/z calculated 
for C25H23N2 [M-BF4]+ 351.1861, observed 351.1864. 
1,3-Bis(2-methylnaphthalen-1-yl)-imidazolin-2-ylidene [SI2MeNap] (4b). A 
suspension of NaH (26 mg, 1.10 mmol) and KOtBu (6 mg, 5.00 $ 10-2 mmol) in 10 
mL THF was added to a suspension of SI2MeNap%HBF4 (3b) (438 mg, 1.00 mmol) in 
10 mL THF. The reaction was stirred overnight at rt in the glovebox, filtered through 
celite and dried in vacuo to yield 338 mg (96%) of the white free carbene. 1H NMR 
(C6D6, 400 MHz): " 8.27 (d, J = 8.0 Hz, 2H), 7.70 (d, J = 7.9 Hz, 2H), 7.55 (d, J = 8.2 
Hz, 2H), 7.47-7.41 (m, 2H), 7.32-7.26 (m, 2H), 7.21 (d, J = 8.5 Hz, 2H), 3.51 (br s, 
4H), 2.49 (s, 6H); 13C NMR (C6D6, 100 MHz): " 246.22, 138.74, 134.26, 134.08, 
132.79, 129.73, 128.93, 127.86, 127.18, 125.84, 123.91, 52.49, 18.88. 
1-Bromo-2,7-dimethylnaphthalene (1c). 25.93 g 2,7-dimethylnaphthalene were 
dissolved in 200 mL CH2Cl2, and then a 100 mL CH2Cl2 solution of Br2 (1.0 eq.) was 
dropped into it over 1h at 0°C. After 3h the reaction was finished (confirmed by GC-
MS). The reaction was quenched by adding a 200 mL of 25% Na2S2O3 aqueous 
solution. The CH2Cl2 phase was separated and washed with 400 mL water, 400 mL 
5% Na2CO3, dried by MgSO4, filtered and concentrated under vacuum to afford light 
yellow crystals (38.65 g, 99%). 1H NMR (CDCl3, 500 MHz): " 8.05 (s, 1H), 7.67 (d, J 
= 5.0 Hz, 1H), 7.64 (d, J = 5.0 Hz, 1H), 7.29-7.24 (m, 2H), 2.60 (s, 3H), 2.55 (s, 3H). 
13C NMR (CDCl3, 125 MHz): " 137.38, 136.13, 132.84, 131.50, 128.1, 128.06, 
127.99, 127.18, 126.14, 123.60, 24.40, 22.24. HRMS (EI) m/z calculated for 
C12H11Br [M]+ 234.0044, observed 234.0044. 
N,N!-Bis(2,7-dimethylnaphthalen-1-yl)ethane-1,2-diamine (2c). A 100 mL two 
necked flask was charged with Pd2(dba)3 (65 mg, 0.07 mmol), (±)-BINAP (88 mg, 
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0.14 mmol), NaOtBu (410 mg, 4.26 mmol), 1-bromo-2,7-dimethylnaphthalene (1c) 
(700 mg, 2.98 mmol) and toluene (25 mL) in the glovebox. Ethylenediamine (95 $L, 
1.42 mmol) were added by syringe outside the glovebox. The reaction mixture was 
stirred at 100°C for 16 h under nitrogen. When it cooled down, filtered through silica 
gel filter, washed with 300 mL hexane and the product was collected by washing with 
400 mL CH2Cl2. The CH2Cl2 fraction was dried by rotavapor to give 517 mg (99%) 
of 2c as a yellow oil. 1H NMR (CDCl3, 400 MHz): " 7.92 (s, 2H), 7.69 (d, J = 5.0 Hz, 
2H), 7.43 (d, J = 5.0 Hz, 2H), 7.25-7.21 (m, 4H), 3.84 (br s, 2H), 3.44 (s, 4H), 2.49 (s, 
6H), 2.45 (s, 6H). 13C NMR (CDCl3, 100 MHz): " 141.67, 135.44, 132.01, 129.02, 
128.71, 128.50, 127.36, 126.19, 122.97, 121.74, 50.69, 25.83, 22.35. HRMS (EI) m/z 
calculated for C26H28N2 [M]+ 368.2252, observed 368.2258. 
1,3-Bis(2,7-dimethylnaphthalen-1-yl)-imidazolinium tetrafluoroborate 
(SIMeNap·HBF4) (3c). Triethyl orthoformate (100 mL) was added to the diamine 
(2c) (3.22 g, 8.75 mmol) in a 250 mL Schlenk flask equipped with a distillation head. 
To this solution was added NH4BF4 (920 mg, 8.75 mmol) and 2 drops of formic acid. 
The reaction was heated to 100  °C and stirred for 12 h. Upon cooling to room 
temperature, the white precipitate was collected by filtration, washed with copious 
amounts of Et2O and 2 $ 5 mL CH2Cl2 and dried in vacuo to yield 3.47 g (85%) of the 
title product. 1H NMR (DMSO-d6, 400 MHz): " 9.42 (s, 0.45H), 9.39 (s, 0.55H) 
(corresponding to the two atropisomers of a single proton), 8.05-7.98 (m, 4.90H), 7.86 
(s, 1.10H) (corresponding to the two atropisomers of six protons), 7.56-7.51 (m, 4H), 
4.90-4.68 (m, 4H), 2.71 (s, 3H), 2.67 (s, 3H), 2.64 (s, 3H), 2.62 (s, 3H). 13C NMR 
(DMSO-d6, 100 MHz) (due to existence of two atropisomers, the 13C NMR spectrum 
is complex): " 162.24, 162.12, 138.52, 134.64, 131.31, 130.49, 130.01, 129.94, 
129.08, 129.02, 128.90, 128.48, 128.39, 52.77, 52.68, 22.21, 18.12, 18.07. 19F NMR 
(CDCl3 376.46 MHz): -152.82, -152.88. HRMS (ESI) m/z calculated for C27H27N2 
[M-BF4]+ 379.2174, observed 379.2179. 
1,3-Bis(2,7-dimethylnaphthalen-1-yl)-imidazolinium chloride (SIMeNap·HCl) 
(3c!). The diamine (2c) (368 mg, 1.00 mmol) was dissolved in 6 mL THF, 7 mL 1.3M 
HCl solution was added at 0°C, and a white precipitation was obtained. The solid was 
filtered, dried under high vaccum, and then transferred into a 10 mL galss vial 
equipped with a stirring bar and charged with 2 mL triethyl orthoformate. The vial 
was capped and irradiated 5min at 145 °C in a CEM Discover instrument with a 50-W 
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microwave power. No ramp and no simultaneous cooling were applied. After rapid 
air-cooling by the unit, the reaction mixture was diluted with Et2O (3 mL) and filtered 
under vacuum. The precipitate was rinsed with a few milliliters of Et2O and dried 
under vacuum to afford a white powder (342 mg, 82%). 1H NMR (DMSO-d6, 400 
MHz): " 9.41 (s, 0.45H), 9.38 (s, 0.55H) (correspond to the two atropisomers of a 
single proton), 8.04-7.97 (m, 4.90H), 7.85 (s, 1.10H) (correspond to the two 
atropisomers of six protons), 7.55-7.50 (m, 4H), 4.89-4.67 (m, 4H), 2.70 (s, 3H), 2.66 
(s, 3H), 2.63 (s, 3H), 2.61 (s, 3H). 13C NMR (DMSO-d6, 100 MHz) (due to existence 
of two atropisomers, 13C NMR spectrum appeared complex): " 161.73, 161.60, 
138.03, 134.13, 130.81, 129.97, 129.93, 129.52, 129.45, 128.61, 128.55, 128.51, 
128.04, 128.37, 127.98, 127.89, 120.36, 120.20, 52.33, 52.23, 21.69, 17.67, 17.62. 
HRMS (ESI) m/z calculated for C27H27N2 [M-Cl]+ 379.2174, observed 379.2179. 
1,3-Bis(2,7-dimethylnaphthalen-1-yl)-imidazolin-2-ylidene (SIMeNap)  (4c). A 
suspension of NaH (26 mg, 1.10 mmol) and KOtBu (6 mg, 5.00 $ 10-2 mmol) in 10 
mL THF was added into a suspension of SIMeNap%HBF4 (3c) (466 mg, 1.00 mmol) in 
10 mL THF. The reaction was stirred overnight at rt in the glovebox, filtered through 
celite and dried in vacuo to yield 348 mg (92%) of the white free carbene. Crystals 
suitable for an X-ray diffraction study were grown from an Et2O solution. 1H NMR 
(Toluene-d8, 500 MHz): " 8.02 (br s, 2H) 7.60 (d, J = 8.3 Hz, 2H), 7.53 (d, J = 8.3 
Hz, 2H), 7.15 (d, J = 8.3 Hz, 2H), 7.12 (dd, J = 8.3, 1.5 Hz, 2H), 3.52 (br s, 4H), 2.50 
(br s, 6H), 2.42 (s, 6H). 13C NMR (C6D6, 126 MHz): " 245.97, 138.30, 136.57, 
134.04, 133.10, 132.67, 128.89, 128.79, 127.99, 127.63, 123.24, 52.44, 22.69, 18.75. 
1-Bromo-2,7-diisopropylnaphthalene (1d). 2.12 g 2,7-diisopropylnaphthalene were 
dissolved in 10 mL CH2Cl2, and then a 10 mL CH2Cl2 solution of Br2 (1.0 eq.) was 
dropped into it over 0.5h at 0°C. After 1h the reaction was completed (confirmed by 
both TLC and GC-MS). The reaction was quenched by adding 10 mL of 25% 
Na2S2O3 aqueous solution. The CH2Cl2 phase was separated and washed with 2 $ 50 
mL water, 2 $ 50 mL 5% Na2CO3, dried by MgSO4, filtered and concentrated under 
vacuum to afford a colorless oil (2.88 g, 99%). 1H NMR (CDCl3, 500 MHz): " 8.16 
(s, 1H), 7.75 (d, J = 5.5 Hz, 1H), 7.73 (d, J = 5.5 Hz, 1H), 7.40 (dd, J = 8.7, 1.6 Hz, 
2H), 7.38 (d, J  = 8.7 Hz, 1H) 3.78 (sept, J = 7.0 Hz, 1H), 3.14 (sept, J = 7.0 Hz, 1H), 
1.37 (d, J = 7.0 Hz, 6H), 1.32 (d, J = 7.0 Hz, 6H). 13C NMR (CDCl3, 125 MHz): " 
148.24, 145.33, 132.82, 132.15, 128.24, 127.3, 125.67, 124.47, 123.62, 123.15, 34.86, 
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34.06, 24.22, 23.10. HRMS (EI) m/z calculated for C16H19Br [M]+ 290.0670, 
observed 290.0673. 
N,N!-Bis(2,7-diisopropylnaphthalen-1-yl)ethane-1,2-diamine (2d). A 250 mL 
schlenk flask was charged with Pd2(dba)3 (320 mg, 0.35 mmol), (±)-BINAP (523 mg, 
0.84 mmol), NaOtBu (2.02 g, 21.00 mmol), 1-bromo-2,7-diisopropylnaphthalene (1d) 
(4.08 g, 14.00 mmol) and toluene (150 mL) in the glovebox. Ethylenediamine (468 
$L, 7.00 mmol) were added by syringe outside the glovebox. The reaction mixture 
was stirred at 110°C for 17 h under nitrogen. When it cooled down, filtered through 
silica gel filter, washed with hexane firstly and the product was collected by washing 
with CH2Cl2. The CH2Cl2 fraction was dried by rotavapor to give 3.04 g (90%) of 2d 
as a yellow oil. 1H NMR (CDCl3, 500 MHz): " 8.14 (s, 2H), 7.76 (d, J = 8.1 Hz, 2H), 
7.57 (d, J = 8.1 Hz, 2H), 7.40-7.34 (m, 4H), 3.95 (s, 2H), 3.53 (sept, J = 6.6 Hz, 2H), 
3.48 (s, 4H), 3.08 (sept, J = 6.6 Hz, 2H), 1.33 (br s, 24H). 13C NMR (CDCl3, 100 
MHz): " 146.40, 140.70, 137.38, 132.03, 129.65, 128.48, 125.04, 123.78, 123.56, 
119.98, 52.13, 34.84, 28.04, 24.33, 24.15. HRMS (EI) m/z calculated for C34H44N2 
[M]+ 480.3504, observed 480.3504. 
1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-imidazolinium tetrafluoroborate 
(SIPrNap·HBF4) (3d). Triethyl orthoformate (60 mL) was added to the diamine (2d) 
(2.02 g, 4.20 mmol) in a 100 mL schlenk flask equipped with a distillation head. To 
this solution was added NH4BF4 (440 mg, 4.20 mmol) and 2 drops of formic acid. 
The reaction was heated to 100  °C and stirred for 12 h. Upon cooling to rt, the white 
precipitate was collected by filtration, washed with a lot of Et2O and 2 $ 3 mL CH2Cl2 
and dried in vacuo to yield 1.65 g (68%) of the title product. 1H NMR (DMSO-d6, 400 
MHz): " 9.62 (s, 0.45H), 9.60 (s, 0.55H) (correspond to the two atropisomers of a 
single proton), 8.15 (dd, J = 8.8, 2.8 Hz, 2H), 8.05 (d, J = 8.5 Hz, 2H), {7.89 (s, 
0.90H), 7.73-7.68 (m, 3.10H) (correspond to the two atropisomers of four protons)}, 
7.66-7.61 (m, 2H), 5.02-4.66 (m, 4H), 3.57 (sept, J = 6.7 Hz, 1H), 3.38 (sept, J = 6.8 
Hz, 1H), 3.31 (sept, J = 6.7 Hz, 1H), 3.23 (sept, J = 6.8 Hz, 1H), 1.50 (d, J = 6.8 Hz, 
3H), 1.46 (d, J = 6.8 Hz, 3H) 1.41 (d, J = 6.8 Hz, 6H), 1.38-1.36 (m, 6H), 1.29 (d, J = 
6.8 Hz, 6H). 13C NMR (DMSO-d6, 125 MHz) (due to existence of two atropisomers, 
13C NMR spectrum appeared complex): " 161.53, 161.43, 148.97, 144.19, 144.17, 
131.11, 130.72, 129.32, 129.28, 128.81, 128.75, 126.76, 126.66, 126.23, 125.69, 
123.45, 118.03, 117.27, 53.54, 53.38, 34.22, 33.96, 28.53, 24.16, 24.13, 24.06, 23.55. 
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19F NMR (CDCl3, 376.46 MHz): -153.40, -153.45. HRMS (ESI) m/z calculated for 
C35H43N2 [M-BF4]+ 491.3426, observed 491.3420. 
1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-imidazolinium chloride (SIPrNap·HCl) 
(3d!). The diamine (2d) (481 mg, 1.00 mmol) was dissolved in 4 mL THF, 7 mL 
1.3M HCl solution was added at 0°C, and a white precipitation was obtained. The 
solid was filtered, dried under high vaccum, and then transferred into a 10 mL galss 
vial equipped with a stirring bar and charged with 1.2 mL triethyl orthoformate. The 
vial was capped and irradiated 5min twice at 145 °C in a CEM Discover instrument 
with a 50-W microwave power. No ramp and no simultaneous cooling were applied. 
After rapid air-cooling by the unit, the reaction mixture was diluted with Et2O (3 mL) 
and filtered under vacuum. The precipitate was rinsed with a few milliliters of Et2O 
and dried under vacuum to afford a white powder (253 mg, 48%). Crystals suitable 
for diffraction study were grown from a CH3Cl/Et2O solution. 1H NMR (DMSO-d6, 
500 MHz): " 9.63 (s, 0.45H), 9.60 (s, 0.55H) (correspond to two atropisomers of a 
single proton), 8.14 (dd, J = 8.7, 3.3 Hz, 2H), 8.05 (dd, J = 8.4, 1.2 Hz, 2H), {7.89 (s, 
0.90H), 7.73-7.68 (m, 3.10H) (correspond to the two atropisomers of four protons)}, 
7.66-7.61 (m, 2H), 5.05-4.65 (m, 4H), 3.57 (sept, J = 6.8 Hz, 1H), 3.38 (sept, J = 6.8 
Hz, 1H), 3.30 (sept, J = 6.8 Hz, 1H), 3.23 (sept, J = 6.8 Hz, 1H), 1.50 (d, J = 6.8 Hz, 
3H), 1.46 (d, J = 6.8 Hz, 3H) 1.41 (d, J = 6.8 Hz, 6H), 1.38-1.36 (m, 6H), 1.29 (d, J = 
6.8 Hz, 6H). 13C NMR (DMSO-d6, 125 MHz) (due to existence of two atropisomers, 
13C NMR spectrum appeared complex): " 161.53, 161.43, 148.97, 144.18, 144.16, 
131.11, 131.09, 130.72, 130.70, 129.32, 129.27,  128.80, 128.74, 128.42, 126.76, 
126.66, 126.22, 125.68, 123.46, 123.44, 118.03, 117.27, 53.54, 53.38, 34.21, 33.95, 
28.53, 28.52 24.15, 24.12, 24.06, 24.04, 23.54, 23.11, 23.09, 23.04. HRMS (ESI) m/z 
calculated for C35H43N2 [M-Cl]+ 491.3426, observed 491.3426. 
1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-imidazolin-2-ylidene (SIPrNap) (4d). A 
suspension of NaH (26 mg, 1.10 mmol) and KOtBu (6 mg, 5.00 $ 10-2 mmol) in 10 
mL THF was added into a suspension of SIPrNap%HBF4 (3d) (578 mg, 1.00 mmol) in 
10 mL THF. The reaction was stirred for 24 h at rt in the glovebox, filtered through 
celite and dried in vacuo to yield 481 mg (98%) of the white free N-heterocyclic 
carbene. Crystals suitable for diffraction study were grown from an Et2O/pentane 
solution. 1H NMR (C6D6, 500 MHz): " 8.16 (s, 0.9H), 8.07 (s, 1.1H) (correspond to 
the two atropisomers of two protons), 7.74-7.68 (m, 4H), {7.40 (d, J = 8.5 Hz, 0.9H), 
Chapter 2 
 37 
7.39 (d, J = 8.5 Hz, 1.1H) (correspond to the two atropisomers of two protons)}, 7.31 
(dd, J = 8.3, 1.5 Hz, 0.9H), 7.27 (dd, J = 8.3, 1.5 Hz, 1.1H) (correspond to the two 
atropisomers of two protons), 3.91-3.80 (m, 2H), 3.76-3.66 (m, 2H), {3.55-3.48 (m, 
1.1H), 3.41-3.39 (m, 0.9) (correspond to the two atropisomers of two protons)}, 3.15-
3.02 (m, 2H), 1.50-1.34 (m, 24H). 13C NMR (C6D6, 100 MHz) (due to existence of 
two atropisomers, 13C NMR spectrum appeared complex): 246.29, 245.49, 147.38, 
147.35, 144.26, 137.07, 133.10, 132.89, 132.85, 129.09, 128.95, 126.05, 125.39, 
124.11, 124.05, 121.04, 120.42, 53.91, 53.78, 35.62, 35.31, 29.48, 29.42, 25.17, 
25.08, 24.77, 24.66, 24.62, 24.31, 24.17, 24.01. 
N,N!-Bis(anthracen-9-yl)ethane-1,2-diamine (2e). A 250 mL schlenk flask was 
charged with Pd(dba)2 (383 mg, 0.67 mmol), (±)-BINAP (423 mg, 0.68 mmol), 
NaOtBu (1.92 g, 20.00 mmol), 9-bromoanthracene (3.60 g, 14.00 mmol), 
ethylenediamine (445 $L, 6.67 mmol) and toluene (100 mL) in the glovebox. The 
reaction mixture was stirred at 110°C for 18 h under nitrogen. When it cooled down, 
it was filtered through a silica gel filter, washed with CH2Cl2, concentrated by 
rotavapor, and the residue was purified by flash chromatography (SiO2, 1:1 
CH2Cl2/hexane) to yield a yellow solid (1.76 g, 64%). 1H NMR (CDCl3 400 MHz): " 
8.33 (m, 4H), 8.21 (m, 2H), 8.02 (m, 4H), 7.44 (m, 8H), 4.58 (br s, 2H), 3.66 (s, 4H). 
13C NMR (CDCl3, 400 MHz): " 141.32, 132.55, 129.25, 125.77, 125.48, 125.28, 
123.11, 122.12, 52.68. HRMS (EI) m/z calculated for C30H24N2 [M]+ 412.1939, 
observed 412.1946. 
1,3-Bis(anthracen-9-yl)-imidazolinium tetrafluoroborate (SIAnt·HBF4) (3e). 
Triethyl orthoformate (25 mL) was added to the diamine (2e) (1.00 g, 2.42 mmol) in a 
50 mL schlenk flask equipped with a distillation head. To this solution was added 
NH4BF4 (267 mg, 2.54 mmol) and 2 drops of formic acid. The reaction was heated to 
100  °C and stirred for 30 min, then 150 °C for 1.5 h. Upon cooling to room 
temperature, the pale yellow precipitate was collected by filtration, washed with 
copious amounts of Et2O and dried in vacuo to yield 883 mg (71%) of the title 
product. 1H NMR (DMSO-d6, 400 MHz): " 9.81 (s, 1H), 9.00 (s, 2H), 8.64 (d, J = 8.8 
Hz, 4H), 8.33 (d, J = 8.7 Hz, 4H), 7.95 (dd, J = 8.8, 6.7 Hz, 4H), 7.76 (dd, J = 8.7, 6.7 
Hz, 4H), 5.12 (s, 4H). 13C NMR (DMSO-d6, 100 MHz): " 163.15, 131.10, 130.31, 
129.10, 128.85, 127.76, 126.37, 125.95, 121.83, 54.09. 19F NMR (DMSO, 376.49): -
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148.27, -148.32. HRMS (ESI) m/z calculated for C31H23N2 [M-BF4]+ 423.1861, 
observed 423.1851. 
1,3-Bis(anthracen-9-yl)-imidazolidene (SIAnt) (4e). A suspension of NaH (26 mg, 
1.10 mmol) and KOtBu (6 mg, 5.00 $ 10-2 mmol) in 10 mL THF was added into a 
suspension of SIAnt%HBF4 (3e) (510 mg, 1.00 mmol) in 10 mL THF. The reaction 
was stirred for 18 h at rt in the glovebox, filtered through celite and dried in vacuo to 
yield 380 mg (90%) of the pale green, free carbene. 1H NMR (C6D6, 400 MHz): 8.63 
(d, J  = 8.7 Hz, 4H), 8.17 (s, 2H), 7.83 (d, J  = 8.5 Hz, 4H), 7.43 (dd, J  = 8.7, 6.5 Hz, 
4H), 7.28 (dd, J  = 8.5, 6.5 Hz, 4H), 3.79 (s, 4H). 13C NMR (C6D6, 400 MHz): 248.21, 
136.80, 133.08, 130.14, 129.49, 127.37, 127.01, 125.94, 124.54, 54.46. 
Allylchloro[1,3-bis(2-methylnaphthalen-1-yl)-imidazolin-2-ylidene]palladium 
[(SI2MeNap)Pd(allyl)Cl] (5b): 4b (280 mg, 0.80 mmol) and [Pd(allyl)Cl]2 (146 mg, 
0.40 mmol) were mixed together in a vial in the glovebox. Dry THF (20 mL) was 
added and the mixture was stirred at room temperature for 12 h. The solvent was 
decanted, the solid was washed with 5 mL cold THF, and dried in vacuo. The crude 
product was dissolved in 10 mL CH2Cl2 and filtered through a celite filter to remove 
traces of palladium black. The white powder 5b was obtained as a 1:1 mixture of the 
two atropisomers bearing meso- and rac-4b respectively (325 mg, 76%). 1H NMR 
(CDCl3, 400 MHz): " 8.05-7.76 (m, 6H), 7.66-7.58 (m, 2H), 7.50-7.40 (m, 4H), 4.34-
4.17 (m, 4H), 4.48-4.45 (m, 0.2H), 4.08-3.96 (m, 0.8H), (corresponding to the 
atropisomers of one proton), 3.53 (d, J = 7.5, 0.2H), 3.45 (d, J = 7.5, 0.8H), 
(corresponding to the atropisomers of one proton), 3.03 (d, J = 6.6, 0.5H), 3.45 (d, J = 
6.6, 0.5H), (corresponding to the atropisomers of one proton), 2.88 (s, 1.5H), 2.76 (s, 
3H), 2.74 (s, 1.5H), (corresponding to the atropisomers of six protons), 2.37-2.27 (m, 
1H), 1.62 (d, J = 12.2 Hz, 0.2H), 1.10 (d, J = 12.2 Hz, 0.8H) (corresponding to the 
atropisomers of one proton). 13C NMR (CDCl3, 100 MHz) (due to the existence of the 
atropisomers, the 13C NMR spectrum is complex): 214.45, 214.34, 213.99, 136.32, 
136.08, 134.80 (two signals overlapped), 134.53, 134.36, 134.25, 133.38, 133.31, 
133.25, 131.07, 131.01, 130.89, 129.98, 129.92, 129.14, 129.09, 128.92, 
128.87.128.79, 128.74, 128.33 (two signals overlapped), 127.06, 126.98, 126.91, 
126.58, 125.90 (two signals overlapped), 125.52, 125.39, 123.54 (two signals 
overlapped), 122.30, 122.21, 114.77, 114, 66, 72.25, 72.17, 72.06, 52.42, 52.29, 
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52.25, 51.11, 50.51, 49.78, 19.54, 19.50, 19.22, 19.15. HRMS (ESI) m/z calculated 
for C28H27PdN2 [M-Cl]+ 495.1210, observed 495.1211. 
Allylchloro[1,3-bis(2,7-dimethyl-naphthalen-1-yl)-imidazolin-2-
ylidene]palladium [(SIMeNap)Pd(allyl)Cl] (5c): 4c (930 mg, 2.46 mmol) and 
[Pd(allyl)Cl]2 (449 mg, 1.23 mmol) were mixed together in a vial in the glovebox. 
Dry THF (20 mL) was added and the mixture was stirred at room temperature for 1.5 
h. The solvent was removed in vacuo, and 20 mL of hexane was added to triturate the 
product. The reaction mixture was filtered in air and the solid washed with hexane. 
The two isomers were successfully separated by repeated fractional crystallization 
with CH2Cl2/hexane to yield 662 mg of 5cmeso (48% yield) and 400 mg of 5crac (23% 
yield). Crystals suitable for diffraction studies were grown from CH2Cl2/hexane 
solutions.  
Data for 5cmeso are as follows. 1H NMR (CDCl3, 400 MHz): " 7.78-7.70 (m, 
6H), 7.40 (d, J = 8.4 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 7.32-7.29 (m, 2H), 4.29-4.24 
(m, 4H), 4.05-3.95 (m, 1H), 3.45 (dd, J = 7.5, 2.5 Hz, 1H), 2.87-2.85 (m, 1H), 2.81 (s, 
3H), 2.72 (s, 3H), 2.59 (s, 6H), 2.29 (d, J = 12.2 Hz, 1H), 1.11 (d, J = 12.2 Hz, 1H). 
13C NMR (CDCl3, 100 MHz): 214.27, 136.34, 136.30, 136.14, 136.01, 133.95, 
133.68, 131.58, 131.17, 131.05, 129.11, 129.09, 129.08, 129.06, 128.77, 128.49, 
128.43, 127.63, 127.49, 121.57, 121.42, 114.66, 71.89, 52.17, 52.11, 50.79, 22.62, 
19.51,19.49. HRMS (ESI) m/z calculated for C30H31PdN2 [M-Cl]+ 523.1523, 
observed 523.1528. 
Data for 5crac are as follows. 1H NMR (CDCl3, 400 MHz): " 7.79-7.70 (m, 
6H), 7.36-7.33 (m, 2H), 7.30-7.26 (m, 2H), 4.35-4.31 (m, 0.4H), 4.23 (s, 4H), 4.14-
4.04 (m, 0.6H), 3.51 (dd, J = 7.5, 2.5 Hz, 0.4H), 3.44 (dd, J = 7.5, 2.5 Hz, 0.6H), 3.09 
(dd, J = 6.6, 2.0 Hz, 0.6H), 3.05 (dd, J = 6.6, 2.0 Hz, 0.4H), 2.79 (s, 1.2H), 2.78 (s, 
1.8H), 2.59 (s, 1.8H), 2.57 (s, 1.2H), 2.29-2.26 (m, 1H), 1.57, (d, J = 1.8 Hz, 0.6H), 
1.26 (d, J = 1.8 Hz, 0.4H). 13C NMR (CDCl3, 100 MHz) (due to existence of two 
isomers, 13C NMR spectrum appeared complex): 214.58, 214.16, 136.67, 136.66, 
134.32, 134.31, 134.09, 131.69, 131.66, 131.21, 131.19, 128.63, 128.58, 128.09, 
128.04, 122.98, 122.90, 114.64, 72.17, 72.02, 52.41, 49.87, 49.33, 22.50, 19.08, 
18.99. HRMS (ESI) m/z calculated for C30H31PdN2 [M-Cl]+ 523.1523, observed 
523.1528. 
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Allylchloro[1,3-bis(2,7-diisopropylnaphthalen-1-yl)-imidazolin-2-
ylidene]palladium [(SIPrNap)Pd(allyl)Cl] (5d): 4d (1.02 g, 2.07 mmol) and 
[Pd(allyl)Cl]2 (377 mg, 1.03 mmol) were mixed together in a round bottom flask in 
the glovebox. Dry THF (50 mL) was added and the mixture was stirred at room 
temperature for 1.5 h. The solvent was removed in vacuo, and 30 mL of hexane was 
added to triturate the product. The reaction mixture was filtered in air and the solid 
washed with hexane. The two isomers were successfully separated by fractional 
crystallization with EtOAc/hexane to yield 585 mg of 5dmeso (42% yield) and 544 mg 
of 5drac (36% yield).  
Data for 5dmeso are as follows. 1H NMR (CDCl3, 400 MHz): " 7.86-7.73 (m, 
6H), 7.53 (d, J = 8.7 Hz, 1H), 7.49 (d, J = 8.7 Hz, 1H), 7.45-7.38 (m, 2H), 4.35-4.20 
(m, 4H), 4.16-4.08 (m, 1H), 3.83, (sept, J = 6.8 Hz, 1H), 3.68, (sept, J = 6.8 Hz, 1H), 
3.48 (dd, J = 7.5, 2.0 Hz, 1H), 3.21-3.13 (m, 2H), 2.87-2.85 (m, 1H), 2.35 (d, J = 13.4 
Hz, 1H), 1.61-1.22 (m, 24H), 1.10 (d, J = 12.1 Hz, 1H). 13C NMR (CDCl3, 100 MHz): 
213.97, 147.38, 146.87, 146.22, 145.70, 133.09, 132.78, 132.02, 131.87, 130.89, 
130.30, 129.15, 129.14, 129.12, 124.47, 124.45, 124.33, 123.89, 120.38, 120.05, 
114.48, 71.56, 60.60, 53.92, 53.59, 51.08, 35.90, 35.70, 31.80, 29.01, 28.90, 26.04, 
26.01, 24.93, 24.83, 24.15, 24.11, 24.03, 24.01, 23.67, 22.87, 21.26, 14.42, 14.32. 
HRMS (ESI) m/z calculated for C30H31PdN2ClNa [M+Na]+ 693.2361, observed 
693.2373. 
Data for 5drac are as follows. 1H NMR (CDCl3, 500 MHz): " 7.86-7.75 (m, 
6H), 7.47-7.38 (m, 4H), 4.64-4.59 (m, 0.8H), 4.35-4.29 (m, 4H), 4.08-4.01 (m, 0.2H), 
2.90-3.82 (m, 2H), 3.60 (dd, J = 7.5, 2.4 Hz, 0.8H), 3.51 (dd, J = 7.5, 2.4 Hz, 0.2H), 
3.16 (sept, J = 6.8, 2H), 2.95-2.93 (m, 0.8H), 2.79-2.77 (m, 0.2H), 2.48-2.42 (m, 1H), 
1.78 (d, J = 11.9 Hz, 0.2H), 1.50-1.36 (m, 24H), 0.78 (d, J = 11.9 Hz, 0.8H). 13C 
NMR (CDCl3, 100 MHz) (due to existence of two isomers, 13C NMR spectrum 
appeared complex): 214.38, 213.27, 147.12, 147.06, 144.69, 144.51, 133.17, 133.10, 
131.93, 131.83, 131.02, 130.99, 129.25, 129.22, 128.29, 128.21, 126.40, 126.21, 
123.51, 123.47, 120.43, 120.35, 114.62, 114.58, 72.58, 52.27, 53.69, 53.63, 50.24, 
49.69, 34.65, 34.61, 28.88, 28.82, 25.91, 25.63, 24.10, 23.94, 23.87, 23.71, 23.66, 
23.54. HRMS (ESI) m/z calculated for C30H31PdN2ClNa [M+Na]+ 693.2361, 
observed 693.2373. 
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{RuCl2[1,3-bis(2-methylnaphthalen-1-yl)-imidazolin-2-ylidene](=CH-Ph)(PCy3)} 
[RuCl2(SI2MeNap)(=CHPh)(PCy3)] (6b): 4b (300 mg, 0.85 mmol) and 
RuCl2(=C(H)Ph)(PCy3)2 (700 mg, 0.85 mmol) were mixed together in a 200 mL flask 
in the glovebox. Dry toluene (40 mL) was added and the mixture was stirred at room 
temperature for 16 h. The solvent was removed in vacuo, washed with 4 $ 10 mL 
hexane, and then dissolved in minimum CH2Cl2 and precipitated with Et2O/pentane 
(1:3). Filtration of the pink precipitate afforded the product 6b in 65% (495 mg) yield. 
1H NMR (CD2Cl2, 400 MHz, 273K) exists as a mixture of atropisomers: " 19.04 (s, 
Ru=CHPh), 19.01 (s, Ru=CHPh), 18.48 (s, Ru=CHPh), 18.45 (s, Ru=CHPh), 
(corresponding to the atropisomers of one proton), 8.87-6.09 (m, ArH, 17H), 4.31-
3.93 (m, NCH2CH2N, 4H), 3.44-2.33 (m, ArCH3, 6H), 1.93-0.40 (m, PCy3, 33H). 13C 
NMR (CD2Cl2, 100 MHz, 300K) (due to the existence of the atropisomers, the 13C 
NMR spectrum is complex): " 294.92, 222.61, 221.85, 151.19, 138.15, 137.78, 
136.46, 135.80, 134.37, 133.89, 133.36, 133.33, 132.04, 131.88, 131.36, 131.18, 
130.22, 130.20, 129.94, 129.38, 129.20, 129.12, 128.18, 128.12, 128.04, 127.95, 
127.25, 127.09, 126.92, 126.50, 126.21, 126.19, 125.69, 124.77, 121.51, 31.98, 31.96, 
31.81, 31.79, 29.41, 29.23, 28.27, 28.23, 28.16, 28.06, 26.65, 21.16, 21.04, 19.49, 
19.31. 31P NMR (CD2Cl2, 162 MHz, 273K): " 30.96, 30.48, 29.92. HRMS (ESI) m/z 
calculated for C50H60PRuN2 [M-2Cl-H]+ 815.3571, observed 815.3556. 
{RuCl2[1,3-bis(2,7-dimethyl-naphthalen-1-yl)-imidazolin-2-ylidene](=CH-
Ph)(PCy3)} [RuCl2(SIMeNap)(=CHPh)(PCy3)] (6c): 4c (322 mg, 0.85 mmol) and 
RuCl2(=C(H)Ph)(PCy3)2 (700 mg, 0.85 mmol) were mixed together in a 200 mL flask 
in the glovebox. Dry toluene (40 mL) was added and the mixture was stirred at room 
temperature for 16 h. The solvent was removed in vacuo, washed with 4 $ 10 mL 
hexane, and then dissolved in minimum CH2Cl2 and precipitated with Et2O/pentane 
(1:3).   Filtration of the pink precipitate afforded the product 6c in 73% (575 mg) 
yield. 1H NMR (CD2Cl2, 400 MHz, 260K) exists as a mixture of atropisomers: " 
18.97 (s, Ru=CHPh), 18.94 (s, Ru=CHPh), 18.44 (s, Ru=CHPh), 18.40 (s, 
Ru=CHPh), (corresponding to the atropisomers of one proton), 9.09-6.08 (m, ArH, 
15H), 4.25-3.88 (m, NCH2CH2N, 4H), 3.05-2.22 (m, ArCH3, 12H), 1.92-0.36 (m, 
PCy3, 33H). 13C NMR (CD2Cl2, 100 MHz, 273K) (due to the existence of the 
atropisomers, the 13C NMR spectrum is complex): " 295.99, 294.61, 293.95, 293.51, 
223.50, 222.74, 221.87, 221.52, 221.11, 160.66, 160.45, 151.32, 150.56, 150.45, 
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139.75, 139.56, 137.37, 136.82, 136.58, 136.18, 135.90, 135.78, 135.63, 135.34, 
135.06, 134.81, 134.52, 133.57, 133.36, 132.19, 131.84, 131.61, 131.50, 131.24, 
130.68, 130.03, 129.75, 129.61, 129.35, 129.28, 129.15, 129.09, 128.81, 128.61, 
128.21, 128.09, 127.76, 127.56, 126.87, 126.29, 126.21, 124.43, 123.87, 123.27, 
122.90, 119.86, 34.55, 32.05, 31.53, 31.39, 31.24, 29.25, 29.12, 28.83, 28.55, 25.05, 
27.96, 27.87, 26.44, 23.13, 22.83, 22.57, 22.43, 22.25, 20.82, 19.31, 19.06, 18.91, 
14.41, 14.35. 31P NMR (CD2Cl2, 162 MHz, 270K): " 30.45, 29.48, 29.09. HRMS 
(ESI) m/z calculated for C52H64PRuN2 [M-2Cl-H]+ 843.3883, observed 843.3878. 
{RuCl2[1,3-bis(2,7-diisopropyl-naphthalen-1-yl)-imidazolin-2-ylidene](=CH-
Ph)(PCy3)} [RuCl2(SIPrNap)(=CHPh)(PCy3)] (6d): 4d (170 mg, 0.35 mmol) and 
RuCl2(=C(H)Ph)(PCy3)2 (277 mg, 0.34 mmol) were mixed together in a vial in the 
glovebox. Dry toluene (19 mL) was added and the mixture was stirred at room 
temperature for 28 h. After transferring it into a flask, the solvent was removed in 
vacuo. The content was dissolved in diethyl ether and filtered over cotton (6 mL 
total). Then, methanol was layered on top of it (14 mL) and the vial was put into the 
freezer for 6 h. The precipitate was taken out of the freezer and left at room 
temperature for an additional hour. Then, the mother liquor was decanted off and 
precipitation was repeated once more (4 mL diethylether/15 mL methanol). 
Decantation was followed by drying in vacuo. From the combined mother liquors, 
another crop of pure pink product was obtained. Combined yield: 81% (280 mg). 1H 
NMR (CD2Cl2, 400 MHz, 300K) exists as a mixture of atropisomers: " 19.23 (s, 
Ru=CHPh), 19.20 (s, Ru=CHPh), (corresponding to the atropisomers of one proton), 
8.56-6.66 (m, ArH, 15H), 4.42-3.14 (m, NCH2CH2N + ArCH(CH3)2, 8H), 1.98-0.56 
(m, ArCH3 + PCy3, 57H). 13C NMR (CD2Cl2, 100 MHz, 300K) (due to the existence 
of the atropisomers, the 13C NMR spectrum is complex): " 294.58, 293.28, 222.82, 
222.05, 150.77, 150.64, 147.58, 147.21, 146.66, 146.48, 145.23, 144.98, 135.28, 
135.10, 133.14, 132.99, 132.57, 131.96, 131.83, 131.76, 131.53, 131.25, 131.21, 
130.48, 130.42, 129.54, 129.50, 128.15, 128.10, 127.88, 127.62, 126.61, 125.89, 
125.58, 124.96, 124.17, 124.12, 124.07, 123.21, 123.16, 122.39, 120.85, 54.72, 51.00, 
35.53, 35.45, 35.07, 34.80, 32.10, 32.01, 31.94, 31.84, 29.86, 29.74, 29.30, 29.24, 
29.02, 28.57, 28.53, 28.26, 28.16. 28.07, 26.70, 26.46, 25.93, 25.83, 24.65, 24.58, 
24.54, 24.17, 24.05, 23.39, 23.23, 23.14, 22.86. 31P NMR (CD2Cl2, 162 MHz, 300K): 
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" 29.49, 29.22. HRMS (ESI) m/z calculated for C60H80PRuN2 [M-2Cl-H]+ 961.5096, 
observed 961.5107. 
 
Suzuki-Miyaura Cross-Coupling Reactions: General Procedure. In a 
glovebox, to a vial closed with a screw cap fitted with a septum and equipped with a 
magnetic stir bar were added in turn catalyst (1.00 mol %), potassium tert-butoxide 
(124 mg, 1.10 mmol), boronic acid (1.05 mmol), 2-propanol (1 mL) and dodecane 
(216 µL, 1.00 mmol). The mixture was then stirred at room temperature. After 15 
min, the aryl chloride (1.00 mmol) was injected. If the reaction was carried out at 80 
°C, the aryl chloride was injected outside the glovebox. The reaction was monitored 
by gas chromatography, and the yields were determined through integration of the 
product against dodecane (internal standard) using pre-established response factors.  
2’-Methyl-2-methoxybiphenyl (Table 3, entries 1-10):33 tR = 11.84 min (80 °C, 3 
min, 15 °C/min). 
1-(4-Methylphenyl)naphthalene (Table 3, entries 11-20):34 tR = 14.79 min (80 °C, 3 
min, 15 °C/min). 
 
Hartwig-Buchwald Cross-Coupling Reactions. General Procedure. In a 
glovebox, to a vial closed with a screw cap fitted with a septum and equipped with a 
magnetic stir bar were added in turn catalyst (1.00 mol %), potassium tert-butoxide 
(124 mg, 1.10 mmol), anhydrous DME (1 mL), and dodecane (216 µL, 1.00 mmol). 
The mixture was then stirred at room temperature. After 5 min, the aryl chloride (1.00 
mmol) and the amine (1.10 mmol) were injected. If the reaction was carried out at 80 
°C, the aryl chloride and the amine were injected outside the glovebox. The reaction 
was monitored by gas chromatography, and the yields were determined through 
integration of the product against dodecane (internal standard) using pre-established 
response factors. 
Hartwig-Buchwald Cross-Coupling Reactions at Low Catalyst Loading. 
In a glovebox, 0.01 mmol of complex (6.7 mg of 5d) was dissolved in 10 mL DME, 
providing catalyst solution A. To another vial closed with a screw cap fitted with a 
septum and equipped with a magnetic stir bar were added in turn potassium tert-
butoxide (124 mg, 1.10 mmol), catalyst solution A (1 mL, 0.1 mol %), and dodecane 
(216 µL, 1.00 mmol). The mixture was then stirred at room temperature. After 5 min, 
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the aryl chloride (1.00 mmol) and the amine (1.10 mmol) were injected. The reaction 
was monitored by gas chromatography, and the yields were determined through 
integration of the product against dodecane (internal standard) using pre-established 
response factors. 
N-(2-pyridyl)morpholine (Table 3, entries 21-26):35 tR = 10.05 min (80 °C, 3 min, 15 
°C/min). 
N-(4-Methylphenyl)piperidine (Table 3, entries 27-31):36 tR = 11.31 min (80 °C, 3 
min, 15 °C/min). 
 
RCM of diethyldiallyl malonate in the presence of 1 mol% of catalyst. An 
NMR tube with screw-cap sample top was charged inside the glove box with 0.80 ml 
of CD2Cl2 catalyst solution 0.0010 M (0.80 µmol, 1.0 mol%). The sample was 
equilibrated at 300 K in the NMR instrument before the substrate (19.3 µl, 19.2 mg, 
0.080 mmol) was added via syringe. Data points were collected after an appropriate 
period of time. The conversion was determined by comparing the ratio of the integrals 
of methylene protons in the starting material, " 2.61(dt), with those in the product, " 
2.98(s). 
RCM of diethyldiallyl malonate in the presence of 0.1 mol% of catalyst. 
An NMR tube with screw-cap sample top was charged inside the glove box with 
0.080 ml of CD2Cl2 catalyst solution 0.0010 M (0.080 µmol, 0.1 mol%) and 0.72 ml 
of CD2Cl2. The sample was equilibrated at 300 K in the NMR instrument before the 
substrate (19.3 µl, 19.2 mg, 0.080 mmol) was added via syringe.  
RCM of linalool in the presence of 1 mol% of catalyst. An NMR tube with 
screw-cap sample top was charged inside the glove box with 0.80 ml of CD2Cl2 
catalyst stock solution 0.0010 M (0.80 µmol, 1.0 mol%). The sample was equilibrated 
at 300 K in the NMR instrument before the substrate (14.3 µl, 12.3 mg, 0.080 mmol) 
was added via syringe. Data points were collected after an appropriate period of time. 
The conversion was determined by comparing the ratio of the integrals of methyl 
protons in the starting material, " 1.24 (s), with those in the product, " 1.34 (s). 
RCM of linalool in the presence of 0.1 mol% of catalyst. An NMR tube 
with screw-cap sample top was charged inside the glove box with 0.080 ml of CD2Cl2 
catalyst stock solution 0.0010 M (0.080 µmol, 0.1 mol%) and 0.72 ml of CD2Cl2. The 
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sample was equilibrated at 300 K in the NMR instrument before the substrate (14.3 
µl, 12.3 mg, 0.080 mmol) was added via syringe. 
RCM of N,N-diallyl-4-methyl-benzenesulfonamide in the presence of 1 
mol% of catalyst. An NMR tube with screw-cap sample top was charged inside the 
glove box with 0.40 ml of a CD2Cl2 catalyst stock solution 0.0020 M (0.80 µmol). 
The sample was equilibrated at 300 K in the NMR instrument before 0.4 ml of a 
CD2Cl2 solution of the substrate (18.9 mg, 0.080 mmol) was added via syringe. Data 
points were collected after an appropriate period of time. The conversion was 
determined by comparing the ratio of the integrals of methylene protons in the starting 
material, " 3.77(d), with those in the product, " 4.08 (s). 
RCM of N,N-diallyl-4-methyl-benzenesulfonamide in the presence of 0.1 
mol% of catalyst. An NMR tube with screw-cap sample top was charged inside the 
glove box with 0.76 ml of a CD2Cl2 solution of the substrate (18.9 mg, 0.080 mmol). 
The sample was equilibrated at 300 K in the NMR instrument before 0.040 ml of a 
CD2Cl2 catalyst stock solution 0.0020 M (0.080 µmol) was added via syringe.  
RCM of diethyl-2,2-di(2-methylallyl)malonate in the presence of 5 mol% 
of catalyst. An NMR tube with screw-cap sample top was charged inside the glove 
box with 0.40 ml of CD2Cl2 catalyst solution 0.010 M (0.004 mmol, 5.0 mol%) and 
0.40 ml of CD2Cl2 solution of the substrate (21.5 mg, 0.08 mmol). The sample was 
kept at 300 K for 72h. The conversion was determined by comparing the ratio of the 
integrals of methylene protons in the starting material, " 2.71(s), with those in the 
product, " 2.90 (s). 
 
General Reaction Procedure for the Alkylation of Meso Epoxides. All 
reactions were carried out in a glovebox, and the epoxides were dried over CaH2 and 
stored inside a glovebox. Into a 20 mL vial equipped with a magnetic stir bar were 
added the epoxide (1.00 mmol), internal standard (30 mg, 0.22 mmol) and toluene (2 
mL). Subsequently, the catalyst (1.00 mol %) and the triethylaluminum reagent (1.10 
mL, 2.00 mmol) were added and the reaction was stirred at room temperature for 12-
24 h. 
The reaction was quenched with HCl (4 mL of a 1M solution in H2O) and extracted 
with ether (3 x 5 mL). The combined organic extracts were washed successively with 
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brine (10 mL) and H2O (10 mL) and dried over MgSO4. The solution was filtered and 
an aliquot was analyzed by GC to determine the yield. 
trans-2-Ethyl-1-cyclohexanol (Table 5, entries 4-6):37 tR = 6.49 min (80 °C, 10 
°C/min). 
trans-2-Ethyl-1-cyclopentanol (Table 5, entries 7-11):38 tR = 4.71 min (80 °C, 3 min, 
10 °C/min). 
anti-2-Hydroxy-3-methylpentane (Table 5, entries 12-16):39 tR = 8.08 min (40 °C, 6 
min, 10 °C/min). 
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Chapter 3 
 
Matching the Chirality of Monodentate N-Heterocyclic 
Carbene Ligands: A Case Study on Well-Defined Palladium 
Complexes for the Asymmetric !-Arylations of Amides. 
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3.1 Abstract 
N-heterocyclic carbene ligands derived from C2-symmetric diamines with 
naphthyl side chains are introduced as chiral monodentate ligands and their palladium 
complexes (NHC)Pd(cin)Cl are prepared. These compounds exist as a mixture of 
diastereomers, and the palladium complexes can be successfully separated and their 
absolute stereochemistry assigned. When used in the asymmetric intramolecular !-
arylation of amides, oxindoles with quaternary carbon centers can be obtained in high 
yield and selectivity when correctly matching the chirality of the NHC complexes. 
 
3.2 Introduction 
N-heterocyclic carbenes often show increased reactivity and stability when 
compared to the commonly employed phosphine ligands.1 Because of their tight metal 
binding and robustness, monodentate, chiral N-heterocyclic carbene ligands appear to 
be a very promising ligand class for asymmetric catalysis.2 Development in this area 
has been relatively slow,3-5 and versatile chiral NHCs remain elusive. Two reasons 
might account for this. First, the overwhelming majority of chiral NHC salts is 
deprotonated and used in situ,6 a circumstance that precludes a detailed discussion on 
the reaction/selection pathway of a given transformation and hinders development of 
optimized ligand structures. Another problem consists in building chirality without 
losing the reactivity/versatility of the most successful achiral ligand architectures, 
which incorporate aromatic N-substituents (for instance IMes/SIMes and IPr/SIPr). 
Elegant work by Grubbs et al. has shown that NHCs derived from C2-symmetric 
diamines and mono-ortho-substituted aryl halide side chains provide successful ligand 
systems in some ruthenium-catalyzed asymmetric metathesis reactions.4 Similar 
architectures with unsymmetrically 2,6-disubstituted phenyl side chains have been 
reported more recently showing encouraging results.5 In all of these cases, no mention 
is made regarding the possibly different orientations of the side chains or their ease of 
rotation with respect to the chiral N-heterocyclic backbone and the resulting impact 
on selectivity or reactivity in catalysis.7 
In the course of studying a series of NHCs that incorporate 2-substituted 
naphthyl side chains,8 we found that NHCs with R1 = methyl/isopropyl have two 
atropisomers with C2-symmetric (anti orientation of side chains) and Cs-symmetric 
(syn) conformations (eq 1). Logically, if the chiral regime of C2-symmetric diamines 
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is introduced to the heterocyclic backbone of these NHCs, three diastereomers should 
be generated. Before embarking on the present study, we reasoned that ligand systems 
with bulky R1 groups would be the best candidates because of their rotational stability 
(eq 1) and excellent catalytic behavior.8 Moreover, building upon the successful 
separation of anti/syn palladium complexes in our previous study, we decided to 
concentrate our preliminary efforts on the palladium-catalyzed asymmetric 
intramolecular !-arylation of amides to give chiral quaternary carbon centers.9 
N N
C2
N N
Cs
R1
R2
R2
R1
R2
R1
R2
R123
4
5
6 7
8
DG‡ = 17.8 kcal/mol 
(for R1 = iPr)
(1)
 
3.3 Results and Discussion 
To get the best insight possible into factors that govern the selectivity and 
reactivity of these new ligands, variations in both the chirality of the imidazolinium 
backbone (R3) and the steric properties of the side chains (R1 = isopropyl or 
cyclohexyl; R2 = isopropyl or hydrogen) were introduced and four different NHC 
salts were prepared (Figure 1). Careful analysis of the N-heterocyclic proton signals 
by 1H NMR showed three different diastereomers for all four ligands (1a-d). 
(4S,5S)-DiPhSIPrNap.HBF4 (1a, R1 = R2 = iPr, R3 = Ph) [54(Ra,Ra):36(Ra,Sa):10(Sa,Sa)]
N NAr Ar
mixture of three diastereomers
BF4
R3 R3
(4R,5R)-CySIPrNap.HBF4 [1d, R1 = R2 = iPr, R3 = -(R,R)-(CH2)4-] (45:40:15)
(4S,5S)-DiPhSI2PrNap.HBF4 (1b, R1 = iPr, R2 = H, R3 = Ph) [51(Ra,Ra):41(Ra,Sa):8(Sa,Sa)]
(4S,5S)-DiPhSI2CyNap.HBF4 (1c, R1 = Cy, R2 = H, R3 = Ph) [71(Ra,Ra):21(Ra,Sa):8(Sa,Sa)]
R2
R1
Ar  =
 
Figure 1. New chiral N-Heterocyclic carbene precursors 1a-d. 
Ligand precursors 1a-d were then tested in the intramolecular !-arylation of 
3a following Hartwig’s in situ method (Table 1).9a Results showed that Pd(dba)2, 
Pd(OAc)2 as well as [Pd(cin)Cl]2 (cin = cinnamyl) could be used as palladium 
sources. Although diastereomeric mixtures of ligands 1a-d were employed, oxindole 
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4a was obtained with selectivities of up to 71% ee whith ligand 1a (entry 1), whereas 
using 1d resulted in almost racemic product (entry 6). This result already indicates 
that the chiral information is probably transferred to the substrate from the chiral 
diamine part of the N-heterocycle. 
Table 1. Asymmetric intramolecular !-arylation of amide 3a with 1a-
d/palladium source. 
N
OBr
Me
Ph
[Pd]/L*(5 mol %)
1.5 equiv NaOtBu
DME N
Me
O
Ph
3a 4a
23 °C or 50 °C
 
entry L* [Pd] t (°C) time (h) % yielda (% eeb,c) 
1 1a Pd(dba)2 23 12 98 (71) 
2 1a [Pd(cin)Cl]2 23 12 98 (69) 
3 1a Pd(OAc)2 23 24 96 (66) 
4 1b Pd(dba)2 50 24 98 (59) 
5 1c Pd(dba)2 50 24 91 (47) 
6 1d Pd(dba)2 23 12 92 (–6) 
aIsolated yields. bDetermined by chiral HPLC. cAbsolute stereochemistry determined 
as (R)-configuration, see ref. 9d. 
Diastereomers of 1a-c were then used for the synthesis of (NHC)Pd(cin)Cl 
complexes 2a-c.10,11 As expected from our previous studies on similar ligands 
(equation 1), crude mixtures of the complexes maintained the ratio between the 
diastereomers of the NHC salts. For all three compounds, we were able to separate 
these diastereomeric compounds via column chromatography and assign the absolute 
configurations unequivocally by using a combination of both NMR spectroscopy and 
X-ray structural determinations (Figure 2). The main anti ligand isomer orients its 
more hindered half of the naphthyl moiety onto the protruding phenyl ring of the 
backbone, an intriguing result in view of the previously assumed prevalence of 
(Sa,Sa)-isomers in this ligand class.12 Numerous broad signals in the 1H NMR spectra 
of 2a-c reflect the important steric crowding and the resulting restricted rotation of 
both the cinnamyl and NHC side chains in these complexes. Nonetheless, very 
diagnostic upfield shifts are found for some of the R1 protons and arise from strong "-
# interactions with the chiral backbone phenyl moieties. Together with the X-ray 
analyses and the proton signals of the N-heterocyclic backbone, the presence [twice 
for (Ra,Ra)-2, once for (Ra,Sa)-2] or absence [for (Sa,Sa)-2] of these upfield signals 
lead to the correct assignment of the different diastereomers. 
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N N
PhPh
R1
R2
R2
R1
N N
PhPh
R2
R1
R2
R1
N N
PhPh
R2
R1
R1
R2
Pd
Cl
Ph
Pd
Cl
Ph
Pd
Cl
Ph
(Ra,Ra)-2a (49.3%) (Ra,Sa)-2a (32.6%) (Sa,Sa)-2a (7.4%)R1 = R2 = iPr
(Ra,Ra)-2b (48.1%) (Ra,Sa)-2b (37.7%) (Sa,Sa)-2b (0.7%)R1 = iPr, R2 = H
(Ra,Ra)-2c (48.5%) (Ra,Sa)-2c (13.5%)R1 = Cy, R2 = H  
Figure 2. Complexes 2a-c (above, yields in brackets) and X-rays of [(Ra,Ra)-(4S,5S)-
DiPhSIPrNap]Pd(cin)Cl (below left, (Ra,Ra)-2a), and [(Ra,Sa)-(4S,5S)-
DiPhSI2PrNap]Pd(cin)Cl (below right, (Ra,Sa)-2b). 
 
The series of pure precatalysts was then applied to the asymmetric oxindole 
synthesis starting from different 2-bromoanilides and the catalytic results are given in 
Table 2. Yields of isolated products are excellent and reaction times of less than 24 
hours were observed. Minor discrepancies in reactivity exist between catalysts (2a 
more active than 2b/2c),13 as well as between the three diastereomers of 2a (see 
Supporting Information). On the other hand, selectivity differences are very 
pronounced and reflect the crucial importance of the ligand architecture. Precatalysts 
derived from the minor diastereomeric form of the ligands (Sa,Sa) failed to give 
products with more than 50% ee. Both (Ra,Sa)- and (Ra,Ra)-isomers proved superior in 
terms of selectivity. Enantiomeric excesses when the (Ra,Sa)-complexes were 
employed ranged from moderate (45% ee) to high (89% ee) and showed a marked 
substrate-dependence. Of all the precatalysts tested, (Ra,Ra)-2a outperformed its 
congeners and gave high and very evenly distributed chiral induction (80-88% ee) for 
all substrates. As such, (Ra,Ra)-2a compares well with the best systems described 
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recently by Kündig et al.,9d giving generally better yields and slightly higher ee’s in 
two cases (entries 10 and 18). 
 
Table 2. Asymmetric intramolecular !-arylation of amides with 2a-c. 
N
R
OBr
Ar
catalyst (5 mol % Pd)
1.5 equiv NaOtBu
DME, rt (4-24 h)
N
R
O
Ar
3a-g 4a-g  
% yielda and (% eeb,c) entry R Ar cat. 
Ra,Ra Ra,Sa Sa,Sa 
7 Me Ph 2a 98 (86) 98 (67) 98 (20) 
8d Me Ph 2b 94 (67) 95 (52) 95 (34) 
9d Me Ph 2c 98 (51) 98 (46) -- 
10 Bn Ph 2a 98 (88) 98 (45) 97 (50) 
11 Bn Ph 2b 89 (76) 96 (61) -- 
12 Me p-Tol 2a 99 (87) 98 (79) 97 (44) 
13 Me p-Tol 2b 98 (84) 98 (74) -- 
14 Me p-Tol 2c 98 (62) 98 (70) -- 
15 Me o-Tol 2a 99 (85) 97 (89) 98 (44) 
16 Me m-Tol 2a 99 (80) 96 (65) 98 (24) 
17d Me m-Tol 2b 98 (71) 98 (49) -- 
18 Me 1-Nap 2a 93 (85) 95 (80) 95 (34) 
19d Me 1-Nap 2b 92 (77) 95 (68) -- 
20 Bn 1-Nap 2a 93 (82) 96 (66) 93 (49) 
aIsolated yields. bDetermined by chiral HPLC. cAbsolute stereochemistry 
determined as (R)-configuration, see ref. 9d. dReaction run at 50 °C. 
 
Overall, results in table 2 validate the assumption made above that it is the 
chiral groups on the N-heterocycle that determine the absolute configuration of the 
carbon center in products 4a-g (all R-configured). Finally, it should also be noted that 
adding up the results of entry 7 of Table 2 with (Ra,Ra)-2a (86% ee), (Ra,Sa)-2a (67% 
ee) and (Sa,Sa)-2a (20% ee) and taking into account the relative abundance of 
diastereomers in the NHC salt 1a essentially replicates the in situ performance 
obtained in entry 2 of Table 1. 
A viable model for the differences in selectivity between the three 
diastereomeric palladium complexes of 2a is depicted in Scheme 1. The steric 
pressure exerted by the chiral NHC-phenyl groups onto the naphthyl side chains and 
subsequently onto the enantiodiscriminating side of the substrate would 
predominantly give intermediates 5 and, after reductive elimination, products with the 
observed (R)-configuration. Depending on the amount of steric pressure exerted onto 
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the naphthyl side chains, either higher or lower proportions of the depicted 
intermediate 5 would therefore be generated in the enantiodiscriminating carbon-
metal bond-forming step preceding intermediate 5. The higher steric pressure in the 
(Ra,Ra)-isomer means that the relative orientation of methyl vs aromatic group of the 
substrate as shown in (Ra,Ra)-5(R) is highly favored over (Ra,Ra)-5(S), while the 
(Sa,Sa)-isomer gives substantial amounts of (Sa,Sa)-5(S) and low enantiomeric excess 
of the (R)-4 products. The lack of a plane of symmetry in (Ra,Sa)-5(R) means that two 
intermediates leading to the major isomer (R)-4 may be operative, giving either high 
(left) or moderate (right) degrees of selectivity. In this case again, the model that we 
propose correctly reflects the observed experimental results that show an apparently 
random distribution of high and moderate selectivites when (Ra,Sa)-2 are employed. 
N N
PhPh
iPr
iPr
iPr
iPr
N
R
Pd
O
Ar
N
R
Ar
O
(Ra,Ra)-5
(R)-4 (major isomer)
Down
Up
(Ra,Sa)-5
N N
PhPh
iPr
iPr
iPr
iPr
N
R
Pd
O
Ar
Down
Up
(Sa,Sa)-5
N N
PhPh
iPr
iPr
iPr
iPr
N
R
Pd
O
Ar
Down
Up
N
R
Ar
O
(R)-4 (major isomer)
N
R
Ar
O
(R)-4 (major isomer)
N N
PhPh
iPr
iPr
N
R
Pd
O
Ar
Down
Up
iPr
iPr
High Low
Enantioselectivity
or
 
Scheme 1. Model explaining the differences in selectivity (derived from catalyst 2a). 
 
3.4 Conclusion 
In conclusion, we report the synthesis of new NHC ligands with a chiral N-
heterocycle and naphthyl side chains. Careful analysis of the imidazolinium salts 
showed the existence of three different isomers in such NHC structures. Pure 
palladium complexes incorporating these ligands were obtained after successful 
separation of their diastereomeric mixtures. The resulting compounds were tested in 
the asymmetric intramolecular !-arylation of amides and lead to the identification of 
a precatalyst [(Ra,Ra)-2a] that formed oxindoles in high yield and high enantiomeric 
purity. Analysis of the catalytic data demonstrates the dramatic effects on selectivity 
the orientation of the aromatic side chains can have in catalysis. In view of the 
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experimental results presented here, the assumption that (Sa,Sa)-isomers are 
responsible for enantioselectivity in this chiral NHC subclass should be questioned. 
Obviously, direct access to diastereomerically pure ligand precursors 1a-c and its 
derivatives would provide an easier entry to their optimized use in catalysis and 
should also facilitate identification of even more effective and widely applicable 
ligand architectures. Studies with this aim are ongoing. 
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2a and (Ra,Sa)-2b. This material is available free of charge via the Internet at 
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3.5 Supplementary Data 
In addition to the above results reported on the asymmetric intramolecular !-
arylation of amides promoted by palladium complexes bearing NHC ligands 1a-d, we 
also examined the catalytic performance of ligands 1e-h in the same transformation. 
The variations of the ligands were carried out upon both the side chains and the N-
heterocyclic backbone. Consequently, 2- and 7-positions of the naphthyl side chains 
were replaced with Me substituents to give 1e, 2- and 6-positions of the naphthyl side 
chains were substituted with iPr and Ad respectively to generate 1f, and the phenyl 
groups on the backbone are replaced with other aromatic substituents (3,5-
dimethylphenyl and p-methoxyphenyl) to give rise to ligands 1g and 1h (Figure 3). 
Following the previous synthetic procedure, ligands 1e-h were prepared and 1H NMR 
spectroscopy showed that these new NHC salts also exist as mixtures of three 
diastereomers. 
Subsequently, the NHC ligands 1e-h were transferred onto palladium, again 
maintaining the diastereomeric ratio. These (NHC)Pd(cin)Cl complexes 2e-h were 
then separated as diastereomerically pure compounds by flash chromatography 
(Figure 4). The absolute configuration of isomers of 2e was assigned by X-ray 
diffraction studies (Figure 5), and the absolute configurations of isomers of 2f-h were 
assigned by NMR spectroscopy. 
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(4S,5S)-DiPhSIMeNap.HBF4:                                                                        
(1e, R1 = R2 = Me, R3 = H, R' = R'' = H) [27(Ra,Ra):64(Ra,Sa):9(Sa,Sa)]
N N
mixture of three diastereomers
BF4
(4S,5S)-DiPhSIPrAd*Nap.HBF4:                                                                 
(1f, R1 = iPr, R2 = H, R3 = Ad, R' = R'' = H) [31(Ra,Ra):54(Ra,Sa):15(Sa,Sa)]
(4S,5S)-Di(3,5-DiMePh)SIPrNap.HBF4:                                                          
(1g, R1 = R2 = iPr, R3 = H, R' = H, R'' = Me) [65(Ra,Ra):27(Ra,Sa):8(Sa,Sa)]
R2
R1
R3
(4S,5S)-Di(p-MeOPh)SIPrNap.HBF4:                                                              
(1h, R1 = R2 = iPr, R3 = H, R' = MeO, R'' = H) [53(Ra,Ra):37(Ra,Sa):10(Sa,Sa)]
R''
R''R' R''
R''
R'
R2
R1
R3
 
Figure 3. New chiral N-Heterocyclic carbene precursors 1e-h. 
N N
R4R4
R1
R2
R2
R1
N N
R4R4
R2
R1
R2
R1
N N
R4R4
R2
R1
R1
R2
Pd
Cl
Ph
Pd
Cl
Ph
Pd
Cl
Ph
(Ra,Ra)-2e (21%) (Ra,Sa)-2e (58%)
(Ra,Ra)-2f (28%) (Ra,Sa)-2f (44%)
R3
R3 R3
R3
R3
R3
(Ra,Ra)-2g (59%) (Ra,Sa)-2g (21%) (Sa,Sa)-2g (5%)
(Ra,Ra)-2h (45%) (Ra,Sa)-2h (31%) --
--
--
 
Figure 4. Complexes 2e-h (yields in brackets). 
Figure 5. X-Rays of [(Ra,Ra)-(4S,5S)-DiPhSIMeNap]Pd(cin)Cl (below left, (Ra,Ra)-
2e), and [(Ra,Sa)-(4S,5S)-DiPhSIMeNap]Pd(cin)Cl (below right, (Ra,Sa)-2e). 
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In order to evaluate the activity of these new palladium complexes, we 
subjected them to the asymmetric intramolecular !-arylation of amides to form 
oxindoles, and the catalytic results are summarized in Table 3. 
Table 3. Asymmetric intramolecular !-arylation of amides with 2e-h. 
N
R
OBr
Ar
catalyst (5 mol % Pd)
1.5 equiv NaOtBu
DME, rt ,24 h
N
R
O
Ar
 
% yielda and (% eeb,c) entry R Ar cat. 
Ra,Ra Ra,Sa 
21 Me Ph 2e 40 (16) 35 (3) 
22 Me Ph 2f 66 (79) 35 (61) 
23 Me Ph 2g 91 (84) 58 (76) 
24 Me Ph 2h 93 (82) 54 (73) 
25 Bn Ph 2f 91 (86) -- 
26 Bn Ph 2g 94 (89) -- 
27 Bn Ph 2h 93 (89) -- 
28 Me p-Tol 2f 79 (80) -- 
29 Me p-Tol 2g 98 (90) -- 
30 Me p-Tol 2h 96 (86) -- 
31 Me m-Tol 2f 94 (66) -- 
32 Me m-Tol 2g 98 (79) -- 
33 Me m-Tol 2h 93 (77) -- 
34 Me 1-Nap 2f 72 (82) -- 
35 Me 1-Nap 2g 92 (86) -- 
36 Me 1-Nap 2h 64 (80) -- 
37 Bn 1-Nap 2f 90 (81) -- 
38 Bn 1-Nap 2g 92 (79) -- 
39 Bn 1-Nap 2h 93 (83) -- 
aIsolated yields. bDetermined by chiral HPLC. cAbsolute stereochemistry 
determined as (R)-configuration, see ref. 9d. 
The results with 2e-h for the model substrate (entries 21-24) revealed that 
bulkier ligands in the series are more efficient both in terms of reactivity and 
enantioselectivity, while catalyst 2e bearing smaller ligand 1e couldn’t promote the 
transformation as well as others. Compared to catalyst Ra,Ra-2a, the enantioselectivity 
was slightly increased in several cases (entries 26, 27, 29, 35 and 39). The results with 
these modified ligand-metal precatalysts certainly show that better enantioselectivities 
can be reached when further fine-tuning is carried out. 
We also investigated the catalytic behavior of one dimeric palladium complex 
bearing the NHC ligand of Ra,Ra-1a. Protonolysis of the cinnamyl ligand of Ra,Ra-2a 
with HCl in diethyl ether delivers [{PdCl2(NHC)}2] (6) in quantitative yield.14 A 
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single-crystal X-ray diffraction study indicated the presence of two Ra,Ra-1a NHC 
ligands in the structure (Figure 6). Complex 6 was applied to the asymmetric 
synthesis of oxindole 3a. The same ee was obtained as Ra,Ra-2a, albeit lower 
reactivity (rt, 48h, 39% yield, 86% ee). 
 
Figure 6. X-Ray of [{PdCl2(Ra,Ra)-(4S,5S)-DiPhSIPrNap)}2] (6). 
3.6 Experimental Part 
General Information. All reactions were carried out under a nitrogen atmosphere 
using Standard Schlenk-lines or gloveboxes (Mecaplex or Innovative Technology). 
All reagents were used as received unless otherwise noted. Solvents were purchased 
in the best quality available, degassed by purging thoroughly with nitrogen and dried 
over activated molecular sieves of appropriate size. Alternatively, they were purged 
with argon and passed through alumina columns in a solvent purification system 
(Innovative Technology). Solvents for NMR spectroscopy were degassed with 
nitrogen and dried over molecular sieves. NMR spectra were recorded on AV2 400 or 
AV2 500 MHz Bruker spectrometers. Chemical shifts are given in ppm. The spectra 
are calibrated to the residual 1H and 13C signals of the solvents. Multiplicities are 
abbreviated as follows: singlet (s), doublet (d), triplet (t), quartet (q), doublet-doublet 
(dd), quintet (quint), septet (sept), multiplet (m), and broad (br). High-resolution 
electrospray ionization mass spectrometry was performed on a Finnigan MAT 900 
(Thermo Finnigan, San Jose, CA; USA) double-focusing magnetic sector mass 
spectrometer. 10 spectra were acquired. A mass accuracy ! 2 ppm was obtained in the 
peak matching acquisition mode by using a solution containing 2 "l PEG200, 2 "l 
PPG450, and 1.5 mg NaOAc (all obtained from Sigma-Aldrich, CH-Buchs) dissolved 
in 100ml MeOH (HPLC Supra grade, Scharlau, E-Barcelona) as internal standard. 
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GC-MS analysis was done on a Finnigan Voyager GC8000 Top. Elemental analyses 
were done on a Leco CHN-932 analyzer. Optical rotations were measured at 25 ºC on 
a Jasco P-2000 Polarimeter using a filtered Hg lamp (# = 589 nm). X-ray 
crystallography was performed on a Nonius Kappa CCD area-detector diffractometer 
using graphite-monochromated Mo K! radiation (# = 0.71073 Å) and an Oxford 
Cryosystems Cryostream 700 cooler. Compounds 3a-g were prepared according to 
literature procedures.9 
1S,2S-N,N$-Bis(2,7-diisopropylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine. 
A 250 mL schlenk flask was charged with Pd(dba)2 (345 mg, 0.60 mmol), (±)-BINAP 
(448 mg, 0.72 mmol), NaOtBu (1.73 g, 18.00 mmol) and toluene (180 mL) and stirred 
for 20 min. 1-Bromo-2,7-diisopropylnaphthalene (3.84 g, 13.20 mmol) and (1S,2S)-(-
)-1,2-diphenylethylenediamine (1.27 g, 6.00 mmol) were then added and the solution 
was heated to 110 °C for 48 h. After cooling to room temperature, the resulting 
mixture was filtered through a celite filter and washed with CH2Cl2. The filtrate was 
concentrated and the residue was purified by flash chromatography (SiO2, 1:20 
EtOAc/n-hexane) to afford 1S,2S-N,N$-bis(2,7-diisopropylnaphthalen-1-yl)-1,2-
diphenylethane-1,2-diamine as a white solid (2.13 g, 57%). 1H NMR (CDCl3, 400 
MHz): % 8.54 (s, 2H), 7.66 (d, J = 8.4 Hz, 2H), 7.45 (d, J = 8.6 Hz, 2H), 7.27 (dd, J = 
8.4, 1.6 Hz, 2H), 7.12 (d, J = 8.6 Hz, 2H), 6.88 (br s, 10H), 5.00 (br s, 2H), 4.96 (br s, 
2H), 3.24 (sept, J = 6.9 Hz, 2H), 3.05 (sept, J = 6.9 Hz, 2H), 1.39 (d, J = 6.9 Hz, 6H), 
1.30 (d, J = 6.9 Hz, 6H), 1.10 (d, J = 6.9 Hz, 6H), 0.49 (d, J = 6.9 Hz, 6H). 13C NMR 
(CDCl3, 100 MHz): % 146.21, 140.75, 139.78, 138.69, 132.19, 130.09, 128.70, 
128.65, 128.08, 127.25, 125.13, 124.39, 123.53, 120.66, 34.95, 27.99, 24.78, 24.36, 
22.77. HRMS (ESI) m/z calculated for C46H52N2Na [M+Na]+ 655.4028, observed 
655.4025. 
4S,5S-1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-4,5-diphenyl-4,5-dihydro-1H-
imidazol-3-ium tetrafluoroborate (DiPhSIPrNap·HBF4) (1a). Diamine 1S,2S-
N,N$-bis(2,7-diisopropylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine (2.33 g, 
3.69 mmol), ammonium tetrafluoroborate (464 mg, 4.43 mmol), triethyl orthoformate 
(6.14 mL, 36.90 mmol) and two drops formic acid were heated to 120 °C and stirred 
for 12 h. The resulting mixture was dried in vacuo, and the residue was purified by 
flash chromatography (SiO2, 1:20 methanol:methylene chloride) to afford the product 
as an off-white foam (2.24 g, 83%). [!]25D = -174.2 (c = 1, CH2Cl2). 1H NMR 
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(CDCl3, 400 MHz) exists as a mixture of three atropisomers (54:10:36): % {8.92 (s, 
NCHN), 8.76 (s, NCHN), 8.69 (s, NCHN) (correspond to the three atropisomers of a 
single proton)}, 7.94-7.13 (m, ArH) (correspond to the three atropisomers of twenty 
protons), {6.51 (d, J = 12.6 Hz, NCHPh), 6.42 (s, NCHPh), 6.20 (s, NCHPh), 6.17 (d, 
J = 12.9 Hz, NCHPh) (correspond to the three atropisomers of two protons)}, {3.71 
(sept, J = 6.9 Hz, ArCH(CH3)2), 3.57 (sept, J = 6.9 Hz, ArCH(CH3)2), 3.39 (sept, J = 
6.9 Hz, ArCH(CH3)2), 3.30 (sept, J = 6.9 Hz, ArCH(CH3)2), 3.08 (sept, J = 6.9 Hz, 
ArCH(CH3)2), 3.01-2.90 (m, ArCH(CH3)2) (correspond to the three atropisomers of 
four protons)}, {1.84 (d, J = 6.9 Hz, ArCH(CH3)2), 1.80 (d, J = 6.9 Hz, ArCH(CH3)2), 
1.61 (d, J = 6.9 Hz, ArCH(CH3)2), 1.58 (d, J = 6.9 Hz, ArCH(CH3)2), 1.54 (d, J = 6.9 
Hz, ArCH(CH3)2), 1.50 (d, J = 6.9 Hz, ArCH(CH3)2), 1.32-1.12 (m, ArCH(CH3)2), 
0.59 (d, J = 6.9 Hz, ArCH(CH3)2), 0.51 (d, J = 6.9 Hz, ArCH(CH3)2) (correspond to 
the three atropisomers of twenty four protons)}. 13C NMR (CDCl3, 100 MHz) (due to 
existence of three atropisomers, 13C NMR spectrum appeared complex): % 159.35, 
158.77, 158.63, 149.74, 149.59, 147.99, 147.94, 146.14, 146.05, 144.31, 143.84, 
131.71, 131.62, 131.60, 131.58, 131.18, 131.11, 131.00, 130.86, 130.81, 130.51, 
130.37, 130.34, 130.32, 130.29, 130.27, 130.07, 129.86, 129.82, 129.76, 129.73, 
129.41, 129.39, 129.20, 129.16, 129.09, 128.95, 128.84, 128.79, 128.76, 128.34, 
128.13, 127.92, 126.88, 126.39, 126.33, 125.52, 125.23, 125.02, 124.24, 123.95, 
123.04, 122.98, 122.81, 118.63, 117.77, 116.78, 115.94, 75.21, 74.88, 73.35, 72.79, 
35.30, 34.89, 34.86, 30.23, 30.20, 29.82, 29.62, 24.86, 24.79, 24.51, 24.46, 24.24, 
24.17, 24.03, 23.83, 23.74, 23.67, 23.59, 22.23, 22.15, 21.79, 14.02. HRMS (ESI) m/z 
calculated for C47H51N2 [M-BF4]+ 643.4052, observed 643.4057. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2,7-diisopropylnaphthalen-
1-yl)-4,5-diphenyl-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(DiPhSIPrNap)Pd(cinnamyl)Cl] (2a): DiPhSIPrNap·HBF4 (1.02 g, 1.40 mmol), 
KOtBu (157 mg, 1.40 mmol) and [Pd(cinnamyl)Cl]2 (344 mg, 0.66 mmol) were 
mixed together in a round flask in the glovebox. Dry THF (60 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by flash chromatography (SiO2, 1:8&1:3 EtOAc/n-
hexane) to afford three atropisomers (1.08 g, 89.4%). Elemental analysis (%) 
calculated for C56H59PdN2Cl•0.5CH2Cl2: C, 71.85; H, 6.40; N, 2.97. Found: C, 72.06; 
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H, 6.40; N, 2.97. HRMS (ESI) m/z calculated for 12C56H59104Pd14N235ClNa [M+Na]+ 
921.3304, observed 921.3290. 
Data for Sa,Sa-2a are as follows (first point). (90 mg, 7.4%). [!]25D = +35.8 (c 
= 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 7.95 (s, 2H), 7.76-7.74 (br m, 2H), 7.56 
(d, J = 8.4 Hz, 2H), 7.49 (d, J = 8.6 Hz, 2H), 7.30 (br s, 4H), 7.19 (d, J = 7.7 Hz, 2H), 
7.03-6.93 (br m, 9H), 6.60-6.55 (br m, 2H), 5.85 (br s, 1H), 5.81 (br s, 1H), 4.54-4.47 
(br m, 0.54H), 4.01-3.80 (br m, 3.36H), 3.28-2.98 (br m, 3.10H), 1.87-1.25 (m, 25H). 
13C NMR (CDCl3, 100 MHz): % 213.77, 145.56, 144.16, 138.79, 136.27, 133.01, 
132.51, 131.70, 129.36, 128.97, 128.86, 128.67, 128.10, 127.60, 127.33, 126.33, 
125.30, 123.84, 123.41, 109.73, 48.97, 34.80, 29.54, 25.80, 24.97, 24.11, 23.44. 
Data for Ra,Ra-2a are as follows (second point). (593 mg, 49.3%). [!]25D = -
439.9 (c = 1, CH2Cl2). Crystals suitable for diffraction studies were grown from a 
diethyl ether/n-hexane solution of Ra,Ra-2a. 1H NMR (CDCl3, 400 MHz): % 8.28 (br 
s, 2H), 7.84-7.59 (br m, 4H), 7.47-6.80 (br m, 19H), 6.04 (br s, 2H), 5.10-5.04 (m, 
0.68H), 4.44-4.42 (br m, 0.32H), 4.18 (d, J = 12 Hz, 0.68H), 4.11 (d, J = 12 Hz, 
0.32H), 3.52-2.49 (br m, 2H), 3.31 (sept, J = 6.9 Hz, 2H), 2.62 (d, J = 4 Hz, 0.68H), 
2.19 (d, J = 4 Hz, 0.32H), 2.00 (d, J = 12 Hz, 0.32H), 1.63-1.18 (m, 18H), 0.50 (d, J = 
12 Hz, 0.68H), 0.46-0.25 (br m, 6H). 13C NMR (CDCl3, 100 MHz): % 211.60, 147.05, 
137.44, 131.92, 130.86, 129.25, 129.15, 128.98, 128.56, 128.19, 127.97, 127.56, 
127.25, 125.82, 108.97, 106.25, 92.63, 90.86, 89.52, 47.62, 46.57, 35.34, 34.33, 
28.81, 28.56, 26.67, 26.24, 24.80, 23.99, 23.85, 23.37, 22.55, 15.49, 14.27. 
Data for Ra,Sa-2a are as follows (third point). (392 mg, 32.6%). [!]25D = -
309.5 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.27 (s, 1H), 8.01-7.44 (br m, 
9H), 7.30-7.22 (br m, 8H), 7.09-6.84 (br m, 6H), 6.57 (br s, 1H), 6.06-6.01 (br m, 
1H), 5.81-5.79 (br m, 1H), 4.48 (br s, 0.5H), 4.28 (br s, 0.5H), 3.96-3.81 (br m, 2H), 
3.59-3.41 (br m, 2H), 3.06 (br s, 1H), 2.91 (br s, 0.5H), 2.69 (br s, 0.5H), 1.78-1.15 
(br m, 21H), 0.35-0.18 (br m, 3H). 13C NMR (CDCl3, 100 MHz): % 213.74, 212.45, 
212.13, 193.88, 163.99, 152.96, 148.35, 148.22, 148.09, 147.82, 147.43, 147.22, 
145.22, 144.97, 144.47, 138.29, 137.79, 137.63, 137.10, 136.49, 132.22, 132.03, 
131.92, 131.76, 131.46, 130.51, 129.92, 129.61, 129.47, 129.33, 129.18, 129.14, 
129.02, 128.96, 128.81, 128.68, 128.62, 128.48, 128.30, 128.15, 128.04, 127.41, 
127.23, 126.36, 125.80, 125.73, 124.83, 124.62, 124.34, 124.11, 123.92, 123.07, 
122.71, 121.07, 120.83, 119.78, 109.96, 190.10, 105.92, 89.33, 89.08, 87.55, 77.44, 
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76.50, 75.93, 75.78, 66.03, 53.00, 49.48, 48.64, 35.88, 35.27, 34.77, 34.31, 32.12, 
30.15, 29.98, 29.89, 29.63, 29.55, 29.00, 28.67, 28.54, 26.54, 26.02, 25.48, 25.32, 
25.22, 24.79, 24.66, 24.58, 24.50, 24.30, 24.23, 24.03, 23.93, 23.93, 23.74, 23.54, 
23.47, 23.53, 23.47, 22.88, 22.52, 15.47, 14.25. 
1S,2S-N,N$-Bis(2-isopropylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine. A 
250 mL schlenk flask was charged with Pd(dba)2 (345 mg, 0.60 mmol), (±)-BINAP 
(448 mg, 0.72 mmol), NaOtBu (1.73 g, 18.00 mmol) and toluene (180 mL) and stirred 
for 20 min. 1-Bromo-2-isopropylnaphthalene (3.29 g, 13.20 mmol) and (1S,2S)-(-)-
1,2-diphenylethylenediamine (1.27 g, 6.00 mmol) were then added and the solution 
was heated to 110 °C for 48 h. After cooling to room temperature, the resulting 
mixture was filtered through a celite and silica gel filter and washed with CH2Cl2. The 
filtrate was concentrated, and the residue was dissolved in hexane and filtered through 
a celite filter. The filtrate was concentrated and the residue was purified by flash 
chromatography (SiO2, 1:3 CH2Cl2/hexane) to afford 1S,2S-N,N$-bis(2-
isopropylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine as a white solid (2.04 g, 
73%). 1H NMR (CDCl3, 400 MHz): % 8.57 (d, J = 8.8 Hz, 2H), 7.77 (d, J = 8.4 Hz, 
2H), 7.53 (d, J = 8.6 Hz, 2H), 7.44-7.32 (m, , 4H), 7.25 (d, J = 8.6 Hz, 2H), 6.99-6.92 
(m, 10H), 5.03 (d, J = 4.3 Hz, 2H), 4.81 (br s, 2H), 3.22 (sept, J = 6.9 Hz, 2H), 1.07 
(d, J = 6.9 Hz, 6H), 0.73 (d, J = 6.9 Hz, 6H). 13C NMR (CDCl3, 100 MHz): % 140.50, 
139.05, 138.81, 133.49, 129.93, 128.66, 128.53, 128.07, 127.31, 125.49, 125.01, 
124.37, 124.26, 124.24, 69.05, 28.02, 24.42, 22.85. HRMS (ESI) m/z calculated for 
C40H40N2Na [M+Na]+ 571.3089, observed 571.3084. 
4S,5S-1,3-Bis(2-diisopropylnaphthalen-1-yl)-4,5-diphenyl-4,5-dihydro-1H-
imidazol-3-ium tetrafluoroborate (DiPhSI2PrNap·HBF4) (1b). Diamine 1S,2S-
N,N$-bis(2-isopropylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine (1.40 g, 2.55 
mmol), ammonium tetrafluoroborate (321 mg, 3.06 mmol), triethyl orthoformate 
(4.25 mL, 25.50 mmol) and two drops formic acid were heated to 120 °C and stirred 
for 12 h. The resulting mixture was dried in vacuo, and the residue was purified by 
flash chromatography (SiO2, 1:20 methanol:methylene chloride) to afford the product 
as an off-white foam (1.52 g, 92%). [!]25D = -195.7 (c = 1, CH2Cl2). 1H NMR 
(CDCl3, 400 MHz) exists as a mixture of three atropisomers (8:41:51): % {8.71 (s, 
NCHN), 8.67 (s, NCHN), 8.60 (s, NCHN) (correspond to the three atropisomers of a 
single proton)}, 8.39-7.18 (m, ArH) (correspond to the three atropisomers of twenty 
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two protons), {6.62 (d, J = 13.2 Hz, NCHPh), 6.59 (s, NCHPh), 6.22 (s, NCHPh), 
6.18 (d, J = 13.2 Hz, NCHPh) (correspond to the three atropisomers of two protons)}, 
{3.76 (sept, J = 6.9 Hz, ArCH(CH3)2), 3.59 (sept, J = 6.9 Hz, ArCH(CH3)2), 3.29-3.05 
(m, ArCH(CH3)2) (correspond to the three atropisomers of two protons)}, {1.77 (d, J 
= 6.9 Hz, ArCH(CH3)2), 1.69 (d, J = 6.9 Hz, ArCH(CH3)2), 1.62-1.53 (m, 
ArCH(CH3)2), 1.31-1.08 (m, ArCH(CH3)2), 0.72 (d, J = 6.9 Hz, ArCH(CH3)2), 0.66 
(d, J = 6.9 Hz, ArCH(CH3)2), (correspond to the three atropisomers of twelve 
protons)}. 13C NMR (CDCl3, 100 MHz) (due to existence of three atropisomers, 13C 
NMR spectrum appeared complex): % 162.02, 158.72, 158.51, 146.62, 145.86, 
144.08, 132.95, 132.82, 132.49, 132.17, 132.05, 132.01, 131.01, 130.98, 130.93, 
130.36, 130.05, 129.84, 129.83, 129.67, 129.57, 129.52, 129.42, 129.35, 129.29, 
129.27, 129.14, 129.07, 128.57, 127.88, 127.23, 127.12, 126.88, 125.74, 124.77, 
124.64, 123.90, 123.62, 123.59, 122.51, 121.29, 120.40, 75.66, 74.12, 73.58, 41.88, 
36.50, 30.37, 29.84, 29.77, 25.22, 25.07, 24.60, 24.11, 22.41, 21.98, 14.83, 12.70. 
HRMS (ESI) m/z calculated for C41H39N2 [M-BF4]+ 559.3113, observed 559.3111. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2-diisopropylnaphthalen-1-
yl)-4,5-diphenyl-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(DiPhSI2PrNap)Pd(cinnamyl)Cl] (2b): DiPhSI2PrNap·HBF4 (1.20 g, 1.86 mmol), 
KOtBu (209 mg, 1.86 mmol) and [Pd(cinnamyl)Cl]2 (458 mg, 0.88 mmol) were 
mixed together in a round flask in the glovebox. Dry THF (70 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by flash chromatography (SiO2, 1:5&1:3 
EtOAc/hexane) to afford three atropisomers (1.25 g, 86%). Elemental analysis (%) 
calculated for C50H47PdN2Cl•0.5C6H14: C, 73.94; H, 6.32; N, 3.25. Found: C, 74.24; 
H, 6.49; N, 3.26. HRMS (ESI) m/z calculated for 12C50H47104Pd14N2 [M-Cl]+ 
779.2779, observed 779.2776. 
Data for Ra,Sa-2b are as follows (first point). (547 mg, 37.7%).  [!]25D = -
291.9 (c = 1, CH2Cl2). Crystals suitable for diffraction studies were grown from a 
EtOAc/n-hexane solution of Ra,Sa-2b. 1H NMR (CDCl3, 400 MHz): % 8.49-8.44 (m, 
2H), 7.96-7.29 (br m, 17H), 7.09-6.86 (br m, 7H), 6.58 (br s, 1H), 6.19-6.19 (br m, 
1H), 5.72 (br s, 1H), 4.40-3.66 (br m, 4H), 2.78 (br s, 0.5H), 2.48 (br s, 0.5 H), 1.81-
0.74 (m, 10H), 0.39 (br s, 1.5H), 0.22 (br s, 1.5H). 13C NMR (CDCl3, 100 MHz): % 
216.59, 214.91, 171.26, 148.15, 147.97, 147.79, 144.50, 144.30, 138.43, 138.23, 
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137.62, 137.47, 136.82, 136.70, 136.50, 133.10, 133.03, 132.36, 131.89, 131.75, 
130.83, 130.70, 129.35, 129.24, 129.16, 128.87, 128.74, 128.08, 128.03, 127.98, 
127.82, 127.70, 127.60, 127.41, 127.25, 127.14, 126.73, 126.33, 125.58, 125.45, 
125.26, 125.11, 124.62, 123.63, 123.37, 110.42, 109.12, 106.15, 88.56, 88.47, 87.20, 
78.05, 60.53, 50.3, 49.74, 30.02, 29.86, 28.71, 28.60, 26.23, 25.59, 24.99, 24.84, 
24.64, 24.53, 24.35, 23.88, 23.7321.20, 14.37. 
Data for Sa,Sa-2b are as follows (second point). (10 mg, 0.7%). [!]25D = -24.5 
(c = 0.25, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.40 (br d, J = 7.1 Hz, 2H), 7.77 
(d, J = 8.3 Hz, 2H), 7.65 (br s, 2H), 7.48 (d, J = 8.7 Hz, 2H), 7.35-7.6.92 (br m, 17H), 
7.51-6.44 (m, 2H), 5.74 (br d, J = 14.3 Hz, 2H), 4.22-3.70 (br m, 5H), 3.18 (br d, J = 
5.8 Hz, 0.5H), 2.90 (br d, J = 5.2 Hz, 0.5H),  1.74-1.24 (m, 12H). 13C NMR (CDCl3, 
100 MHz): % 214.63, 143.36, 137.48, 137.02, 132.87, 131.89, 129.49, 129.01, 128.83, 
128.58, 128.47, 128.30, 127.97, 127.48, 127.41, 127.01, 126.39, 125.68, 124.46, 
110.29, 110.01, 88.06, 53.63, 49.93, 29.92, 29.65, 25.13, 24.44. 
Data for Ra,Ra-2b are as follows (third point). (697 mg, 48.1%). [!]25D = -
351.3 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.49 (br s, 2H), 7.89-7.75 (br 
m, 6H), 7.57 (br s, 2H), 7.51-6.76 (br m, 17H), 6.06 (br s, 2H), 5.08-5.00 (m, 0.68H), 
4.53-4.44 (br m, 0.32H), 4.20 (d, J = 12 Hz, 0.68H), 4.10 (d, J = 12 Hz, 0.32H), 3.66-
3.34 (br m, 2H), 2.54 (d, J = 4 Hz, 0.68H), 1.97 (d, J = 4 Hz, 0.32H), 1.79-1.17 (m, 
7H), 0.94-0.26 (br m, 6H). 13C NMR (CDCl3, 100 MHz): % 212.23, 137.52, 133.20, 
130.77, 129.44, 129.24, 129.11, 129.03, 128.39, 128.10, 127.58, 127.33, 126.84, 
126.66, 125.71, 109.33, 108.97, 92.02, 74.84, 47.11, 29.74, 25.76, 23.39. 
2-Cyclohexylnaphthalene. In a 50 mL 3-necked flask, equipped with a condenser, an 
addition funnel and a N2 inlet, were added 592 mg of magnesium turnings (and 1 
crystal of I2) under N2 flow. In the addition funnel was charged 4.80 g of 2-
bromonaphthalene and 25 mL THF. 5 mL of this solution was added into the flask 
and warmed with the heating gun for 1 min and the solution became light brown. The 
flask was then warmed with an oil bath at 60°C and the remaining solution was added 
dropwise. At the end of the addition, the mixture was reflux for 1h. In a 250 mL 
schlenk flask was added 3.78 g of 1-bromocyclohexane and 390 mg of 
(FeCl3)2(TMEDA)3 in 20 mL THF. The grignard reagent was then added dropwise 
into the schlenk flask and stirred at room temperature for 2h. The reaction was 
quenched with 1 N HCl aqueous solution, and extracted with Et2O. The product was 
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isolated as a colorless oil by flash chromatography using n-hexane as eluent (4.10 g, 
84%). 1H NMR (CDCl3, 400 MHz): % 7.89-7.85 (m, 3H), 7.73 (s, 1H), 7.58-7.45 (m, 
3H), 2.80-2.72 (m, 1H), 2.09-1.88 (m, 5H), 1.68-1.39 (m, 5H). 13C NMR (CDCl3, 100 
MHz): % 145.73, 133.92, 132.35, 127.92, 127.80, 127.75, 126.38, 125.94, 125.20, 
124.73, 44.88, 34.63, 27.16, 26.45. HRMS (EI) m/z calculated for C16H18 [M]+ 
210.1409, observed 210.1406. 
1-Bromo-2-cyclohexylnaphthalene. 2.63 g 2-cyclohexylnaphthalene were dissolved 
in 50 mL CH2Cl2, and then a 50 mL CH2Cl2 solution of Br2 (1.0 eq.) was added 
dropwise over 1h at 0°C. After 3h the reaction was finished (confirmed by GC-MS). 
The reaction was quenched by adding 100 mL of a 25% Na2S2O3 aqueous solution. 
The CH2Cl2 phase was separated and washed with 200 mL water, 200 mL 5% 
Na2CO3, dried by MgSO4, filtered and concentrated under vacuum to afford a light 
yellow oil (3.25 g, 90%). 1H NMR (CDCl3, 400 MHz): % 8.33 (d, J = 6.8 Hz, 1H), 
7.78-7.71 (m, 2H), 7.58-7.34 (m, 3H), 3.47-3.33 (m, 1H), 2.72-1.78 (m, 5H), 1.56-
1.24 (m, 5H). 13C NMR (CDCl3, 100 MHz): % 144.45, 133.47, 132.81, 128.13, 
127.97, 127.93, 127.39, 125.97, 125.18, 123.65, 44.64, 33.39, 27.09, 26.47. HRMS 
(EI) m/z calculated for C16H17Br [M]+ 288.0514, observed 288.0514. 
1S,2S-N,N$-Bis(2-cyclohexylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine. A 
250 mL schlenk flask was charged with Pd(dba)2 (282 mg, 0.49 mmol), (±)-BINAP 
(367 mg, 0.59 mmol), NaOtBu (1.42 g, 14.76 mmol) and toluene (170 mL) and stirred 
for 20 min. 1-Bromo-2-cyclohexylnaphthalene (3.13 g, 10.82 mmol) and (1S,2S)-(-)-
1,2-diphenylethylenediamine (1.04 g, 4.92 mmol) were then added and the solution 
was heated to 110 °C for 16 h. After cooling to room temperature, the resulting 
mixture was filtered through a celite filter and washed with CH2Cl2. The filtrate was 
concentrated and the residue was purified by flash chromatography (SiO2, 1:20 
EtOAc/n-hexane) to afford 1S,2S-N,N$-bis(2-cyclohexylnaphthalen-1-yl)-1,2-
diphenylethane-1,2-diamine as a white solid (1.46 g, 47%). 1H NMR (CDCl3, 500 
MHz): % 8.61 (d, J = 7.8 Hz, 2H), 7.79 (d, J = 7.0 Hz, 2H), 7.56 (d, J = 8.6 Hz, 2H), 
7.46-4.39 (m, 4H), 7.30 (d, J = 8.6, 2H), 7.01-6.96 (m, 10H), 5.03 (br s, 2H), 4.94 (br 
s, 2H), 2.98-2.94 (m, 2H), 1.92-1.11 (m, 20H). 13C NMR (CDCl3, 125 MHz): % 
140.51, 139.40, 138.18, 133.41, 130.22, 128.60, 128.38, 128.13, 127.24, 125.40, 
125.13, 124.98, 124.45, 124.23, 69.25, 38.86, 34.95, 33.26, 31.81, 27.60, 27.19, 
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26.46, 22.87, 14.34. HRMS (ESI) m/z calculated for C46H48N2Na [M+Na]+ 651.3715, 
observed 651.3723. 
4S,5S-1,3-Bis(2-cyclohexylnaphthalen-1-yl)-4,5-diphenyl-4,5-dihydro-1H-
imidazol-3-ium tetrafluoroborate (DiPhSI2CyNap·HBF4) (1c). Diamine 1S,2S-
N,N$-bis(2-cyclohexylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine (1.46 g, 2.32 
mmol), ammonium tetrafluoroborate (292 mg, 2.79 mmol), triethyl orthoformate 
(3.86 mL, 23.20 mmol) and two drops formic acid were heated to 120 °C and stirred 
for 16 h. The resulting mixture was dried in vacuo, and the residue was purified by 
flash chromatography (SiO2, 1:20 methanol:methylene chloride) to afford the product 
as an off-white foam (1.57 g, 93%). [!]25D = -230.9 (c = 1, CH2Cl2). 1H NMR 
(CDCl3, 400 MHz) exists as a mixture of three atropisomers (71:21:8): % {8.99 (s, 
NCHN), 8.73 (s, NCHN), 8.55 (s, NCHN) (correspond to the three atropisomers of a 
single proton)}, 8.34-7.22 (m, ArH) (correspond to the three atropisomers of twenty 
two protons), {6.61 (s, NCHPh), 6.43 (d, J = 11.4 Hz, NCHPh), 6.28 (d, J = 11.4 Hz, 
NCHPh), 6.03 (s, NCHPh) (correspond to the three atropisomers of two protons)}, 
{3.32-3.22 (m, Cy), 2.75-2.56 (m, Cy), 2.33-1.17 (m, Cy), 0.28-0.26 (m, Cy) 
(correspond to the three atropisomers of twenty two protons)}. 13C NMR (CDCl3, 100 
MHz) (due to existence of three atropisomers, 13C NMR spectrum appeared 
complex): % 159.89, 158.85, 158.80, 145.56, 144.93, 142.97, 142.58, 133.21, 132.75, 
132.13, 132.03, 131.85, 131.26, 131.17, 130.40, 129.97, 129.95, 129.78, 129.74, 
129.67, 129.62, 129.33, 129.05, 128.95, 128.88, 128.41, 128.31, 127.29, 127.19, 
127.00, 126.71, 124.93, 124.86, 124.81, 124.64, 121.75, 120.86, 120.20, 76.54, 76.22, 
74.54, 73.20, 66.01, 41.48, 40.80, 40.64, 35.42, 35.03, 34.63, 34.57, 34.22, 32.67, 
31.86, 31.06, 27.62, 27.51, 27.19, 26.98, 26.72, 26.12, 25.96, 25.82, 22.51, 15.44, 
14.23. HRMS (ESI) m/z calculated for C47H47N2 [M-BF4]+ 639.3739, observed 
639.3741. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2-cyclohexylnaphthalen-1-
yl)-4,5-diphenyl-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(DiPhSI2CyNap)Pd(cinnamyl)Cl] (2c): DiPhSI2CyNap·HBF4 (1.03 g, 1.42 mmol), 
KOtBu (159 mg, 1.42 mmol) and [Pd(cinnamyl)Cl]2 (352 mg, 0.68 mmol) were 
mixed together in a round flask in the glovebox. Dry THF (60 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by flash chromatography (SiO2, 1:5&1:3 EtOAc/n-
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hexane) to afford two pure atropisomers (753 mg, 62%) (One of the three 
atropisomers couldn’t be isolated as a pure isomer). Elemental analysis (%) 
calculated for C56H55PdN2Cl•1.5CH2Cl2: C, 67.36; H, 5.70; N, 2.73. Found: C, 67.56; 
H, 5.73; N, 2.62. HRMS (ESI) m/z calculated for 12C56H55104Pd14N2 [M-Cl]+ 
859.3405, observed 859.3397. 
Data for Ra,Sa-2c are as follows (first point). (164 mg, 14%). [!]25D = -274.8 
(c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.50 (d, J = 8.2Hz, 2H), 7.97-6.65 
(m, 25H), 6.13-6.07 (m, 1H), 5.79 (d, J = 9.3Hz, 0.38H), 5.67 (d, J = 9.3Hz, 0.62H), 
4.56-2.52 (m, 6H), 2.17-0.76 (m, 19H), (-0.01)-(-0.18) (m, 1H). 13C NMR (CDCl3, 
100 MHz): % 216.07, 214.01, 171.19, 163.79, 146.87, 143.15, 138.17, 138.13, 137.78, 
137.62, 137.50, 137.14, 137.04, 136.50, 133.01, 132.51, 132.37, 131.84, 131.71, 
130.72, 130.67, 129.37, 129.20, 129.14, 129.01, 128.90, 128.78, 128.67, 128.02, 
127.96, 127.83, 127.55, 127.24, 127.06, 126.64, 126.32, 126.26, 126.18, 126.04, 
125.62, 125.49, 125.05, 124.95, 123.52, 109.86, 108.89, 106.16, 86.77, 78.59, 77.78, 
76.66, 60.48, 50.73, 40.88, 39.13, 38.79, 35.16, 34.97, 33.82, 33.67, 33.59, 31.70, 
27.60, 27.57, 27.29, 26.91, 26.83, 26.76, 26.40, 26.35, 26.27, 22.77, 22.45, 14.33, 
14.26, 14.20. 
Data for Ra,Ra-2c are as follows (third point). (589 mg, 48%). [!]25D = -292.5 
(c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.58 (br s, 2H), 7.87-7.03 (br m, 
25H), 6.04 (br s, 2H), 5.00 (br s, 0.5H), 4.45-4.23 (m, 1.6H), 3.04-2.87 (br m, 2.4H), 
2.60 (br s, 1H), 1.87-1.07 (m, 18H), 0.37 (d, J = 8Hz, 0.5H), (-0.06)-(-0.30) (br m, 
2H). 13C NMR (CDCl3, 100 MHz): % 211.80, 171.29, 137.71, 137.36, 133.20, 130.87, 
129.24, 129.14, 129.04, 128.95, 128.31, 128.11, 127.93, 127.35, 126.77, 126.54, 
125.67, 109.05, 108.37, 92.22, 89.89, 88.79, 75.18, 60.55, 53.64, 48.20, 46.30, 39.43, 
35.19, 34.30, 33.22, 27.35, 27.04, 26.37, 22.51, 14.38, 14.24. 
1R,2R-N,N$-Bis(2,7-diisopropylnaphthalen-1-yl)-1,2-diaminocyclohexane. A 250 
mL schlenk flask was charged with Pd(dba)2 (173 mg, 0.30 mmol), (±)-BINAP (187 
mg, 0.30 mmol), NaOtBu (865 mg, 9.00 mmol) and toluene (90 mL) and stirred for 20 
min. 1-Bromo-2,7-diisopropylnaphthalene (1.92 g, 6.60 mmol) and (1R,2R)-(-)-1,2-
diaminocyclohexane (343 mg, 3.00 mmol) were then added and the solution was 
heated to 90 °C for 48 h. After cooling to room temperature, the resulting mixture was 
filtered through a celite filter and washed by CH2Cl2. The filtrate was concentrated 
and the residue was purified by flash chromatography (SiO2, 1:40 EtOAc/n-hexane) 
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to afford 1R,2R-N,N$-bis(2,7-diisopropylnaphthalen-1-yl)-1,2-diaminocyclohexane as 
a white solid (1.18 g, 74%). 1H NMR (CDCl3, 400 MHz): % 8.46 (s, 2H), 7.74 (d, J = 
8.4 Hz, 2H), 7.59 (d, J = 8.6 Hz, 2H), 7.39 (d, J = 8.6 Hz, 2H), 7.34 (dd, J = 8.4, 1.6 
Hz, 2H), 4.44 (br s, 2H), 3.80 (sept, J = 6.9 Hz, 2H), 4.96 (br d, J = 7.4 Hz, 2H), 3.11 
(sept, J = 6.9 Hz, 2H), 1.81 (br d, J = 13.3 Hz, 2H), 1.57-1.54 (br m, 2H), 1.43-1.30 
(m, 26H), 1.05-1.03 (m, 2H). 13C NMR (CDCl3, 100 MHz): % 145.98, 139.85, 139.03, 
132.05, 128.33, 125.17, 124.16, 123.46, 121.10, 64.54, 34.83, 33.12, 27.93, 25.26, 
24.81, 24.51, 24.41, 23.53. HRMS (ESI) m/z calculated for C38H50N2Na [M+Na]+ 
557.3872, observed 557.3864. 
4R,5R-1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-octahydro-1H-benzoimidazol-3-
ium tetrafluoroborate (CySIPrNap·HBF4) (1d). Diamine 1R,2R-N,N$-bis(2,7-
diisopropylnaphthalen-1-yl)-1,2-diaminocyclohexane (869 mg, 1.62 mmol), 
ammonium tetrafluoroborate (170 mg, 1.62 mmol), triethyl orthoformate (2.70 mL, 
16.20 mmol) and two drops formic acid were heated to 120 °C and stirred for 14 h. 
The resulting mixture was dried in vacuo, and the residue was purified by flash 
chromatography (SiO2, 1:20 methanol:methylene chloride) to afford the product as an 
off-white foam (870 mg, 85%). [!]25D = -132.3 (c = 1, CH2Cl2). 1H NMR (CDCl3, 
400 MHz) exists as a mixture of three atropisomers (40:15:45): % {8.36 (s, NCHN), 
8.33 (s, NCHN), 8.26 (s, NCHN) (correspond to the three atropisomers of a single 
proton)}, 7.97-7.37 (m, ArH) (correspond to the three atropisomers of ten protons), 
{4.72-4.50 (m, NCHPh) (correspond to the three atropisomers of two protons)}, {3.74 
(sept, J = 6.9 Hz, ArCH(CH3)2), 3.66 (sept, J = 6.9 Hz, ArCH(CH3)2), 3.30-3.18 (m, 
ArCH(CH3)2), 3.15 (sept, J = 6.9 Hz, ArCH(CH3)2) (correspond to the three 
atropisomers of four protons)}, {1.98-1.92 (m, 6H), 1.55-1.31 (m, 26H) (correspond 
to the three atropisomers of thirty two protons)}. 13C NMR (CDCl3, 100 MHz) (due to 
existence of three atropisomers, 13C NMR spectrum appeared complex): % 161.93, 
161.49, 161.22, 150.56, 149.93,149.84, 149.52, 146.84, 146.09,144.81, 144.17, 
131.96, 131.93, 131.72, 131.65, 131.63, 131.11, 130.86, 129.88, 129.75, 129.65, 
129.51, 129.10, 128.81, 127.13, 126.49, 126.25, 126.21, 125.70, 125.47, 124.89, 
124.76, 123.79, 123.60, 123.34, 123.24, 118.57, 118.06, 117.21, 116.95, 73.68, 73.65, 
72.92, 72.64, 35.24, 35.21, 35.12, 34.57, 29.85, 29.80, 29.76, 29.56, 28.64, 27.92, 
27.79, 27.16, 25.43, 25.17, 24.92, 24.59, 24.38, 24.32, 24.31, 24.14, 24.02, 23.94, 
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23.86, 23.75, 23.56, 23.15, 22.79. HRMS (ESI) m/z calculated for C39H49N2 [M-BF4]+ 
545.3896, observed 545.3896. 
1S,2S-N,N$-Bis(2,7-dimethylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine. A 
250 mL schlenk flask was charged with Pd(dba)2 (230 mg, 0.40 mmol), (±)-BINAP 
(299 mg, 0.48 mmol), NaOtBu (1.15 g, 12.00 mmol) and toluene (120 mL) and stirred 
for 20 min. 1-Bromo-2,7-dimethylnaphthalene (1.98 g, 8.40 mmol) and (1S,2S)-(-)-
1,2-diphenylethylenediamine (0.85 g, 4.00 mmol) were then added and the solution 
was heated to 110 °C for 16 h. After cooling to room temperature, the resulting 
mixture was filtered through a celite filter and washed with CH2Cl2. The filtrate was 
concentrated and the residue was purified by flash chromatography (SiO2, 1:4 
CH2Cl2/n-hexane) to afford 1S,2S-N,N$-bis(2,7-dimethylnaphthalen-1-yl)-1,2-
diphenylethane-1,2-diamine as a white solid (1.90 g, 91%). 1H NMR (CDCl3, 500 
MHz): % 8.01 (s, 2H), 7.64 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.3 Hz, 2H), 7.19 (d, J = 
8.3 Hz, 2H), 7.08-7.01 (m, 12H), 5.05 (br s, 2H), 4.66 (br s, 2H), 2.40 (s, 6H), 2.12 (s, 
6H). 13C NMR (CDCl3, 125 MHz): % 141.07, 140.54, 134.90, 132.06, 129.09, 128.74, 
128.41, 128.06, 127.44, 127.04, 126.57, 122.59, 122.53, 68.09, 22.26, 19.12. HRMS 
(ESI) m/z calculated for C38H36N2Na [M+Na]+ 543.2771, observed 543.2767. 
4S,5S-1,3-Bis(2,7-dimethylnaphthalen-1-yl)-4,5-diphenyl-4,5-dihydro-1H-
imidazol-3-ium tetrafluoroborate (DiPhSIMeNap·HBF4) (1e). Diamine 1S,2S-
N,N$-bis(2,7-dimethylnaphthalen-1-yl)-1,2-diphenylethane-1,2-diamine (1.87 g, 3.60 
mmol), ammonium tetrafluoroborate (453 mg, 4.32 mmol), triethyl orthoformate 
(6.00 mL, 36.00 mmol) and two drops formic acid were heated to 110 °C and stirred 
for 12 h. The resulting mixture was dried in vacuo, and the residue was purified by 
flash chromatography (SiO2, 1:20 MeOH:CH2Cl2) to afford the product as an off-
white foam (2.15 g, 97%). [!]27D = -336.81 (c = 1, CH2Cl2). 1H NMR (CDCl3, 500 
MHz) exists as a mixture of three atropisomers (27:64:9): % {9.13 (s, NCHN), 8.90 (s, 
NCHN), 8.54 (s, NCHN) (correspond to the three atropisomers of a single proton)}, 
7.96-7.14 (m, ArH) (correspond to the three atropisomers of twenty protons), {6.34 
(d, J = 12.8 Hz, NCHPh), 6.32 (s, NCHPh), 6.28 (s, NCHPh), 6.20 (d, J = 11.7 Hz, 
NCHPh) (correspond to the three atropisomers of two protons)}, {3.04 (s, ArCH3), 
2.99 (s, ArCH3), 2.85 (s, ArCH3), 2.75 (s, ArCH3), 2.48 (s, ArCH3), 2.43 (s, ArCH3), 
2.17 (s, ArCH3), 2.16 (s, ArCH3), (correspond to the three atropisomers of twenty four 
protons)}. 13C NMR (CDCl3, 100 MHz) (due to existence of three atropisomers, 13C 
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NMR spectrum appeared complex): % 160.20, 160.11, 159.41, 139.00, 138.72, 
138.31, 138.12, 137.49, 136.61, 134.71, 133.76, 131.99, 131.81, 131.78, 131.62, 
131.58, 131.19, 131.15, 131.13, 130.94, 130.85, 130.80, 130.76, 130.73, 129.98, 
129.79, 129.67, 129.65, 129.63, 129.54, 129.43, 129.38, 129.18, 129.09, 128.76, 
128.71, 128.65, 128.63, 128.54, 128.50, 128.24, 128.12, 128.02, 127.14, 126.84, 
126.42, 126.15, 120.72, 119.95, 119.69, 119.03, 74.89, 74.41, 73.76, 73.55, 22.96, 
22.67, 22.29, 22.08, 19.66, 19.56, 18.84, 18.72. HRMS (ESI) m/z calculated for 
C39H35N2 [M-BF4]+ 531.2795, observed 531.2802. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2,7-dimethylnaphthalen-1-
yl)-4,5-diphenyl-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(DiPhSIMeNap)Pd(cin)Cl] (2e): DiPhSIMeNap·HBF4 (320 mg, 0.52 mmol), 
KOtBu (58 mg, 0.52 mmol) and [Pd(cin)Cl]2 (134 mg, 0.26 mmol) were mixed 
together in a round flask in the glovebox. Dry THF (15 mL) was added and the 
mixture was stirred at room temperature for 14 h. The solvent was removed in vacuo, 
and the residue was separated by flash chromatography (SiO2, 1:6&1:3 EtOAc/n-
hexane) to afford two pure atropisomers (322 mg, 79%) (One of the three 
atropisomers couldn’t be isolated as a pure isomer). Elemental analysis (%) 
calculated for C48H43PdN2Cl: C, 73.01; H, 5.49; N, 3.55. Found: C, 73.21; H, 5.59; N, 
3.55. HRMS (ESI) m/z calculated for 12C48H43104Pd14N2 [M-Cl]+ 753.2473, observed 
753.2478. 
Data for Ra,Ra-2e are as follows (first spot). (86 mg, 21%). Crystals suitable 
for diffraction studies were grown from a CH2Cl2/n-hexane solution of Ra,Ra-2e. 
[!]27D = -243.26 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.18 (d, J = 17.1 Hz, 
2H), 7.82-7.67 (m, 4H), 7.40-7.35 (m, 2H), 7.30-7.31 (m, 10H), 7.11 (d, J = 8.4 Hz, 
2H), 6.99-6.94 (br m, 3H), 6.82-6.81 (br m, 2H), 6.71-6.70 (br m, 2H), [5.97 (s) and 
5.95 (s), 2H], 4.95-4.87 (m, 0.4H), 4.18-4.10 (m, 0.6H), 3.98 (d, J = 12.6 Hz, 0.4H), 
3.92 (d, J = 12.6 Hz, 0.6H), 3.06 (d, J = 6.6 Hz, 0.4H), 2.85 (d, J = 6.6 Hz, 0.6H), 
2.75 (s, 3H), 2.74 (s, 3H), 2.20 (s, 3H), 2.11 (s, 3H), 1.97 (d, J = 12.0 Hz, 0.6H), 1.05 
(d, J = 12.0 Hz, 0.4H). 13C NMR (CDCl3, 100 MHz): % 214.44, 213.35, 138.66, 
138.23, 136.64, 136.52, 136.25, 135.70, 135.53, 132.89, 131.72, 131.66, 131.33, 
131.21, 129.35, 129.30, 129.22, 129.06, 128.70, 128.59, 128.45, 128.12, 128.04, 
127.82, 127.75, 127.34, 127.22, 127.18, 126.45, 126.26, 123.52, 109.89, 109.56, 
89.65, 87.60, 77.55, 77.23, 76.91, 74.64, 74.54, 48.62, 48.07, 22.52, 22.47, 19.64. 
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Data for Ra,Sa-2e are as follows (third spot). (236 mg, 58%). Crystals suitable 
for diffraction studies were grown from a EtOAc/n-hexane solution of Ra,Sa-2e. 
[!]27D = -265.16 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.20 (d, J = 8.4 Hz, 
1H), 7.88-6.72 (m, 23H), 6.44 (d, J = 8.2 Hz, 1H), 6.09-5.92 (m, 2H), 4.19-4.01 (m, 
1H), 3.79-3.74 (m, 1H), [3.10 (s), 3.00 (s), 2.92 (s), 2.91 (s), 2.53 (s), 2.47 (s), 2.34 (s) 
and 2.16 (s), 12H], 2.97 (d, J = 8.2 Hz, 0.6H), 2.78 (d, J = 8.2 Hz, 0.4H), 1.48 (d, J = 
12.0 Hz, 0.4H), 1.00 (d, J = 12.0 Hz, 0.4H). 13C NMR (CDCl3, 100 MHz): % 214.10, 
213.26, 138.68, 138.49, 138.45, 136.35, 136.27, 136.22, 136.07, 135.91, 135.64, 
135.33, 134.48, 134.22, 133.10, 132.96, 132.87, 132.11, 132.06, 131.57, 131.36, 
131.23, 131.11, 129.51, 129.47, 129.39, 129.26, 129.23, 129.09, 128.84, 128.79, 
128.74, 128.59, 128.52, 128.30, 128.23, 128.13, 127.85, 127,75, 127.41, 127.37, 
127.16, 127.08, 126.97, 126.46, 126.37, 123.62, 123.36, 121.98, 121.76, 110.42, 
109.60, 88.60, 87.22, 75.01, 74.76, 74.26, 49.86, 49.09, 31.80, 22.89, 22.26, 22.19, 
21.39, 21.02, 20.69, 20.53, 14.32. 
1S,2S-N,N$-Bis(2-isopropyl-6-adamantyl-naphthalen-1-yl)-1,2-diphenylethane-
1,2-diamine. A 250 mL schlenk flask was charged with Pd(dba)2 (288 mg, 0.50 
mmol), (±)-BINAP (374 mg, 0.60 mmol), NaOtBu (1.44 g, 15.00 mmol) and toluene 
(150 mL) and stirred for 20 min. 1-Bromo-2-isopropyl-6-adamantyl-naphthalene 
(4.22 g, 11.00 mmol) and (1S,2S)-(-)-1,2-diphenylethylenediamine (1.06 g, 5.00 
mmol) were then added and the solution was heated to 110 °C for 20 h. After cooling 
to room temperature, the resulting mixture was filtered through a celite filter and 
washed with CH2Cl2. The filtrate was concentrated and the residue was purified by 
flash chromatography (SiO2, 1:4 CH2Cl2/n-hexane) to afford 1S,2S-N,N$-bis(2-
isopropyl-6-adamantyl-naphthalen-1-yl)-1,2-diphenylethane-1,2-diamine as a white 
solid (1.50 g, 73%). 1H NMR (CDCl3, 500 MHz): % 8.44 (d, J = 9.0 Hz, 2H), 7.65 (d, 
J = 2.0 Hz, 2H), 7.51-7.46 (m, 4H), 7.22 (d, J = 8.6 Hz, 2H), 7.03-6.95 (m, 10H), 5.05 
(br s, 2H), 4.76 (br s, 2H), 3.19 (sept, J = 6.8 Hz, 2H), 2.14 (br s, 6H), 2.02 (br s, 
12H), 1.82 (br S, 12H), 1.16 (d, J = 6.8 Hz, 6H), 0.71 (d, J = 6.8 Hz, 6H). 13C NMR 
(CDCl3, 125 MHz): % 147.79, 140.75, 138.91, 137.82, 133.60, 128.78, 128.06, 
128.02, 127.24, 124.18, 124.08, 124.02, 123.67, 123.49, 68.98, 43.34, 37.15, 36.34, 
29.25, 27.90, 24.43, 22.88. HRMS (ESI) m/z calculated for C60H68N2Na [M+Na]+ 
839.5280, observed 839.5273. 
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4S,5S-1,3-Bis(2-isopropyl-6-adamantyl-naphthalen-1-yl)-4,5-diphenyl-4,5-
dihydro-1H-imidazol-3-ium tetrafluoroborate (DiPhSIPrAd*Nap·HBF4) (1f). 
Diamine 1S,2S-N,N$-bis(2-isopropyl-6-adamantyl-naphthalen-1-yl)-1,2-
diphenylethane-1,2-diamine (900 mg, 1.10 mmol), ammonium tetrafluoroborate (139 
mg, 1.32 mmol), triethyl orthoformate (1.80 mL, 11.00 mmol) and two drops formic 
acid were heated to 110 °C and stirred for 12 h. The resulting suspension was cooled 
down, and filtered to obtain a white solid. The excess ammonium tetrafluoroborate 
was removed by dissolving the solid in 10 ml CH2Cl2 and purging through a celite 
filter. The filtrate was concentrated and the product was obtained as a white solid (840 
mg, 83%). [!]27D = -101.59  (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz) exists as a 
mixture of three atropisomers (15:31:54): % {8.67 (s, NCHN), 8.54 (s, NCHN), 8.42 
(s, NCHN) (correspond to the three atropisomers of a single proton)}, 8.26-7.25 (m, 
ArH) (correspond to the three atropisomers of twenty two protons), {6.60 (s, 
NCHPh), 6.59 (d, J = 12.8 Hz, NCHPh), 6.26 (s, NCHPh), 6.23 (d, J = 12.6 Hz, 
NCHPh) (correspond to the three atropisomers of two protons)}, {3.80-2.97 (m, 
ArCH(CH3)2) (correspond to the three atropisomers of two protons)}, {2.24-0.68 (m, 
Ad and ArCH(CH3)2), (correspond to the three atropisomers of forty two protons)}. 
13C NMR (CDCl3, 100 MHz) (due to existence of three atropisomers, 13C NMR 
spectrum appeared complex): % 159.05, 158.32, 158.27, 153.78, 150.46, 150.00, 
145.81, 145.21, 143.54, 143.31, 133.35, 133.25, 132.87, 132.31, 132.24, 131.18, 
131.10, 130.99, 130.25, 129.95, 129.68, 129.62, 129.59, 129.48, 129.32, 129.20, 
129.14, 128.68, 128.36, 128.23, 127.85, 127.61, 126.85, 125.47, 124.89, 124.70, 
124.46, 124.33, 123.81, 123.60, 123.54, 123.19, 121.95, 120.67, 120.00, 76.06, 75.68, 
74.27, 73.64, 65.98, 43.16, 42.97, 42.95, 36.92, 36.90, 36.87, 36.74, 36.72, 36.45, 
30.35, 29.83, 29.74, 29.07, 29.05, 28.97, 25.35, 24.71, 24.23, 22.48, 22.41, 22.02. 
HRMS (ESI) m/z calculated for C61H67N2 [M-BF4]+ 827.5299, observed 827.5304. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2-isopropyl-6-adamantyl-
naphthalen-1-yl)-4,5-diphenyl-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(DiPhSIPrAd*Nap)Pd(cin)Cl] (2f): DiPhSIPrAd*Nap·HBF4 (528 mg, 0.58 mmol), 
KOtBu (65 mg, 0.58 mmol) and [Pd(cin)Cl]2 (142 mg, 0.28 mmol) were mixed 
together in a round flask in the glovebox. Dry THF (18 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by flash chromatography (SiO2, 1:9&1:3 EtOAc/n-
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hexane) to afford two pure atropisomers (430 mg, 72%) (One of the three 
atropisomers couldn’t be isolated as a pure isomer). Elemental analysis (%) 
calculated for C48H43PdN2Cl·CH2Cl2: C, 72.39; H, 6.60; N, 2.37. Found: C, 72.91; H, 
6.37; N, 2.31. HRMS (ESI) m/z calculated for 12C70H75104Pd14N2 [M-Cl]+ 1049.4995, 
observed 1049.4982. 
Data for Ra,Ra-2f are as follows (first spot). (167 mg, 28%). [!]27D = -272.39 
(c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.38 (br s, 2H), 7.85-7.72 (br m, 6H), 
7.19-6.80 (m, 17H), 6.03 (br s, 2H), 5.04-5.03 (m, 0.6H), 4.40-4.08 (m, 1.4H), 3.59-
3.48 (br m, 2.4H), 2.49-2.47 (br m, 0.6H), 2.17-1.22 (br m, 36.6H), 0.45-0.34 (br m, 
6.4H). 13C NMR (CDCl3, 100 MHz): % 211.54, 148.45, 137.51, 136.59, 136.28, 
133.28, 129.45, 129.22, 129.03, 128.39, 128.04, 127.18, 126.72, 124.65, 124.02, 
109.07, 106.21, 91.81, 89.43, 88.59, 74.77, 53.63, 46.90, 43.34, 37.06, 36.46, 29.31, 
29.16, 28.53, 25.82, 23.47. 
Data for Ra,Sa-2f are as follows (third spot). (263 mg, 44%). [!]27D = -369.71 
(c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.47-8.33 (m, 2H), 7.96-6.85 (m, 
22H), 6.49 (br s, 1H), 6.24-6.13 (br m, 1H), 5.73 (d, J = 9.6 Hz, 1H), 4.46-3.44 (br m, 
4H), [2.81 (br s) and 2.50 (br s), 1H], 2.26-0.63 (m, 40H), 0.43-0.27 (br m, 3H). 13C 
NMR (CDCl3, 100 MHz): % 213.88, 148.45, 147.79, 146.73, 143.18, 138.77, 138.29, 
137.67, 133.13, 132.33, 131.91, 129.95, 129.22, 129.08, 128.98, 128.78, 128.70, 
128.58, 128.04, 127.93, 127.75, 127.41, 127.15, 126.19, 125.57, 125.32, 125.01, 
124.92, 124.39, 123.55, 122.96, 122.54, 110.98, 108.99, 87.22, 53.62, 50.32, 49.98, 
43.36, 43.27, 37.01, 36.98, 36.49, 36.26, 34.25, 30.08, 29.14, 29.07, 28.48, 26.32, 
25.97, 25.72, 24.73, 24.57, 24.44, 24.26, 23.81, 22.46, 14.21. 
1S,2S-N,N$-Bis(2,7-diisopropylnaphthalen-1-yl)-1,2-di-(3,5-dimethylphenyl)-
ethane-1,2-diamine. A 250 mL schlenk flask was charged with Pd(dba)2 (243 mg, 
0.42 mmol), (±)-BINAP (318 mg, 0.51 mmol), NaOtBu (1.22 g, 12.70 mmol) and 
toluene (150 mL) and stirred for 20 min. 1-Bromo-2,7-diisopropylnaphthalene (2.95 
g, 10.20 mmol) and (1S,2S)-(-)-1,2-di-(3,5-dimethylphenyl)-ethylenediamine (1.14 g, 
4.23 mmol) were then added and the solution was heated to 120 °C for 48 h. After 
cooling to room temperature, the resulting mixture was filtered through a celite filter 
and washed with CH2Cl2. The filtrate was concentrated and the residue was purified 
by flash chromatography (SiO2, 1:6 CH2Cl2/n-hexane) to afford 1S,2S-N,N$-bis(2,7-
diisopropylnaphthalen-1-yl)-1,2-di-(3,5-dimethylphenyl)-ethane-1,2-diamine as a 
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white foam (1.90 g, 65%). 1H NMR (CDCl3, 500 MHz): % 8.29 (s, 2H), 7.72 (d, J = 
8.4 Hz, 2H), 7.47 (d, J = 7.6 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.6 Hz, 
2H), 6.69 (s, 2H), 6.64 (s, 4H), 4.90 (s, 2H), 4.83 (br s, 2H), 3.26 (sept, J = 6.9 Hz, 
2H), 2.99 (sept, J = 6.9 Hz, 2H), 1.32 (d, J = 6.9 Hz, 6H), 1.29 (d, J = 6.9 Hz, 6H), 
1.15 (d, J = 6.9 Hz, 6H), 0.67 (d, J = 6.9 Hz, 6H). 13C NMR (CDCl3, 125 MHz): % 
145.97, 140.86, 139.24, 138.59, 137.18, 132.24, 129.76, 128.91, 128.51, 126.80, 
124.85, 123.67, 123.49, 120.91, 68.75, 34.94, 28.02, 24.56, 24.55, 24.27, 22.88. 
HRMS (ESI) m/z calculated for C50H61N2 [M+H]+ 689.4829, observed 689.4839. 
4S,5S-1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-4,5-di-(3,5-dimethylphenyl)-4,5-
dihydro-1H-imidazol-3-ium tetrafluoroborate (Di(3,5-DiMePh)SIPrNap·HBF4) 
(1g). Diamine 1S,2S-N,N$-bis(2,7-diisopropylnaphthalen-1-yl)-1,2-di-(3,5-
dimethylphenyl)-ethane-1,2-diamine (267 mg, 0.39 mmol), ammonium 
tetrafluoroborate (49 mg, 0.47 mmol), triethyl orthoformate (0.65 mL, 3.90 mmol) 
and two drops formic acid were heated to 120 °C and stirred for 16 h. The resulting 
mixture was dried in vacuo, and the residue was purified by flash chromatography 
(SiO2, 1:20 MeOH:CH2Cl2) to afford the product as an off-white foam (255 mg, 
84%). [!]27D = -84.26 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz) exists as a 
mixture of three atropisomers (65:27:8): % {8.88 (s, NCHN), 8.73 (s, NCHN), 8.72 (s, 
NCHN) (correspond to the three atropisomers of a single proton)}, 7.95-6.79 (m, 
ArH) (correspond to the three atropisomers of sixteen protons), {6.32 (d, J = 12.0 Hz, 
NCHPh), 6.26 (s, NCHPh), 5.99 (s, NCHPh), 5.92 (d, J = 12.0 Hz, NCHPh) 
(correspond to the three atropisomers of two protons)}, 3.64-2.87 (m, ArCH(CH3)2), 
(correspond to the three atropisomers of four protons), 2.26-2.08 (m, PhCH3), 
(correspond to the three atropisomers of twelve protons), {1.84-1.80 (m, 
ArCH(CH3)2), 1.62-1.15 (m, ArCH(CH3)2), 0.63-0.58 (m, ArCH(CH3)2), (correspond 
to the three atropisomers of twelve four protons)}. 13C NMR (CDCl3, 100 MHz) (due 
to existence of three atropisomers, 13C NMR spectrum appeared complex): % 159.76, 
159.07, 158.48, 149.79, 149.66, 148.27, 146.41, 146.26, 144.03, 139.77, 139.41, 
139.32, 132.86, 132.73, 132.67, 132.06, 131.96, 131.78, 131.26, 131.22, 130.80, 
130.05, 129.78, 129.53, 128.47, 127.06, 126.99, 126.88, 126.70, 126.31, 125.99, 
125.67, 124.68, 124.48, 123.35, 123.15, 119.06, 117.37, 116.36, 76.07, 73.60, 35.81, 
35.36, 35.20, 30.43, 30.23, 30.08, 25.15, 25.09, 24.73, 24.67, 24.41, 24.21, 23.82, 
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22.52, 22.32, 21.93, 21.41, 21.30, 14.24. HRMS (ESI) m/z calculated for C51H59N2 
[M-BF4]+ 699.4673, observed 699.4683. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2,7-diisopropylnaphthalen-
1-yl)-4,5-di-(3,5-dimethyl-phenyl)-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(Di(3,5-DiMePh)SIPrNap)Pd(cin)Cl] (2g): Di(3,5-DiMePh)SIPrNap·HBF4 (560 
mg, 0.70 mmol), KOtBu (80 mg, 0.71 mmol) and [Pd(cin)Cl]2 (184 mg, 0.35 mmol) 
were mixed together in a round flask in the glovebox. Dry THF (30 mL) was added 
and the mixture was stirred at room temperature for 16 h. The solvent was removed in 
vacuo, and the residue was separated by flash chromatography (SiO2, 1:8&1:3 
EtOAc/n-hexane) to afford three pure atropisomers (580 mg, 85%). Elemental 
analysis (%) calculated for C60H67PdN2Cl: C, 75.22; H, 7.05; N, 2.92. Found: C, 
75.59; H, 7.26; N, 2.92. HRMS (ESI) m/z calculated for 12C60H67104Pd14N2 [M-Cl]+ 
921.4354, observed 921.4352. 
Data for Sa,Sa-2g are as follows (first spot). (34 mg, 5%). [!]25D = 9.25 (c = 1, 
CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 7.91 (s, 2H), 7.77 (d, J = 8.5 Hz, 2H), 7.60 
(d, J = 8.4 Hz, 2H), 7.49 (d, J = 8.6 Hz, 2H), 7.21 (d, J = 8.4 Hz, 2H), 6.92-6.90 ( br 
m, 7H), 6.71-6.67 (br m, 2H), 6.51-6.50 (br m, 2H), 5.72-5.68 (br m, 2H), 4.24-2.93 
(br m, 7H), 2.08 (s, 12H), 1.77-1.19 (br m, 25H). 13C NMR (CDCl3, 100 MHz): % 
212.46, 145.45, 144.50, 143.87, 143.42, 138.91, 138.48, 137.69, 137.01, 136.64, 
134.71, 132.95, 132.86, 132.37, 132.10, 131.47, 131.19, 130.53, 130.44, 129.30, 
129.10, 128.03, 127.78, 127.67, 127.35, 127.16, 126.87, 126.70, 126.41, 126.13, 
125.12, 124.64, 123.72, 123.34, 109.85, 109.40, 106.27, 91.90, 88.50, 87.07, 51.51, 
49.57, 48.88, 35.01, 34.77, 34.49, 32.14, 29.92, 29.88, 29.58, 29.31, 28.91, 26.27, 
26.10, 25.82, 24.76, 24.67, 24.45, 24.33, 24.15, 23.98, 23.76, 23.33, 22.91, 21.40, 
14.33. 
Data for Ra,Ra-2g are as follows (second spot). (403 mg, 59%). [!]23D = -
306.54 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.32 (br s, 2H), 7.81-6.60 (br 
m, 19H), 6.05 (br s, 2H), 5.17-5.09 (m, 0.6H), 4.45 (br s, 0.4H), 4.26-4.15 (m, 1H), 
3.65 (br s, 2H), 3.41 (sept, J = 6.8 Hz, 2H), 2.67 (d, J = 5.4 Hz, 0.6H), 2.17 (br s, 
12.4H), 1.70-0.88 (m, 19H), 0.58-0.49 (br m, 6H). 13C NMR (CDCl3, 100 MHz): % 
211.10, 146.66, 138.36, 137.85, 137.43, 131.84, 130.91, 130.72, 128.89, 128.45, 
128.21, 128.09, 127.51, 127.19, 126.84, 126.66, 125.70, 125.00, 123.72, 108.84, 
106.12, 92.52, 90.80, 89.12, 74.09, 64.57, 47.69, 46.42, 35.32, 34.82, 32.07, 31.73, 
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29.85, 29.81, 29.51, 29.21, 28.74, 28.52, 27.06, 26.15, 25.43, 25.20, 23.90, 23.15, 
22.84, 22.80, 22.48, 21.34, 21.21, 20.86, 14.28, 11.59. 
Data for Ra,Sa-2g are as follows (third spot). (143 mg, 21%). [!]23D = -315.15 
(c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.20 (s, 1H), 8.11 (br s, 1H), 7.91-
6.59 (m, 19H), 5.95 (br s, 1H), 5.63 (br s, 1H), 4.51-2.60 (br m, 7H), 2.18-1.15 (br m, 
34H), 0.40-0.24 (br m, 3H). 13C NMR (CDCl3, 100 MHz): % 213.74, 212.62, 148.17, 
147.26, 147.06, 145.15, 144.90, 144.45, 144.32, 138.67, 138.35, 138.10, 137.99, 
137.45, 137.20, 136.57, 132.65, 132.29, 132.16, 132.04, 131.88, 131.81, 130.74, 
130.60, 130.45, 129.54, 129.24, 128.83, 128.68, 128.57, 128.50, 128.34, 128.15, 
128.00, 127.42, 127.25, 127.01, 126.34, 125.74, 124.89, 124.61, 124.36, 124.18, 
123.85, 123.54, 123.26, 123.01, 122.79, 122.65, 121.21, 121.01, 109.77, 109.03, 
106.10, 105,84, 89.29, 87.37, 81.99, 76.33, 76.12, 59.60, 52.94, 49.44, 48.40, 36.28, 
36.05, 35.89, 34.88, 34.33, 32.14, 31.80, 29.97, 29.91, 29.87, 29.57, 29.27, 28.79, 
28.69, 27.13, 26.43, 26.04, 25.49, 25.41, 25.32, 25.21, 24.97, 24.66, 24.41, 24.30, 
24.18, 23.70, 22.90, 22.86, 22.54, 21.44, 21.33, 21.28, 20.92, 15.54, 14.33, 14.27, 
11.64. 
1S,2S-N,N$-Bis(2,7-diisopropylnaphthalen-1-yl)-1,2-di-(4-methoxylphenyl)-
ethane-1,2-diamine. A 250 mL Schlenk flask was charged with Pd(dba)2 (207 mg, 
0.36 mmol), (±)-BINAP (274 mg, 0.44 mmol), NaOtBu (1.06 g, 11.00 mmol) and 
toluene (120 mL) and stirred for 20 min. 1-Bromo-2,7-diisopropylnaphthalene (2.35 
g, 8.10 mmol) and (1S,2S)-(-)-1,2-di-(4-methoxylphenyl)-ethylenediamine (1.00 g, 
3.67 mmol) were then added and the solution was heated to 110 °C for 24 h. After 
cooling to room temperature, the resulting mixture was filtered through a celite filter 
and washed with CH2Cl2. The filtrate was concentrated and the residue was purified 
by flash chromatography (SiO2, 1:1 CH2Cl2/n-hexane) to afford 1S,2S-N,N$-bis(2,7-
diisopropylnaphthalen-1-yl)-1,2-di-(4-methoxylphenyl)-ethane-1,2-diamine as a white 
foam (1.47 g, 58%). 1H NMR (CDCl3, 400 MHz): % 8.46 (s, 2H), 7.73 (d, J = 8.4 Hz, 
2H), 7.51 (d, J = 8.6 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 7.19 (d, J = 8.6 Hz, 2H), 6.85 
(d, J = 8.6 Hz, 4H), 6.53 (d, J = 8.6 Hz, 4H), 4.91 (br s, 4H), 3.62 (s, 6H), 3.27 (sept, 
J = 6.9 Hz, 2H), 3.06 (sept, J = 6.9 Hz, 2H), 1.40 (d, J = 6.9 Hz, 6H), 1.33 (d, J = 6.9 
Hz, 6H), 1.15 (d, J = 6.9 Hz, 6H), 0.64 (d, J = 6.9 Hz, 6H). 13C NMR (CDCl3, 100 
MHz): % 158.71, 146.14, 139.50, 138.93, 133.10, 132.16, 130.08, 129.72, 128.55, 
125.02, 124.15, 123.53, 120.75, 113.53, 68.47, 55.31, 34.93, 27.96, 24.70, 24.31, 
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22.86. HRMS (ESI) m/z calculated for C48H56N2O2Na [M+Na]+ 715.4239, observed 
715.4230. 
4S,5S-1,3-Bis(2,7-diisopropylnaphthalen-1-yl)-4,5-di-(4-methoxylphenyl)-4,5-
dihydro-1H-imidazol-3-ium tetrafluoroborate (Di(p-MeOPh)SIPrNap·HBF4) 
(1h). Diamine 1S,2S-N,N$-bis(2,7-diisopropylnaphthalen-1-yl)-1,2-di-(4-
methoxylphenyl)-ethane-1,2-diamine (1.47 g, 2.11 mmol), ammonium 
tetrafluoroborate (266 mg, 2.54 mmol), triethyl orthoformate (3.51 mL, 21.10 mmol) 
and two drops formic acid were heated to 120 °C and stirred for 16 h. The resulting 
mixture was dried in vacuo, and the residue was purified by flash chromatography 
(SiO2, 1:20 MeOH:CH2Cl2) to afford the product as an off-white foam (997 mg, 
60%). [!]25D = -138.65 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz) exists as a 
mixture of three atropisomers (53:10:37): % {8.74 (s, NCHN), 8.53 (s, NCHN), 8.51 
(s, NCHN) (correspond to the three atropisomers of a single proton)}, 7.94-6.69 (m, 
ArH) (correspond to the three atropisomers of eighteen protons), {6.42 (d, J = 12.8 
Hz, NCHPh), 6.32 (s, NCHPh), 6.11 (s, NCHPh), 6.09 (d, J = 12.8 Hz, NCHPh) 
(correspond to the three atropisomers of two protons)}, {3.73 (s, OCH3), 3.71 (s, 
OCH3), 3.63 (s, OCH3), 3.61 (s, OCH3) (correspond to the three atropisomers of six 
protons)}, 3.48-2.92 (m, ArCH(CH3)2), (correspond to the three atropisomers of four 
protons), 1.82-0.61 (m, ArCH(CH3)2), (correspond to the three atropisomers of twenty 
four protons). 13C NMR (CDCl3, 100 MHz) (due to existence of three atropisomers, 
13C NMR spectrum appeared complex): % 161.83, 161.73, 161.57, 161.50, 159.06, 
158.28, 150.06, 149.87, 148.54, 148.40, 146.57, 146.40, 144.70, 144.14, 132.04, 
132.01, 131.86, 131.78, 131.52, 131.46, 130.63, 130.57, 130.43, 130.06, 130.02, 
129.76, 129.56, 128.68, 128.49, 127.13, 126.74, 126.57, 125.84, 125.61, 125.42, 
124.62, 124.39, 123.46, 123.34, 123.08, 122.44, 122.25, 122.07, 121.70, 118.97, 
118.14, 117.08, 116.27, 115.47, 115.25, 115.07, 114.98, 75.33, 75.06, 73.49, 72.95, 
66.02, 55.81, 55.77, 55.54, 35.60, 35.27, 35.20, 34.85, 34.31, 30.47, 30.12, 29.95, 
25.34, 25.21, 24.88, 24.74, 24.66, 24.48, 24.43, 24.27, 24.22, 24.08, 23.93, 23.70, 
22.52, 22.48, 22.15, 15.45, 14.24. HRMS (ESI) m/z calculated for C49H55N2O2 [M-
BF4]+ 703.4258, observed 703.4263. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis(2,7-diisopropylnaphthalen-
1-yl)-4,5-di-(4-methoxyl-phenyl)-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(Di(p-MeOPh)SIPrNap)Pd(cin)Cl] (2h): Di(p-MeOPh)SIPrNap·HBF4 (408 mg, 
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0.52 mmol), KOtBu (58 mg, 0.52 mmol) and [Pd(cin)Cl]2 (134 mg, 0.26 mmol) were 
mixed together in a round flask in the glovebox. Dry THF (10 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by first flash chromatography (SiO2, 1:12&1:3 
EtOAc/n-hexane) to afford two pure atropisomers (376 mg, 76%) (One of the three 
atropisomers couldn’t be isolated as a pure isomer). Elemental analysis (%) 
calculated for C58H63PdN2O2Cl: C, 72.41; H, 6.60; N, 2.91. Found: C, 72.20; H, 6.61; 
N, 2.84. HRMS (ESI) m/z calculated for 12C58H63104Pd14N2O2 [M-Cl]+ 925.3938, 
observed 925.3937. 
Data for Ra,Ra-2h are as follows (second spot). (223 mg, 45%). [!]24D = -
334.29 (c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.26 (br s, 2H), 7.81-6.55 (br 
m, 21H), 5.96 (br s, 2H), 5.12-5.04 (m, 0.6H), 4.42 (br s, 0.4H), 4.21-4.18 (m, 1H), 
3.86 (s, 6H), 3.66-3.57 (br m, 2H), 3.31 (sept, J = 6.8 Hz, 2H), 2.64-2.63 (br m, 
0.6H), 2.21-2.15 (br m, 0.4H), 1.73-1.24 (m, 19H), 0.51-0.45 (br m, 6H). 13C NMR 
(CDCl3, 100 MHz): % 211.08, 160.27, 146.95, 137.44, 131.87, 130.84, 130.25, 
129.03, 128.50, 128.28, 128.14, 127.54, 127.21, 126.73, 125.57, 114.28, 108.94, 
104.39, 92.57, 73.81, 63.96, 55.51, 46.47, 35.27, 28.75, 26.16, 24.73, 23.99, 23.41, 
18.12, 15.56. 
Data for Ra,Sa-2h are as follows (third spot). (153 mg, 31%). [!]25D = -282.53 
(c = 1, CH2Cl2). 1H NMR (CDCl3, 400 MHz): % 8.27 (s, 1H), 8.00 (br s, 1H), 7.91-
6.54 (m, 21H), 5.94 (br s, 1H), 5.76 (br s, 1H), 4.49-2.71 (br m, 13H), 1.84-1.19 (br 
m, 19H), 0.46-0.30 (br m, 3H). 13C NMR (CDCl3, 100 MHz): % 213.15, 211.81, 
211.48, 160.22, 159.79, 148.19, 148.08, 147.27, 147.08, 145.93, 145.17, 144.43, 
138.37, 136.51, 132.34, 132.10, 131.91, 131.74, 131.15, 130.53, 130.27, 130.17, 
129.84, 129.69, 129.56, 129.31, 129.21, 129.10, 128.85, 128.56, 128.41, 128.25, 
128.12, 127.96, 127.71, 127.46, 127.39, 127.20, 126.31, 125.67, 124.85, 124.64, 
124.29, 124.07, 123.86, 123.08, 122.77, 122.61, 121.12, 120.91, 113.87, 113.78, 
109.92, 109.08, 105.87, 89.34, 89.04, 87.43, 76.46, 76.27, 76.05, 75.52, 75.35, 55.51, 
55.26, 52.78, 49.34, 48.55, 39.32, 36.14, 35.86, 34.46, 34.13, 32.10, 29.91, 29.54, 
28.64, 28.51, 26.52, 26.02, 25.55, 25.39, 25.19, 24.68, 24.55, 24.04, 23.93, 23.74, 
23.48, 22.87, 14.30. 
Bimetallic palladium complex [{PdCl2((Ra,Ra)-(4S,5S)-DiPhSIPrNap)}2] (6): In a 
20 mL vial, complex Ra,Ra-2a (100 mg, 0.12 mmol) was added and put under 
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nitrogen atmosphere. To this, 10 mL Et2O and 4.0M HCl in dioxane (1 mL) were 
added. The resultant suspension was stirred for 1h, filtered through a cotton filter, and 
washed by Et2O (5 mL). The solid was collected by washing with 5 mL CH2Cl2, and 
dried in vacuo to give the dimeric complex 5 (87 mg, 96%). Crystals suitable for 
diffraction studies were grown from a CHCl3/pentane solution of 5. 1H NMR (CDCl3, 
400 MHz): % 8.09 (s, 2H), 7.81-7.71 (m, 8H), 7.60 (s, 2H), 7.35 (d, J = 8.3 Hz, 2H), 
7.31 (d, J = 8.3 Hz, 2H), 7.19-7.06 (m, 16H), 7.00 (t, J = 7.7 Hz, 4H), 6.86 (d, J = 7.5 
Hz, 4H), 3.52 (sept, J = 6.6 Hz, 2H), 3.20 (sept, J = 6.7 Hz, 4H), 3.01 (sept, J = 6.9 
Hz, 2H), 1.45 (d, J = 6.9 Hz, 6H), 1.44 (d, J = 6.7 Hz, 6H), 1.40 (d, J = 6.6 Hz, 6H), 
1.33 (d, J = 6.9 Hz, 6H), 1.27 (d, J = 6.9 Hz, 6H), 0.99 (d, J = 6.7 Hz, 6H), 0.28 (d, J 
= 6.6 Hz, 6H), 0.24 (d, J = 6.7 Hz, 6H). 13C NMR (CDCl3, 100 MHz): % 179.88, 
147.46, 147.11, 146.66, 145.97, 136.57, 135.54, 131.91, 130.38, 130.16, 130.09, 
129.92, 129.66, 129.45, 129.31, 129.29, 129.08, 129.00, 128.84, 128.80, 128.66, 
128.39, 125.10, 125.06, 124.03, 123.90, 123.72, 121.98, 73.60, 72.77, 35.28, 35.14, 
28.65, 28.54, 27.06, 26.68, 24.69, 24.65, 23.99, 23.80, 23.76, 23.31. 
Catalytic results for asymmetric intramolecular !-arylation of 3a catalyzed by 
2a versus (SIPr)Pd(cin)Cl: 
N
OBr
Me
Ph
catalyst (5 mol % Pd)
1.5 equiv NaOtBu
DME
N
Me
O
Ph
3a 4a  
entry catalyst temperature time % yielda (% eeb,c) 
1 (Ra,Ra)-2a 23°C 12h 98 (86) 
2 (Ra,Sa)-2a 23°C 4h 98 (67) 
3 (Sa,Sa)-2a 23°C 6h 98 (20) 
4 (SIPr)Pd(cin)Cl 23°C 32h 73d(--) 
aIsolated yields. bDetermined by chiral HPLC. cAbsolute stereochemistry determined 
as (R)-configuration, see ref. 9d. d GC yield. 
Pd catalyzed asymmetric intramolecular !-arylation to give oxindoles 3a-g: 
Gerneral procedure: Catalyst (5 mol%) and base (1.5 eq.) were charged in a 20 mL 
vial in a glovebox. DME (2 mL) was added and the mixture was stirred for 5 min. The 
2-bromo-N-alkylanilide (0.2 mmol, 1 eq.) was then added as a solution in 2 mL DME. 
The reaction was stirred at room temperature or 50 °C, and monitored by GC-MS. 
After the required time, the reaction was treated with aq. NH4Cl and this phase was 
extracted with 2'15 mL ether. The combined organic phases were washed with brine 
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and dried over MgSO4. Flash chromatography afforded the product oxindoles. The 
enantiomeric purity of products 4a-g was determined by chiral HPLC analysis. 
 (R)-4a:9 colorless oil, 98% yield. 86% ee [Chiracel OD-H column, n-hexane/i-PrOH 
= 99:1, 1.0 mL/min, tR = 15.04 min (minor) and 18.08 min (major)]; 1H NMR (400 
MHz, CDCl3): % 7.25-7.18 (m, 5H), 7.16-7.14 (m, 1H), 7.11-7.09 (m, 1H), 7.00 (dt, J 
= 7.5, 1.0 Hz, 1H), 6.82 (d, J = 7.8 Hz, 1H), 3.15 (s, 3H), 1.70 (s, 3H). 13C NMR 
(CDCl3, 100 MHz): % 179.61, 143.42, 140.98, 135.00, 128.69, 128.28, 127.38, 
126.81, 124.37, 122.94, 108.46, 52.31, 26.63, 23.93. HRMS (EI) m/z calculated for 
C16H15NO [M]+ 237.1154, observed 237.1151. 
 (R)-4b:9 colorless oil, 98% yield. 88% ee [Chiralpak IB column, n-hexane/i-PrOH = 
97:3, 1.0 mL/min, tR = 10.17 min (minor) and 11.43 min (major)] (racemic sample 
was prepared by using SIPrNapPd(allyl)Cl as catalyst); 1H NMR (400 MHz, CDCl3): 
% 7.33-7.22 (m, 10H), 7.19 (d, J = 7.4 Hz, 1H), 7.05 (dt, J = 7.7, 1.0 Hz, 1H), 6.81 (d, 
J = 7.8 Hz, 1H), 4.94 (dd, J = 28.8, 15.6 Hz, 2H), 1.88 (s, 3H). 13C NMR (CDCl3, 100 
MHz): % 179.69, 142.46, 141.00, 136.17, 135.15, 128.94, 128.76, 128.15, 127.75, 
127.43, 127.39, 126.83, 124.36, 122.98, 109.53, 52.32, 43.99, 23.98. HRMS (EI) m/z 
calculated for C22H19NO [M]+ 313.1467, observed 313.1469. 
 (R)-4c:9 colorless oil, 99% yield. 87% ee [Chiralpak IB column, n-hexane/i-PrOH = 
97:3, 1.0 mL/min, tR = 8.85 min (minor) and 9.96 min (major)] (racemic sample was 
prepared by using SIPrNapPd(allyl)Cl as catalyst); 1H NMR (400 MHz, CDCl3): % 
7.31 (dt, J = 7.7, 1.3 Hz, 1H), 7.20-7.17 (m, 3H), 7.11-7.06 (m, 3H), 6.90 (d, J = 7.7 
Hz, 1H), 3.22 (s, 3H), 2.29 (s, 3H), 1.77 (s, 3H). 13C NMR (CDCl3, 100 MHz): % 
179.76, 143.45, 138.03, 137.06, 135.17, 129.40, 128.20, 126.69, 124.32, 122.90, 
108.41, 52.01, 26.62, 23.93, 21.12. HRMS (EI) m/z calculated for C17H17NO [M]+ 
251.1310, observed 251.1313. 
 (R)-4d:9 colorless oil, 97% yield. 89% ee [Chiracel OD-H column, n-hexane/i-PrOH 
= 98:2, 1.0 mL/min, tR = 15.96 min (minor) and 22.95 min (major)]; 1H NMR (400 
MHz, CDCl3): % 7.65 (t, J = 7.9 Hz, 1H), 7.30-7.25 (m, 2H), 7.18 (dt, J = 7.4, 1.1 Hz, 
1H), 7.01 (d, J = 7.4 Hz, 1H), 6.96 (t, J = 7.4 Hz, 1H), 6.90 (d, J = 7.8 Hz, 1H), 6.85 
(d, J = 7.3 Hz, 1H),  3.31 (s, 3H), 1.77 (s, 3H), 1.61 (s, 3H). 13C NMR (CDCl3, 100 
MHz): % 180.15, 143.14, 138.05, 136.98, 135.24, 131.85, 127.96, 127.83, 127.57, 
126.16, 123.11, 123.04, 108.21, 52.48, 26.60, 25.94, 19.35. HRMS (EI) m/z 
calculated for C17H17NO [M]+ 251.1310, observed 251.1306. 
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 (R)-4e:9 colorless oil, 99% yield. 80% ee [Chiracel OD-H column, n-hexane/i-PrOH 
= 98:2, 1.0 mL/min, tR = 11.04 min (minor) and 12.73 min (major)]; 1H NMR (400 
MHz, CDCl3): % 7.32 (dt, J = 7.6, 1.0 Hz, 1H), 7.17 (t, J = 7.6 Hz, 2H), 7.12-7.04 (m, 
4H), 6.91 (d, J = 7.8 Hz, 1H), 3.24 (s, 3H), 2.30 (s, 3H), 1.78 (s, 3H). 13C NMR 
(CDCl3, 100 MHz): % 179.72, 143.38, 140.87, 138.28, 135.19, 128.54, 128.19, 
127.45, 124.31, 123.82, 122.91, 108.42, 52.25, 26.62, 23.88, 21.73. HRMS (EI) m/z 
calculated for C17H17NO [M]+ 251.1310, observed 251.1311. 
(R)-4f:9 white solid, 93% yield. 85% ee [Chiralpak IB column, n-hexane/i-PrOH = 
97:3, 1.0 mL/min, tR = 22.97 min (minor) and 53.27 min (major)] (racemic sample 
was prepared by using SIPrNapPd(allyl)Cl as catalyst); 1H NMR (400 MHz, CDCl3): 
% 7.85 (d, J = 7.3 Hz, 1H), 7.82 (d, J = 8.3 Hz, 1H), 7.79 (d, J = 8.1 Hz, 1H), 7.54 (dd, 
J = 7.8, 7.6 Hz, 1H), 7.34-7.28 (m, 2H), 7.17-7.13 (m, 1H), 7.04 (d, J = 7.8 Hz, 1H), 
6.92 (dt, J = 7.5, 1.0 Hz, 1H), 6.88 (d, J = 8.8 Hz, 1H), 6.83 (d, J = 7.0 Hz, 1H), 3.43 
(s, 3H), 1.90 (s, 3H). 13C NMR (CDCl3, 100 MHz): % 180.64, 142.40, 136.95, 135.31, 
134.58, 131.55, 129.32, 129.25, 128.10, 126.45, 125.44, 125.27, 123.69, 123.28, 
123.05, 108.79, 52.66, 27.01, 26.89. HRMS (EI) m/z calculated for C20H17NO [M]+ 
287.1310, observed 287.1307. 
(R)-4g:9 white solid, 93% yield. 84% ee [Chiralpak IB column, n-hexane/i-PrOH = 
97:3, 1.0 mL/min, tR = 20.46 min (minor) and 40.32 min (major)] (racemic sample 
was prepared by using SIPrNapPd(allyl)Cl as catalyst); 1H NMR (400 MHz, CDCl3): 
% 7.88 (d, J = 7.2 Hz, 1H), 7.84 (d, J = 8.2 Hz, 1H), 7.80 (d, J = 8.1 Hz, 1H), 7.58-
7.51 (m, 3H), 7.42-7.30 (m, 4H), 7.20 (dt, J = 7.7, 1.2 Hz, 1H), 7.02 (d, J = 7.8 Hz, 
1H), 6.96 (t, J = 6.8 Hz, 1H), 6.90-6.81 (m, 3H), 5.11 (dd, J = 94.8, 15.2 Hz, 2H), 
1.96 (s, 3H). 13C NMR (CDCl3, 100 MHz): % 180.48, 141.46, 136.96, 136.26, 135.29, 
134.54, 131.51, 129.33, 129.l7, 129.02, 128.49, 128.06, 127.93, 126.49, 126.33, 
125.48, 125.26, 124.23, 123.24, 123.09, 109.76, 52.64, 44.50, 27.26. HRMS (EI) m/z 
calculated for C26H21NO [M]+ 363.1623, observed 363.1622. 
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4.1 Abstract 
A new NHC•Pd-catalyzed asymmetric a-arylation of amides is reported giving 
direct access to synthetically valuable, allylated oxindoles with quaternary carbon 
centers. The reaction is made possible by the introduction of a new chiral NHC 
ligand. The palladium complexes derived thereof combine excellent reactivity with 
high chemo- and enantioselectivity for the title transformation. 
 
 
4.2 Introduction 
Oxindoles bearing a quaternary carbon stereocenter at the 3-position represent 
a prominent structural motif in a range of alkaloid natural products,1 and 
pharmaceutical compounds,2 and the development of synthetic methods for these 
compounds, including the ones with new substitution patterns, is therefore of high 
importance in organic chemistry. Consequently, several transition-metal-catalyzed 
enantioselective approaches were established over the last decade: Overman’s elegant 
intramolecular Heck reactions,1b-c,3 Trost’s Pd- or Mo-mediated allylic alkylations,4 
Pd-catalyzed intra- and intermolecular arylations pioneered by Hartwig,5 and 
Buchwald,6 Takemoto’s Pd-catalyzed cyanoamidation protocol,7 and most recently, 
Stoltz’s Cu-catalyzed alkylations.8 
As part of our ongoing research on employing chiral monodentate N-
heterocyclic carbene (NHC) ligands for metal-catalyzed asymmetric catalysis, we 
recently reported the synthesis of diastereomerically pure palladium complexes 
incorporating new chiral NHC ligands and their successful application in the Pd-
catalyzed intramolecular !-arylation of amides to obtain enantiomerically enriched 3-
aryl-3-methyl oxindoles.5c While elegant as a methodology to obtain chiral quaternary 
carbon centers, the intramolecular !-arylation at present has the drawback of 
providing oxindoles that are difficult to functionalize further. We therefore wondered 
whether 3-allyl-3-aryl oxindoles, previously only accessible via a two-step procedure 
involving a Pd-catalyzed intramolecular !-arylation followed by an asymmetric Pd-
catalyzed allylic alkylation,4a,9 could be obtained directly. Herein we report the 
successful achievement of this strategy by using a newly designed NHC ligand. 
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4.3 Results and Discussion 
Our investigation commenced by examining the ability of NHC•Pd complexes 
1a-c (Scheme 1), previously developed in our laboratories,5c to promote the 
intramolecular !-arylation of the model substrate 2a. At the outset of the study and 
under the reaction conditions used, it was not clear whether such !-arylations would 
be preferred over a reaction scenario involving Heck cyclizations giving rise to 7-exo-
trig (or 8-endo-trig) products. The catalytic results reported in Table 1 indeed indicate 
that Heck cyclization is competitive and product 4a was formed in noticeable 
amounts (15-20%) with all diastereomers of precatalysts 1a-c. Trends in 
enantioselectivity though were immediately apparent. Somewhat surprising was the 
fact that the diastereomers of catalyst 1a, which performed best in our previous 
investigation, gave erratic results with inconsistent absolute configurations of product 
3a. In fact, omitting the R2-isopropyl group on the naphthyl wingtips of the NHC 
(precatalysts 2b) gave more usable results (Entries 4/5). Furthermore, precatalyst 1c 
that incorporates a slightly bulkier R2-cyclohexyl group resulted in better 
enantioselection (Entries 6/7). Although both the chemoselectivity as well as the 
enantioselectivity (66% ee) were still not practical, the simple fact that representative 
chiral mono- and bidentate phosphorus ligands showed inferior results (see the 
Supporting Information) suggested that complexes 1a-c contained the more promising 
overall catalyst motif. 
 
N N
R1
R2
R1
R2
Ph Ph
Pd
Cl
Ph
N N
R2
R1 R1
R2
Ph Ph
Pd
Cl
Ph
N N
R2
R1
R2
R1
Ph Ph
Pd
Cl
Ph
Ra,Ra-1a Ra,Sa-1a Sa,Sa-1a
Ra,Ra-1b Ra,Sa-1b
Ra,Ra-1c Ra,Sa-1c
1a: R1 = R2 = iPr    1b: R1 = iPr, R2 = H    1c: R1 = Cy, R2 = H  
Scheme 1. Previously reported palladium complexes 1a-c. 
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Table 1. Initial screening of Pd-complexes 1a-c. 
Br
N
O
Ph
1 (5 mol %)
1.5 eq. NaOtBu
DME, 16h
N
O
Ph
N
O
Ph+
2a 3a 4a  
Entry NHC•Pd T (°C) Conv [%][a] 3a/4a[b] ee [%][c,d] 
1 Ra,Ra-1a 23 >99 5:1 -24 (S) 
2 Ra,Sa-1a 23 >99 4:1  56 (R) 
3 Sa,Sa-1a 23 >99 5:1  34 (R) 
4 Ra,Ra-1b 50 >99 4:1  39 (R) 
5 Ra,Sa-1b 50 >99 4:1  58 (R) 
6 Ra,Ra-1c 50 >99 6:1  46 (R) 
7 Ra,Sa-1c 50 >99 4:1  66 (R) 
[a] Determined by GC-MS. [b] Determined by analysis of 1H NMR spectra of 
product mixtures prior to purification. [c] Determined by chiral HPLC for 3a. [d] 
The absolute configuration of 3a was assigned according to ref 10. 
 
 
The tendencies in selectivity observed in Table 1 were subsequently 
implemented in the design of a modified chiral NHC structure that lacks the R2 
wingtip group and incorporates a bulkier, unstrained 3-pentyl moiety on the 2-
position of the naphthyl side chains. We were hoping that the bulkier group would 
help transfer the chiral information more effectively from the NHC backbone to the 
side chains, and hence induce higher enantioselectivity. The precursor imidazolinium 
salt was obtained relatively easily via the four-step synthetic procedure outlined in 
Scheme 2. Subsequent deprotonation, reaction with [Pd(cin)Cl]2 and column 
chromatographic workup gave precatalyst 1d in 82% yield as three separable 
diastereomers [Ra,Ra-1d (37%), Ra,Sa-1d (32%) and Sa,Sa-1d (13%)]. 
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Br
N N
Ph Ph
Pd
Cl
Ph
N N
Ph Ph
Pd
Cl
Ph
N N
Ph Ph
Pd
Cl
Ph
Ra,Ra-1d (37%) Ra,Sa-1d (32%) Sa,Sa-1d (13%)
Br
NHHNAr Ar
Ph Ph
N NAr Ar
Ph Ph
BF4
a) b)
c)
d)
e)
 
Scheme 2. Synthesis of complexes 1d bearing a newly designed NHC ligand. 
Reaction conditions: a) Mg/THF, 3-bromopentane, (FeCl3)2(TMEDA)3 (2.5 mol%), 
THF, 70%.11 b) Br2 (1 eq.), CH2Cl2, -78°C, 24h, 97%. c) Pd(dba)2 (5 mol%), (±)-
BINAP (6 mol%), NaOtBu, (1S,2S)-(-)-1,2-diphenylethylenediamine, Toluene, 
120°C, 48h, 57%. d) HC(OEt)3, NH4BF4, 120°C, 16 h, 84%. e) [Pd(cin)Cl]2 (0.5 eq.), 
KOtBu, THF, rt, 16h, 82%. 
 
In a first test, these new catalysts were subjected to our standard substrate 2a 
(Table 2, Entries 1-3). The results were very encouraging and all three diastereomeric 
precatalysts 1d proved superior to their congeners 1a-c both in terms of their higher 
reactivity (room temperature) and their enhanced selectivity. As an unexpected and 
very welcome side effect, incorporation of the new NHC ligand also greatly enhanced 
the chemoselectivity of the transformation with generation of only trace amounts (if 
any) of Heck byproduct 4a. As a consequence, treatment of 2a in the presence of 5 
mol % Ra,Ra-1d gave rise to oxindole 3a in 96% isolated yield and 81% ee. Because 
both catalysts Ra,Ra-1d and Ra,Sa-1d showed identical enantiomeric excesses with 
substrate 2a and before embarking in a thorough substrate scope study, we examined 
the two catalysts with three other substrates, varying both the aromatic group at the !-
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carbon as well as the protecting group at nitrogen (Table 2, Entries 4-11). The results 
indicated that Ra,Ra-1d was overall giving better chemoselectivities and evenly high 
enantiomeric excesses with all four substrates, thereby outperforming Ra,Sa-1d 
(Exception; Entries 7/8, see discussion below). 
 
Table 2. Identification of the optimal catalyst. 
Br
N
PG
O
Ar
1d (5 mol %)
1.5 eq. NaOtBu
DME, 23°C, 16h
N
O
PG
Ar
N
O
Ar
PG
+
2a-d 3a-d 4a-d  
Entry NHC•Pd Substrate (Ar, PG) 3/4[a] Yield [%][b] ee [%][c] 
1 Ra,Ra-1d 2a (Ph, Me) 10:0 96 81 (R) 
2 Ra,Sa-1d 2a (Ph, Me) 16:1 90 81 (R) 
3 Sa,Sa-1d 2a (Ph, Me) 10:0 93 52 (R) 
4 Ra,Ra-1d 2b (1-Napht, Me) 10:0 98 87 (R) 
5 Ra,Sa-1d 2b (1-Napht, Me) 17:1 88 39 (R) 
6 Sa,Sa-1d 2b (1-Napht, Me) 19:1 91 53 (R) 
7 Ra,Ra-1d 2c (2-Napht, Me) 10:0 98 82 (R) 
8 Ra,Sa-1d 2c (2-Napht, Me) 18:1 90 85 (R) 
9 Sa,Sa-1d 2c (2-Napht, Me) 10:0 97 56 (R) 
10 Ra,Ra-1d 2d (Ph, Bn) 10:1 86 81 (R) 
11 Ra,Sa-1d 2d (Ph, Bn) 8:1 83 63 (R) 
[a] Determined by analysis of 1H NMR spectra of product mixtures prior to purification. 
[b] Isolated yields of 3a-d. [c] Determined by chiral HPLC for 3a-d. 
 
With the optimized catalyst in hand, we sought to examine the scope of the 
reaction. Thus, an important number of different amides were synthesized and 
subjected to the standard reaction conditions (5 mol % Ra,Ra-1d, 1.5 eq. NaOtBu, 
DME, 23°C, 16h). Results in Table 3 show that broad structural variations in the 
amide system can be accommodated. In nearly all cases, excellent yields, virtually 
complete chemoselectivities and good-to-excellent enantioselectivities were obtained. 
For example, ortho-substituted aromatic groups are tolerated, and the sterically 
demanding products were obtained with selectivities of up to 91 % ee (Entry 5). The 
method is compatible with both electron-rich and electron-poor aromatic groups, and 
ortho-, meta-, as well as para-positions could be varied (Table 4, Entry 4-15). We 
also examined two substrates containing a 5-methoxy group, a motif commonly found 
in bioactive oxindole-based compounds, with equally satisfying results (Entries 
17,18). Furthermore, the remarkable reactivity of catalyst Ra,Ra-1d allows the reaction 
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with less reactive aryl chlorides to proceed at room temperature with high yield and 
ee (Entry 16).5a,d,e Limitations became only apparent when the sterically highly 
congested substrate 2s was tested. Here, a complete loss of enantioselectivity was 
accompanied with lower than normal reactivity (Entry 19). Nevertheless, the simple 
fact that catalyst Ra,Sa-1d could promote such a difficult C–C coupling at room 
temperature is noteworthy. Substrate 2t containing a heteroaromatic N-Me-3-indolyl 
moiety also undergoes smooth cyclization to give oxindole 3t (94% yield, 86% ee, 
Entry 21). Contrary to what has been described,12 the possible indolo-benzazepine 
byproduct arising from competitive Heck cyclization of the indolyl group was not 
observed. The framework of 3t is of particular synthetic interest as it is widely found 
in natural products, and a range of total syntheses have been carried out based on this 
type of core structure.2a-b 
Table 3. Scope of asymmetric synthesis of oxindoles with Ra,Ra-1d. 
Br
N
O
N
O
2a 3a
1 96 81
Entry Substrate Product R Yield 
[%][a]
ee 
[%][b]
Br
N
O
N
O
2b 3b
2 98 87
Br
N
O
N
O
2c 3c
3 98 82
Br
N
O
N
ORR
Me  
F 
MeO
2e-g 3e-g
97 
94 
92
85 
91 
83
5   
6   
7
Br
N
Bn
O
N
O
Bn
2d 3d
4 86 81
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Br
N
O
N
O
Me  
F 
MeO
2h-j 3h-j
93 
98 
91
77 
79 
80
8   
9   
10
R
R
Br
N
O
N
O
Me  
F 
MeO
CF3 
Ph2k-o 3k-o
94 
94 
89 
97 
95
82 
83 
77 
86 
87
11  
12  
13 
14 
15
R
R
Br
N
O
N
O
o-F  
p-Ph
2q-r 3q-r
91 
90
94 
88
17  
18
O
OR
R
Br
N
O
N
O
2s 3s
19
20
40 
95
8
2
Cl
N
O
N
O
2p 3p
16 90 86
F
F
F
F
[c]
Br
N
O
N
O
2t 3t
21 94 86
N
N
 
[a] Isolated yields of 3. [b] Determined by chiral HPLC for 3, and the absolute 
configuration of 3 is depicted. [c] Catalyst Ra,Sa-1d was used to replace 
catalyst Ra,Ra-1d. 
To exemplify the generality of the present protocol and highlight catalyst 1d’s 
excellent performance, substrate 2u with two alkyl substituents at the !-position of 
the carbonyl moiety was also tested. The reaction with this more challenging substrate 
once again proceeded smoothly at ambient temperature to give oxindole 3u with 
acceptable levels of enantioselectivity and excellent chemoselectivity (>20:1). To our 
knowledge, this is the first successful example of preparing enantiomerically enriched 
3,3'-dialkyl oxindoles via a Pd-catalyzed !-arylation protocol,13 and Scheme 3 
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underlines the importance of 3u as a key intermediate for the synthesis (-)-
physostigmine.4b,14 
Br
N
O
N
O
2u 3u
92% yield, 70% ee
O
O ref 4b,12
N
N
H
O
a)
R
R = MeNHCO-
(-)-Physostigmine
 
Scheme 3. Enantioselective synthesis of 3,3'-dialkyl oxindole 3x and its related 
natural product. Condition: (a) 5 mol % Ra,Ra-1d, 1.5 eq. NaOtBu, DME, 23°C, 16h. 
A last question that we wanted to answer stemmed from our preliminary runs 
in Table 2. Data showed that catalyst Ra,Sa-1d performed slightly better for substrate 
2c than Ra,Ra-1d and we were therefore wondering whether the same trend is 
followed with substrates 2h-j that also contain meta-substituted aromatic moieties. 
Results in Table 4 indeed point to a general trend for these substrates with slightly 
higher enantiomeric excesses when employing Ra,Sa-1d. Differences in selectivity are 
further amplified with sterically more demanding, doubly meta-substituted amide 2y 
(Scheme 4). Together with simple molecular models of both catalysts Ra,Sa-1d and 
Ra,Ra-1d, these last results provided valuable indications on the enantioselection 
process that might be at play in the present catalytic system. 
Table 4. Ra,Sa-1d versus Ra,Ra-1d with meta-substituted substrates. 
Entry Substrate Product Yield [%][a] ee [%][b,c] 
1 2c 3c 94 85 vs (82) 
2 2h 3h 91 83 vs (77) 
3 2i 3i 97 85 vs (79) 
4 2j 3j 90 85 vs (80) 
[a] Isolated yields. [b] Determined by chiral HPLC. [c] The values in 
brackets were obtained with catalyst Ra,Ra-1d. 
Br
N
O Ra,Ra-1d or Ra,Sa-1d 
(5 mol %)
DME, 23°C, 16h N
O
2y 3y
1.5 eq. NaOtBu
Ra,Ra-1d: 95% yield, 60% ee 
Ra,Sa-1d: 92% yield, 84% ee  
Scheme 4. Ra,Ra-1d and Ra,Sa-1d catalyzed formation of oxindole 3v. 
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In analogy to the postulated model for the asymmetric synthesis of 3-aryl-3-
methyl oxindoles involving members of catalyst family 1,5c the key event for 
enantiodiscrimination involves the carbon-palladium bond formation that leads to 
intermediate 5 (Scheme 5) and the relative orientation of the groups on the 
deprotonated !-carbon of the amide during this step. Simple molecular modeling of 5 
showed that the allyl moiety neatly resides on the same side of the 3-pentyl unit of the 
NHC framework, while the aromatic moiety is accommodated on the opposite, more 
open side of the naphthyl moiety. Discrimination in these ligands is therefore initiated 
via chirality transfer from the chiral backbone of the NHC ligand (A) to the 2-position 
(3-pentyl group) of the naphthyl side chains (B) which subsequently distinguish the 
different substrate groups during the bond formation step that leads to intermediate 5 
(C). The erosion in enantioselectivity with catalyst Ra,Ra-1d and meta-substituted aryl 
substrates such as 2v seems to originate from a strong repulsion between the meta-
position of the aromatic unit and the 3-pentyl group on the opposite side chain of the 
Ra,Ra-configured NHC ligand. Indeed, the repulsion is absent when switching to 
catalyst Ra,Sa-1d, therefore providing compound 3v with higher enantioselectivity 
(84% ee). 
N N
Ph Ph
Pd
N O
R
H Ph
Nap
3-Pentyl
Ar
Allyl
N
O
1st Chirality Transfer
2nd Chirality Transfer
R'
N
O
R' R
oberved absolute 
stereochemistry
3
5
5
Red. El.
H
Ph
Nap
3-Pentyl
A
B
C
A
B
C
R'
 
Scheme 5. Proposed model for enantiodiscrimination. 
4.4 Conclusion 
In conclusion, we have devised a new synthetic strategy to access 
functionalizable 3-allyl oxindoles bearing a chiral quaternary carbon stereocenter via 
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a direct palladium-catalyzed !-arylation protocol. Impressive reactivities and high 
chemo- and enantioselectivities were achieved through the use of a new chiral N-
heterocyclic carbene ligand structure. Diastereomerically pure palladium complex 
Ra,Ra-1d proved to be the most general catalyst for the transformation and gave 
enantiomerically enriched oxindoles with selectivities of up to 94% ee. For making 
oxindoles bearing meta-substituted aromatic groups at the 3-position, catalyst Ra,Sa-
1d was found to be slightly more efficient. A mechanistic model is proposed that 
rationalizes the catalytic results and explains the enantioselection pathway. 
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4.5 Experimental Part 
General Information. All reactions were carried out under a nitrogen atmosphere 
using Standard Schlenk-Lines or gloveboxes (Mecaplex or Innovative Technology). 
All reagents were used as received unless otherwise noted. Solvents were purchased 
in the best quality available, degassed by purging thoroughly with nitrogen and dried 
over activated molecular sieves of appropriate size. Alternatively, they were purged 
with argon and passed through alumina columns in a solvent purification system 
(Innovative Technology). Solvents for NMR spectroscopy were degassed with 
nitrogen and dried over molecular sieves. NMR spectra were recorded on AV2 400 or 
AV2 500 MHz Bruker spectrometers. Chemical shifts are given in ppm. The spectra 
are calibrated to the residual 1H and 13C signals of the solvents. Coupling constants J 
are quoted in Hz. Analytical HPLC analyses were performed using a JASCO series 
PU-2089/MD-2010 apparatus with a chiral stationary phase (see details where 
applies). High-resolution electrospray ionization mass spectrometry was performed on 
a Finnigan MAT 900 (Thermo Finnigan, San Jose, CA; USA) double-focusing 
magnetic sector mass spectrometer. 10 spectra were acquired. A mass accuracy ! 2 
ppm was obtained in the peak matching acquisition mode by using a solution 
containing 2 "l PEG200, 2 "l PPG450, and 1.5 mg NaOAc (all obtained from Sigma-
Aldrich, CH-Buchs) dissolved in 100ml MeOH (HPLC Supra grade, Scharlau, E-
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Barcelona) as internal standard. GC-MS analyses were done on a Finnigan Voyager 
GC8000 Top. Elemental analyses were done on a Leco CHN-932 analyzer. Optical 
rotations were measured at 25 ºC on a Jasco P-2000 Polarimeter using a filtered Hg 
lamp (# = 589 nm). X-ray crystallography was performed on a Nonius Kappa CCD 
area-detector diffractometer using graphite-monochromated Mo K! radiation (# = 
0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. Ligand 
SIPrNap•HBF415 and catalysts5c ([(DiPhSIPrNap)Pd(cin)Cl] (1a), 
[(DiPhSI2PrNap)Pd(cin)Cl] (1b) and [(DiPhSI2CyNap)Pd(cin)Cl] (1c) were prepared 
according to literature procedures. 
2-(3-Pentyl)-naphthalene. In a 100 mL 3-necked flask, equipped with a condenser, 
an addition funnel and a N2 inlet, were added magnesium turnings (0.59 g, 24.36 
mmol) (and 1 crystal of I2) and 20 mL THF under N2 flow. In the addition funnel was 
charged 2-bromonaphthalene (4.80 g, 23.18 mmol) and 25 mL THF, and this solution 
was added slowly into the 3-necked flask at 60°C. At the end of the addition, the 
mixture was reflux for 1h. In a 250 mL schlenk flask was added 3-bromopentane 
(3.50 g, 23.18 mmol) and (FeCl3)2(TMEDA)3 (0.39 g, 0.58 mmol) in 20 mL THF. 
The Grignard reagent was then added dropwise into the Schlenk flask at 0°C and 
stirred at room temperature for 2h. The reaction was quenched with 1 N HCl aqueous 
solution, and extracted with Et2O. The product was isolated as a colorless oil by flash 
chromatography using n-hexane as eluent (3.21 g, 70%). 1H NMR (CDCl3, 400 
MHz): " 7.18-7.76 (m, 3H), 7.56 (s, 1H), 7.46-7.38 (m, 2H), 7.30 (dd, J = 8.4, 1.5 Hz, 
1H), 2.52-2.46 (m, 1H), 1.81-1.73 (m, 2H), 1.70-1.61 (m, 2H), 0.80 (t, J = 7.4 Hz, 
6H). 13C NMR (CDCl3, 100 MHz): " 143.42, 133.81, 132.49, 128.02, 127.80, 127.74, 
126.71, 126.28, 125.92, 125.18, 50.09, 29.47, 12.49. HRMS (EI) m/z calculated for 
C15H18 [M]+ 198.1409, observed 198.1407. 
1-Bromo-2-(3-Pentyl)-naphthalene. 2-(3-Pentyl)-naphthalene (5.00 g, 25.21 mmol) 
was dissolved in 150 mL CH2Cl2, and then a 50 mL CH2Cl2 solution of Br2 (4.03 g, 
25.21 mmol) was added dropwise over 2h at -78°C. After 24h at the same 
temperature, the reaction was finished (confirmed by GC-MS). The reaction was 
quenched by adding 100 mL of an aqueous solution of NaOH. The CH2Cl2 phase was 
separated and washed with 200 mL water, 200 mL 5% Na2CO3, dried by MgSO4, 
filtered and purified by flash chromatography (n-hexane as eluent) to afford a light 
yellow oil (6.44 g, 97%). 1H NMR (CDCl3, 400 MHz): " 8.40 (d, J = 8.6 Hz, 1H), 
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7.82-7.77 (m, 2H), 7.59 (dt, J = 6.8, 1.3 Hz, 1H), 7.49 (dt, J = 7.0, 1.2 Hz, 1H), 7.32 
(d, J = 8.6 Hz, 1H), 3.54-3.47 (m, 1H), 1.86-1.77 (m, 2H), 1.70-1.63 (m, 2H), 0.85 (t, 
J = 7.4 Hz, 6H). 13C NMR (CDCl3, 100 MHz): " 142.89, 133.52, 132.79, 128.22, 
128.15, 127.96, 127.35, 126.00, 125.63, 125.07. HRMS (EI) m/z calculated for 
C15H17Br [M]+ 276.0514, observed 276.0509. 
1S,2S-N,N#-Bis[2-(3-pentyl)-naphthalen-1-yl]-1,2-diphenylethane-1,2-diamine. A 
500 mL schlenk flask was charged with Pd(dba)2 (0.51 g, 0.88 mmol), (±)-BINAP 
(0.67 g, 1.07 mmol), NaOtBu (2.54 g, 26.46 mmol) and toluene (240 mL) and stirred 
for 20 min. 1-Bromo-2-(3-pentyl)-naphthalene (5.62 g, 20.28 mmol) and (1S,2S)-(-)-
1,2-diphenylethylenediamine (1.87 g, 8.82 mmol) were then added and the reaction 
mixture was heated to 120 °C for 48 h. After cooling to room temperature, the 
resulting mixture was filtered through a celite filter and washed with CH2Cl2. The 
filtrate was concentrated and the residue was purified by flash chromatography (SiO2, 
1:3 CH2Cl2/n-hexane) to afford 1S,2S-N,N#-bis[2-(3-pentyl)-naphthalen-1-yl]-1,2-
diphenylethane-1,2-diamine as a white solid (3.04 g, 57%). 1H NMR (CDCl3, 400 
MHz): " 8.68 (d, J = 6.8 Hz, 2H), 7.78 (d, J = 6.8 Hz, 2H), 7.56 (d, J = 8.5 Hz, 2H), 
7.45-7.39 (m, 4H), 7.23 (d, J = 8.6, 2H), 7.01-6.95 (m, 10H), 5.09 (br s, 2H), 5.01 (br 
s, 2H), 2.90-2.83 (m, 2H), 1.88-1.81 (m, 2H), 1.55-1.45 (m, 4H), 1.04-0.98 (m, 2H), 
0.96 (t, J = 7.3 Hz, 6H), 0.52 (t, J = 7.3 Hz, 6H). 13C NMR (CDCl3, 100 MHz): " 
141.01, 140.51, 136.00, 133.39, 130.12, 128.74, 128.27, 128.12, 127.24, 125.22, 
124.97, 124.79, 124.78, 124.23, 69.03, 42.24, 28.97, 28.55, 12.67, 12.09. HRMS 
(ESI) m/z calculated for C44H48N2Na [M+Na]+ 627.3710, observed 627.3714. 
4S,5S-1,3-Bis[2-(3-pentyl)-naphthalen-1-yl]-4,5-diphenyl-4,5-dihydro-1H-
imidazol-3-ium tetrafluoroborate (DiPhSI2(3-Pen)Nap·HBF4). Diamine 1S,2S-
N,N#-bis[2-(3-pentyl)-naphthalen-1-yl]-1,2-diphenylethane-1,2-diamine (1.80 g, 2.98 
mmol), ammonium tetrafluoroborate (0.37 g, 3.57 mmol), triethyl orthoformate (4.96 
mL, 29.80 mmol) and two drops of formic acid were heated to 120 °C and stirred for 
16 h. The resulting mixture was dried in vacuo, and the residue was purified by flash 
chromatography (SiO2, 1:20 methanol:methylene chloride) to afford the product as an 
off-white foam (1.75 g, 84%). [!]27D = -113.84 (c = 1, CHCl3). 1H NMR (CDCl3, 400 
MHz) exists as a mixture of three atropisomers (41:41:18): " 8.31-7.16 (m, NCHN 
and ArH) (correspond to the three atropisomers of twenty three protons), {6.71 (s, 
NCHPh), 6.57 (d, J = 12.0 Hz, NCHPh), 6.23 (s, NCHPh), 6.22 (d, J = 12.8 Hz, 
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NCHPh) (correspond to the three atropisomers of two protons)}, 3.66-0.20 (m, 3-
Pentyl) (correspond to the three atropisomers of twenty two protons)}. 13C NMR 
(CDCl3, 100 MHz) (due to existence of three atropisomers, 13C NMR spectrum 
appeared complex): " 159.37, 158.74, 158.45, 144.81, 143.71, 142.43, 141.66, 
133.17, 133.07, 132.78, 132.71, 132.55, 132.47, 132.27, 132.20, 131.36, 131.30, 
131.24, 130.78, 130.71, 130.62, 130.49, 130.39, 130.20, 130.14, 130.10, 130.03, 
129.87, 129.81, 129.69, 129.61, 129.37, 129.33, 129.23, 129.15, 128.63, 128.44, 
128.18, 127.78, 127.56, 127.46, 127.17, 127.07, 127.05, 126.08, 124.89, 124.36, 
124.26, 123.87, 122.28, 121.42, 121.08, 120.29, 76.08, 74.73, 73.63, 45.17, 44.84, 
43.63, 43.16, 29.61, 28.94, 28.77, 28.62, 27.87, 27.78, 27.18, 27.12, 13.61, 13.46, 
12.95, 12.73, 12.58, 12.28, 12.21, 11.95. HRMS (ESI) m/z calculated for C45H47N2 
[M-BF4]+ 615.3734, observed 615.3732. 
Chloro[(1,2,3-n)-3-phenyl-2-propenyl][4S,5S-1,3-Bis[2-(3-pentyl)-naphthalen-1-
yl]-4,5-di-(4-methoxyl-phenyl)-4,5-dihydro-imidazol-2-ylidene] palladium(II) 
[(DiPhSI2(3-Pen)Nap)Pd(cin)Cl] (1d). DiPhSI2(3-Pen)Nap·HBF4 (1.07 g, 1.52 
mmol), KOtBu (0.17 g, 1.52 mmol) and [Pd(cin)Cl]2 (0.38 g, 0.73 mmol) were mixed 
together in a round flask in the glovebox. Dry THF (20 mL) was added and the 
mixture was stirred at room temperature for 16 h. The solvent was removed in vacuo, 
and the residue was separated by first flash chromatography (SiO2, 1:6$1:3 
EtOAc/n-hexane) to afford three pure atropisomers (1.04 g, 82%). Elemental analysis 
(%) calculated for C54H55PdN2Cl: C, 74.21; H, 6.34; N, 3.20. Found: C, 74.39; H, 
6.51; N, 3.08. HRMS (ESI) m/z calculated for 12C54H55104Pd14N2 [M-Cl]+ 837.3413, 
observed 837.3407. 
Data for Ra,Sa-1d are as follows (first spot). (0.40 g, 32%). [!]28D = -274.05 (c = 1, 
CH2Cl2). 1H NMR (CDCl3, 400 MHz): " 8.47 (d, J = 8.4 Hz, 1H), 8.42 (d, J = 8.4 Hz, 
1H), 7.92-6.96 (br m, 25H), 6.11 (br d, J = 8.8 Hz, 1H), 5.67 (d, J = 9.2 Hz, 1H), 
4.62-3.00 (br m, 4H), 2.51-0.24 (br m, 22H). 13C NMR (CDCl3, 100 MHz): " 215.40, 
163.32, 145.68, 143.91, 138.30, 138.15, 137.85, 137.17, 133.58, 133.06, 132.98, 
132.64, 131.88, 130.94, 129.22, 129.19, 128.98, 128.89, 128.68, 128.61, 128.47, 
128.11, 128.09, 127.97, 127.40, 127.21, 126.69, 126.55, 126.49, 126.37, 125.98, 
125.51, 125.07, 124.74, 124.67, 124.05, 121.30, 109.59, 106.05, 88.74, 88.28, 81.94, 
59.56, 50.24, 49.44, 42.64, 41.47, 40.11, 34.29, 32.09, 29.87, 29.83, 29.53, 29.27, 
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28.65, 28.04, 27.85, 27.62, 26.92, 22.86, 22.50, 14.58, 14.30, 14.24, 12.35, 11.94, 
11.74, 11.64. 
Data for Sa,Sa-1d are as follows (second spot). (0.17 g, 13%). [!]28D = -193.27 (c = 
0.4, CH2Cl2). 1H NMR (CDCl3, 400 MHz): " 8.58 (d, J = 8.5 Hz, 2H), 7.74 (d, J = 8.6 
Hz, 2H), 7.67 (d, J = 8.8 Hz, 2H), 7.51 (d, J = 7.9 Hz, 4H), 7.41-6.96 (m, 15H), 6.53 
(d, J = 6.5 Hz, 2H), 5.75 (s, 2H), 3.69-3.43 (br m, 4H), 2.31-0.90 (br m, 22H). 13C 
NMR (CDCl3, 100 MHz): " 216.87, 142.56, 139.01, 138.32, 133.42, 132.87, 131.81, 
129.21, 128.96, 128.89, 128.13, 128.02, 127.96, 127.40, 127.36, 127.24, 126.43, 
125.59, 125.52, 125.29, 109.58, 78.18, 49.54, 42.05, 28.76, 28.64, 14.25, 13.87, 
12.09. 
Data for Ra,Ra-1d are as follows (third spot). (0.47 g, 37%). [!]28D = -314.30 (c = 1, 
CH2Cl2). 1H NMR (CDCl3, 400 MHz): " 8.51 (br s, 2H), 7.91-7.04 (br m, 25H), 6.08 
(br s, 2H), 5.04 (br s, 0.6H), 4.62 (br s, 0.4H), 4.23 (d, J = 12.1 Hz, 1H), 3.26 (br s, 
2H), 2.44-0.28 (br m, 22H). 13C NMR (CDCl3, 100 MHz): " 212.39, 144.82, 137.43, 
135.83, 133.17, 131.27, 129.20, 128.96, 128.68, 128.34, 127.35, 126.86, 128.34, 
127.35, 126.86, 126.38, 125.95, 125.60, 108.82, 92.49, 89.91, 74.75, 47.58, 40.81, 
32.09, 29.87, 29.83, 29.53, 27.73, 26.00, 22.86, 22.50, 14.29, 14.23, 12.62, 11.44. 
4.5.3 Synthesis of the substrates:5a 
4.5.3.1 General procedure for the synthesis of 2-allyl-arylacetic acids 
LDA was freshly prepared by adding a 2.5 M n-BuLi (2.1 eq.) solution in 
hexanes into 2.1 eq. diisopropylamine in THF at 0 ºC. The LDA solution was then 
cooled to –78 ºC, and 1.0 eq. arylacetic acid was added. After 1h, 2.1 eq. of ally 
bromide was added, and the reaction mixture was warmed to rt and kept for 2h. The 
reaction was quenched by 2N HCl aqueous solution, extracted with EtOAc, dried over 
MgSO4, and concentrated to obtain the desired acid. 
4.5.3.2 General procedure for the synthesis of substrates 
Method A: 
Br
N
O
R1OH
O
R1
2 eq. SOCl2
Reflux, 2h Cl
O
R1
1.5 eq. Et3N
CH2Cl2
0 ºC
0 ºC to RT, 16h
Br
N
H
R2
R2
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The 2-allyl-arylacetic acid (1.0 eq.) was refluxed with SOCl2 (2.0 eq.) for 2 h. 
The excess SOCl2 was distilled out, 1.5 eq. Et3N in CH2Cl2 was added at 0 ºC 
followed by the desired substituted N-methylaniline (1.0 eq.), and the resulting 
mixture was stirred for 16 h. The reaction was then quenched by an aqueous solution 
of NH4Cl, extracted by CH2Cl2, dried over MgSO4 and purified by flash 
chromatography to afford the corresponding substrate. 
Method B: 
Br
N
H
O
R1OH
O
R1
2 eq. SOCl2
Reflux, 2h Cl
O
R1
1.5 eq. Et3N
CH2Cl2
0 ºC
0 ºC to RT, 16h
Br
NH2
R2
R2
(Cl)
Br
N
O
R1
1.1 eq. NaH
THF
RT, 30 min
R2
Me
(Bn)
MeI or BnBr
RT, 16h
 
The 2-allyl-arylacetic acid (1.0 eq.) was refluxed with SOCl2 (2.0 eq.) for 2 h. 
The excess SOCl2 was distilled out, 1.5 eq. Et3N in CH2Cl2 was added at 0 ºC 
followed by the desired substituted aniline (1.0 eq.), and the resulting mixture was 
stirred for 16 h. The reaction was then quenched by an aqueous solution of NH4Cl, 
extracted by CH2Cl2, dried over MgSO4 and purified by flash chromatography to 
afford the corresponding amide. 
To a solution of the corresponding amide (1.0 equiv) in THF, 1.1 eq. NaH 
(60% in mineral oil) was added in small portions at RT, and the resulting mixture was 
stirred for 30 min. Subsequently, 1.1 MeI (or BnBr) in THF was added dropwise at 0 
°C, and the resulting mixture was stirred overnight at RT. The reaction mixture was 
then filtered through a pad of silica/celite, washed by CH2Cl2, and dried in vacuo. The 
residue was then purified by flash chromatography to afford the corresponding 
substrate. 
N-(2-Bromophenyl)-N-methyl-2-phenyl-pent-4-enamide (2a) (Route B). Isolated 
as a colorless oil (82%). 1H NMR (400 MHz, CDCl3): " 7.68 (dd, J = 8.0, 1.4 Hz, 
0.7H), 7.54 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.43-7.08 (m, 5.3H), 6.95-6.89 (m, 1H), 6.58 
(dd, J = 7.8, 1.7 Hz, 0.7H), 5.67-5.57 (m, 1H), 5.01-4.86 (m, 2H), 3.40 (t, J = 7.0 Hz, 
0.3H), 3.17 (t, J = 7.0 Hz, 0.7H), 3.16 (s, 0.9H), 3.14 (s, 2.1H), 2.85-2.77 (m, 1H), 
2.45-2.35 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 172.66, 172.60, 142.58, 142.24, 
139.72, 138.79, 136.46, 136.26, 134.20, 133.80, 131.29, 130.81, 129.93, 128.77, 
128.62, 128.54, 128.51, 128.41, 128.23, 127.11, 127.06, 124.61, 123.69, 116.85, 
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116.64, 50.61, 49.59, 39.63, 39.39, 36.35, 36.31. HRMS (EI) m/z calculated for 
C18H18BrNO [M]+ 343.0572, observed 343.0562. 
N-(2-Bromophenyl)-N-methyl-2-(1-naphthyl)-pent-4-enamide (2b) (Route B). 
Isolated as a colorless oil (85%). 1H NMR (400 MHz, CDCl3): " 7.74-7.53 (m, 4H), 
7.40-7.29 (m, 2.7H), 7.14-7.09 (m, 2.2H), 6.85 (dt, J = 7.6, 1.6 Hz, 0.7H), 6.39 (dt, J 
= 7.7, 1.4 Hz, 0.7H), 5.98 (dd, J = 7.8, 1.6 Hz, 0.7H), 5.82-5.68 (m, 1H), 5.07-4.88 
(m, 2H), 4.37 (dd, J = 8.6, 6.2 Hz, 0.3H), 4.05 (dd, J = 8.6, 6.2 Hz, 0.7H), 3.18 (s, 
0.9H), 3.16 (s, 2.1H), 3.03-2.93 (m, 1H), 2.48-2.39 (m, 1H). 13C NMR (CDCl3, 100 
MHz): " 172.92, 172.75, 142.28, 141.67, 136.78, 136.67, 136.57, 134.94, 134.20, 
133.90, 133.79, 133.45, 131.42, 131.03, 130.78, 130.51, 129.59, 129.44, 128.81, 
128.77, 128.69, 128.21, 127.48, 126.10, 125.95, 125.84, 125.70, 125.67, 125.40, 
125.09, 124.96, 124.43, 123.30, 122.24, 122.07, 116.66, 116.45, 45.53, 39.60, 39.35, 
36.31, 36.29. HRMS (EI) m/z calculated for C22H20BrNO [M]+ 393.0728, observed 
393.0727. 
N-(2-Bromophenyl)-N-methyl-2-(2-naphthyl)-pent-4-enamide (2c) (Route B). 
Isolated as a colorless oil (76%). 1H NMR (400 MHz, CDCl3): " 7.78-7.64 (m, 3.7H), 
7.51-7.18 (m, 5.2H), 7.10 (dd, J = 8.5, 1.7 Hz, 0.7H), 7.02 (dt, J = 7.7, 1.4 Hz, 0.7H), 
6.50(dd, J = 7.8, 1.6 Hz, 0.7H), 5.71-5.60 (m, 1H), 5.04-4.87 (m, 2H), 3.60 (t, J = 7.5 
Hz, 0.3H), 3.36 (t, J = 7.5 Hz, 0.7H), 3.18 (s, 0.9H), 3.16 (s, 2.1H), 2.94-2.87 (m, 
1H), 2.56-2.47 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 172.54, 172.48, 142.56, 
142.16, 137.14, 136.36, 136.16, 134.13, 133.83, 133.53, 133.51, 132.79, 132.67, 
131.37, 130.78, 129.97, 129.95, 128.82, 128.43, 138.22, 128.04, 127.93, 127.76, 
127.71, 127.63, 127.01, 126.61, 126.40, 126.14, 125.91, 125.84, 125.66, 124.69, 
123.69, 116.93, 116.75, 50.74, 49.71, 39.53, 39.2126.34, 36.31. HRMS (EI) m/z 
calculated for C22H20BrNO [M]+ 393.0728, observed 393.0727. 
N-Benzyl-N-(2-bromophenyl)-2-phenyl-pent-4-enamide (2d) (Route B). Isolated 
as a colorless oil (79%). 1H NMR (400 MHz, CDCl3): " 7.67 (dd, J = 8.0, 1.3 Hz, 
0.7H), 7.57-7.55 (m, 0.3H), 7.26-6.98 (m, 10H), 6.92-6.85 (m, 2H), 6.80-6.78 (m, 
0.3H), 6.20 (dd, J = 7.8, 1.6 Hz, 0.7H), 5.80-5.58 (m, 2H), 5.27-4.89 (m, 2H), 3.98 (d, 
J = 14.4 Hz, 0.7H), 3.84 (d, J = 14.4 Hz, 0.3H), 3.37 (dd, J = 8.5, 6.5 Hz, 0.3H), 3.19 
(t, J = 7.4 Hz, 0.7H), 2.91-2.83 (m, 1H), 2.48-2.40 (m, 1H). 13C NMR (CDCl3, 100 
MHz): " 172.51, 172.43, 140.35, 140.11, 139.63, 138.71, 137.32, 137.20, 136.46, 
136.03, 134.07, 133.64, 132.71, 132.59, 129.94, 129.89, 129.44, 129.22, 128.67, 
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128.50, 128.42, 128.16, 128.07, 127.75, 127.64, 127.51, 127.18, 1727.05, 124.89, 
124.09, 1217.00, 116.67, 51.77, 51.56, 50.93, 49.59, 39.64. HRMS (EI) m/z 
calculated for C24H22BrNO [M]+ 419.0885, observed 419.0879. 
N-(2-Bromophenyl)-N-methyl-2-o-tolyl-pent-4-enamide (2e) (Route B). Isolated 
as a colorless oil (74%). 1H NMR (400 MHz, CDCl3): " 7.64 (dd, J = 8.0, 1.4 Hz, 
0.8H), 7.48-7.46 (m, 0.2H), 7.39-7.32 (m, 1.2H), 7.18-6.87 (m, 5H), 6.25 (dd, J = 7.8, 
1.7 Hz, 0.8H), 5.78-5.70 (m, 1H), 5.03-4.89 (m, 2H), 3.76 (dd, J = 8.8, 6.0 Hz, 0.2H), 
3.40 (dd, J = 8.8, 6.0 Hz, 0.8H), 3.16 (s, 0.6H), 3.13 (s, 2.4H), 2.84-2.75 (m, 1H), 
2.24-2.15 (m, 1H), 1.42 (s, 0.6H), 1.38 (s, 2.4H). 13C NMR (CDCl3, 100 MHz): " 
172.82, 172.73, 142.53, 141.98, 138.74, 137.16, 136.77, 136.54, 135.67, 135.49, 
134.32, 133.57, 131.02, 130.88, 130.17, 130.04, 129.70, 128.88, 128.53, 127.87, 
126.82, 126.76, 126.55, 124.47, 123.90, 116.60, 116.39, 53.60, 46.46, 44.84, 39.42, 
38.93, 36.30, 36.27, 18.60, 18.53. HRMS (EI) m/z calculated for C19H20BrNO [M]+ 
357.0728, observed 357.0722. 
N-(2-Bromophenyl)-N-methyl-2-(o-fluorophenyl)-pent-4-enamide (2f) (Route A). 
Isolated as a colorless oil (72%). 1H NMR (400 MHz, CDCl3): " 7.66 (dd, J = 8.0, 1.4 
Hz, 0.7H), 7.52-7.37 (m, 1.7H), 7.31-7.28 (m, 0.3H), 7.23-7.01 (m, 3.6H), 6.82-6.75 
(m, 1H), 6.48 (dd, J = 7.8, 1.5 Hz, 0.7H), 5.69-5.58 (m, 1H), 5.00-4.86 (m, 2H), 3.89 
(t, J = 7.3 Hz, 0.3H), 3.63 (t, J = 7.3 Hz, 0.7H), 3.17 (s, 0.9H), 3.15 (s, 2.1H), 2.81-
2.75 (m, 1H), 2.41-2.31 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 172.20, 172.09, 
161.58, 161.25, 159.14, 158.80, 142.11, 141.78, 135.81, 135.65, 134.13, 133.83, 
130.55, 130.44, 129.95, 129.83, 129.80, 129.08, 129.04, 128.88, 128.63, 128.57, 
128.54, 128.49, 127.07, 126.92, 125.97, 125.82, 124.54, 124.08, 123.58, 117.19, 
116.95, 115.18, 115.02, 114.96, 114.79, 41.72, 41.70, 40.22, 40.20, 38.84, 38.57, 
36.35, 36.32. HRMS (EI) m/z calculated for C18H17BrNOF [M]+ 361.0478, observed 
361.0470. 
N-(2-Bromophenyl)-N-methyl-2-(o-methoxylphenyl)-pent-4-enamide (2g) (Route 
B). Isolated as a colorless oil (61%). 1H NMR (400 MHz, CDCl3): " 7.64 (dd, J = 8.0, 
1.4 Hz, 0.7H), 7.47 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.45 (dd, J = 3.5, 1.3 Hz, 0.3H), 7.38-
7.28 (m, 1.3H), 7.20-7.08 (m, 2H), 6.96 (dt, J = 7.7, 1.4 Hz, 0.7H), 6.89-6.85 (m, 1H), 
6.61 (d, J = 8.2 Hz, 0.3H), 6.57 (d, J = 8.2 Hz, 0.7H), 6.38 (dd, J = 7.8, 1.6 Hz, 0.7H), 
5.76-5.65 (m, 1H), 5.03-4.85 (m, 2H), 4.12 (dd, J = 8.7, 1.4 Hz, 0.3H), 3.80 (dd, J = 
8.7, 1.4  Hz, 0.7H), 3.35 (s, 0.9H), 3.32 (s, 2.1H), 3.15 (s, 0.9H), 3.13 (s, 2.H), 2.82-
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2.71 (m, 1H), 2.31-2.23 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 173.43, 173.39, 
156.28, 156.11, 142.69, 142.17, 136.92, 136.63, 133.64, 133.45, 130.92, 130.89, 
129.31, 129.26, 129.10, 128.60, 128.19, 128.05, 127.96, 127.88, 127.34, 124.41, 
123.93, 120.84, 120.77, 116.43, 116.02, 109.84, 109.67, 54.91, 54.88, 41.84, 39.96, 
38.96, 38.50, 36.27. HRMS (EI) m/z calculated for C19H20BrNO2 [M]+ 373.0677, 
observed 373.0674. 
N-(2-Bromophenyl)-N-methyl-2-m-tolyl-pent-4-enamide (2h) (Route B). Isolated 
as a colorless oil (77%). 1H NMR (400 MHz, CDCl3): " 7.67 (dd, J = 8.0, 1.4 Hz, 
0.7H), 7.52 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.40 (dt, J = 7.7, 1.4 Hz, 0.3H), 7.31 (dd, J = 
7.8, 1.6 Hz, 0.3H), 7.24-7.16 (m, 1H), 7.11-7.00 (m, 1.7H), 6.97-6.93 (m, 1H), 6.72-
6.64 (m, 2H), 6.57 (dd, J = 7.7, 1.6 Hz, 0.7H), 5.58-5.57 (m, 1H), 5.02-4.85 (m, 2H), 
3.38 (dd, J = 8.8, 6.0 Hz, 0.3H), 3.13 (dd, J = 8.8, 6.0 Hz, 0.7H), 3.16 (s, 0.9H), 3.12 
(s, 2.1H), 2.86-2.77 (m, 1H), 2.43-2.35 (m, 1H), 2.23 (s, 2.1H), 2.22 (s, 0.9H). 13C 
NMR (CDCl3, 100 MHz): " 172.60, 172.56, 142.49, 142.12, 139.51, 138.49, 138.01, 
137.77, 136.50, 136.31, 134.03, 133.67, 131.38, 130.76, 129.82, 129.24, 128.78, 
128.68, 128.28, 128.16, 127.72, 125.55, 125.25, 124.58, 123.61, 116.66, 116.45, 
50.52, 49.49, 39.49, 39.11, 36.25, 36.22, 21.52, 21.50. HRMS (EI) m/z calculated for 
C19H20BrNO [M]+ 357.0728, observed 357.0724. 
N-(2-Bromophenyl)-N-methyl-2-(m-fluorophenyl)-pent-4-enamide (2i) (Route B). 
Isolated as a colorless oil (80%). 1H NMR (400 MHz, CDCl3): " 7.69 (dd, J = 8.0, 1.4 
Hz, 0.7H), 7.56 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.44-7.39 (m, 0.3H), 7.32-7.10 (m, 3.4 H), 
6.89-6.84 (m, 1H), 6.72-6.61 (m, 2.3H), 5.64-5.54 (m, 1H), 5.01-4.87 (m, 2H), 3.40 
(t, J = 7.5 Hz, 0.3H), 3.19 (t, J = 7.5 Hz, 0.7H), 3.17 (s, 0.9H), 3.15 (s, 2.1H), 2.83-
2.75 (m, 1H), 2.45-2.34 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 172.10, 172.02, 
164.15, 164.09, 161.71, 161.66, 142.35, 142.17, 142.09, 142.05, 141.24, 141.16, 
135.93, 135.74, 134.24, 133.91, 131.09, 130.70, 130.11, 129.96, 129.88, 129.76, 
129.68, 128.88, 128.59, 124.44, 124.34, 124.31, 123.90, 123.87, 123.62, 117.19, 
117.01, 115.64, 115.42, 115.25, 115.04, 114.12, 113.91, 50.26, 50.24, 49.26, 49.24, 
39.48, 39.27, 36.37, 36.34. HRMS (EI) m/z calculated for C18H17BrNOF [M]+ 
361.0478, observed 361.0468. 
N-(2-Bromophenyl)-N-methyl-2-(m-methoxylphenyl)-pent-4-enamide (2j) (Route 
A). Isolated as a colorless oil (58%). 1H NMR (400 MHz, CDCl3): " 7.67 (dd, J = 8.0, 
1.4 Hz, 0.7H), 7.54 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.40 (dt, J = 7.6, 1.4 Hz, 0.3H), 7.31-
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7.03 (m, 3H), 6.72-6.66 (m, 1H), 6.62 (dd, J = 7.7, 1.6 Hz, 0.7H), 6.51-6.47 (m, 2H), 
5.67-5.57 (m, 1H), 5.02-4.86 (m, 2H), 3.70 (s, 0.9H), 3.69 (s, 2.1H), 3.38 (dd, J = 8.1, 
6.9 Hz, 0.3H), 3.18 (s, 0.9H), 3.14 (dd, J = 8.1, 6.9 Hz, 0.7H), 3.13 (s, 2.1H), 2.84-
2.76 (m, 1H), 2.44-2.34 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 172.45, 172.41, 
159.74, 159.62, 142.53, 142.18, 141.21, 140.20, 136.42, 136.21, 134.13, 133.76, 
131.35, 130.77, 129.91, 129.43, 139.27, 128.76, 128.47, 124.60, 123.65, 121.07, 
120.61, 116.83, 116.61, 114.27, 113.88, 113.46, 113.00, 112.83, 55.31, 50.62, 49.59, 
39.53, 39.24, 36.34, 36.30. HRMS (EI) m/z calculated for C19H20BrNO2 [M]+ 
373.0677, observed 373.0662. 
N-(2-Bromophenyl)-N-methyl-2-p-tolyl-pent-4-enamide (2k) (Route B). Isolated 
as a colorless oil (78%). 1H NMR (400 MHz, CDCl3): " 7.68 (dd, J = 8.0, 1.4 Hz, 
0.7H), 7.55 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.39 (dt, J = 7.7, 1.4 Hz, 0.3H), 7.32-7.10 (m, 
2H), 6.99-6.96 (m, 2H), 6.62 (dd, J = 7.7, 1.6 Hz, 0.7H), 5.67-5.56 (m, 1H), 5.00-4.85 
(m, 2H), 3.37 (dd, J = 8.8, 6.0 Hz, 0.3H), 3.11 (dd, J = 8.8, 6.0 Hz, 0.7H), 3.16 (s, 
0.9H), 3.13 (s, 2.1H), 2.83-2.75 (m, 1H), 2.43-2.36 (m, 1H), 2.28 (s, 2.1H), 2.26 (s, 
0.9H). 13C NMR (CDCl3, 100 MHz): " 172.83, 172.82, 142.63, 142.25, 136.59, 
136.57, 136.54, 136.31, 135.74, 134.15, 133.74, 131.30, 130.76, 129.88, 129.21, 
129.05, 128.73, 128.48, 128.45, 128.07, 124.53, 123.65, 116.75, 116.51, 50.08, 49.05, 
39.62, 39.36, 36.28, 26.24, 21.24, 21.22. HRMS (EI) m/z calculated for C19H20BrNO 
[M]+ 357.0728, observed 357.0723. 
N-(2-Bromophenyl)-N-methyl-2-(p-fluorophenyl)-pent-4-enamide (2l) (Route A). 
Isolated as a colorless oil (84%). 1H NMR (400 MHz, CDCl3): " 7.69 (dd, J = 8.0, 1.4 
Hz, 0.7H), 7.55 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.41 (dt, J = 8.7, 1.3 Hz, 0.3H), 7.32-7.19 
(m, 1.6 H), 7.14 (dt, J = 7.7, 1.4 Hz, 0.7H), 6.93-6.82 (m, 4H), 6.60 (dd, J = 7.7, 1.6 
Hz, 0.7H), 5.63-5.53 (m, 1H), 4.99-4.86 (m, 2H), 3.38 (t, J = 7.5 Hz, 0.3H), 3.18 (t, J 
= 7.5 Hz, 0.7H), 3.16 (s, 0.9H), 3.14 (s, 2.1H), 2.81-2.74 (m, 1H), 2.43-2.32 (m, 1H). 
13C NMR (CDCl3, 100 MHz): " 172.58, 172.51, 163.40, 163.26, 160.96, 160.82, 
142.49, 142.17, 136.11, 135.91, 135.40, 135.36, 134.55, 134.52, 134.23, 133.92, 
131.12, 130.76, 130.16, 130.08, 130.05, 129.77, 129.69, 128.87, 128.57, 124.48, 
123.70, 117.09, 116.91, 115.48, 115.31, 115.27, 115.09, 49.71, 48.72, 39.63, 39.43, 
36.35, 36.31. HRMS (EI) m/z calculated for C18H17BrNOF [M]+ 361.0478, observed 
361.0474. 
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N-(2-Bromophenyl)-N-methyl-2-(p-methoxylphenyl)-pent-4-enamide (2m) 
(Route B). Isolated as a colorless oil (65%). 1H NMR (400 MHz, CDCl3): " 7.67 (dd, 
J = 8.0, 1.4 Hz, 0.7H), 7.55 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.31-7.11 (m, 2H), 6.87-6.80 
(m, 2H), 6.72-6.68 (m, 2H), 6.62 (dd, J = 7.7, 1.6 Hz, 0.7H), 5.65-5.55 (m, 1H), 4.99-
4.84 (m, 2H), 3.74 (s, 2.1H), 3.72 (s, 0.9H), 3.34 (t, J = 7.5 Hz, 0.3H), 3.15 (s, 0.9H), 
3.12 (s, 2.1H), (t, J = 7.5 Hz, 0.7H), 2.80-2.73 (m, 1H), 2.42-2.32 (m, 1H). 13C NMR 
(CDCl3, 100 MHz): " 172.93, 172.89, 158.75, 158.66, 142.59, 142.23, 136.50, 
136.27, 134.13, 133.74, 131.72, 131.26, 130.93, 130.74, 129.87, 129.57, 129.19, 
128.73, 138.46, 124.54, 123.64, 116.74, 116.52, 113.87, 113.76, 55.35, 49.59, 48.58, 
39.60, 39.37, 36.24, 36.19. HRMS (EI) m/z calculated for C19H20BrNO2 [M]+ 
373.0677, observed 373.0673. 
N-(2-Bromophenyl)-N-methyl-2-(p-trifluoromethylphenyl)-pent-4-enamide (2n) 
(Route B). Isolated as a colorless oil (79%). 1H NMR (400 MHz, CDCl3): " 7.70 (dd, 
J = 8.0, 1.4 Hz, 0.7H), 7.56 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.44-7.40 (m, 2.3H), 7.33-
7.20 (m, 1.6H), 7.16-7.03 (m, 2.4H), 6.59 (dd, J = 7.7, 1.6 Hz, 0.7H), 5.63-5.52 (m, 
1H), 5.00-4.88 (m, 2H), 3.46 (t, J = 7.5 Hz, 0.3H), 3.25 (t, J = 7.5 Hz, 0.7H), 3.16 (s, 
0.9H), 3.15 (s, 2.1H), 2.85-2.77 (m, 1H), 2.46-2.35 (m, 1H). 13C NMR (CDCl3, 100 
MHz): " 171.92, 171.87, 143.69, 142.80, 142.34, 142.02, 135.67, 135.48, 134.29, 
134.03, 130.97, 130.72, 130.20, 129.59, 129.27, 129.03, 128.98, 128.66, 128.59, 
125.78, 125.70, 125.55, 125.51, 125.47, 125.44, 125.34, 125.30, 124.34, 123.67, 
122.99, 117.44, 117.27, 50.36, 49.37, 39.49, 39.27, 36.42, 36.39. HRMS (EI) m/z 
calculated for C19H17BrNOF3 [M]+ 411.0446, observed 411.0440. 
N-(2-Bromophenyl)-N-methyl-2-(p-biphenyl)-pent-4-enamide (2o) (Route B). 
Isolated as a white solid (84%). 1H NMR (400 MHz, CDCl3): " 7.70 (dd, J = 8.0, 1.4 
Hz, 0.7H), 7.57-7.53 (m, 2.6H), 7.44-7.20 (m, 7.3H), 7.14 (dt, J = 7.7, 1.3 Hz, 0.7H), 
7.03 (d, J = 8.2 Hz, 0.6H), 7.00 (d, J = 8.2 Hz, 1.4H), 6.67 (dd, J = 7.8, 1.6 Hz, 0.7H), 
5.72-5.61 (m, 1H), 5.05-4.90 (m, 2H), 3.46 (t, J = 7.5 Hz, 0.3H), 3.23 (t, J = 7.5 Hz, 
0.7H), 3.19 (s, 0.9H), 3.17 (s, 2.1H), 2.89-2.82 (m, 1H), 2.51-2.41 (m, 1H). 13C NMR 
(CDCl3, 100 MHz): " 172.63, 172.60, 142.57, 142.23, 141.19, 140.88, 139.95, 
139.86, 138.74, 137.85, 136.38, 136.18, 134.23, 133.84, 131.31, 130.79, 129.97, 
129.03, 128.95, 128.87, 128.79, 128.64, 128.56, 127.43, 127.27, 127.20, 127.12, 
124.59, 123.68, 116.95, 116.75, 50.21, 49.22, 39.58, 39.27, 36.37, 36.34. HRMS (EI) 
m/z calculated for C24H22BrNO [M]+ 419.0885, observed 419.0882. 
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N-(2-Chlorophenyl)-N-methyl-2-(o-fluorophenyl)-pent-4-enamide (2p) (Route B). 
Isolated as a colorless oil (80%). 1H NMR (400 MHz, CDCl3): " 7.50-7.41 (m, 1.7H), 
7.34-7.23 (m, 2H), 7.15-7.00 (m, 2.6H), 6.78 (t, J = 9.7 Hz, 1H), 6.51 (dd, J = 7.8, 1.5 
Hz, 0.7H), 5.68-5.58 (m, 1H), 5.00-4.87 (m, 2H), 3.90 (t, J = 7.3 Hz, 0.3H), 3.64 (t, J 
= 7.3 Hz, 0.7H), 3.17 (s, 0.9H), 3.16 (s, 2.1H), 2.83-2.73 (m, 1H), 2.39-2.31 (m, 1H). 
13C NMR (CDCl3, 100 MHz): " 172.35, 172.22, 161.51, 161.24, 159.07, 158.79, 
140.50, 140.29, 135.75, 135.69, 133.93, 133.02, 130.84, 130.65, 130.48, 130.39, 
129.79, 129.76, 129.72, 129.69, 129.09, 129.05, 128.62, 128.54, 128.47, 128.17, 
127.96, 127.09, 126.94, 125.94, 125.79, 124.54, 124.50, 124.42, 124.38, 117.14, 
116.91, 115.19, 114.96, 114.94, 114.71, 41.52, 41.50, 40.37, 40.35, 38.70, 38.49, 
36.34, 36.21. HRMS (EI) m/z calculated for C18H17ClNOF [M]+ 317.0983, observed 
317.0981. 
N-(2-Bromo-4-methoxyl-phenyl)-N-methyl-2-(o-fluorophenyl)-pent-4-enamide 
(2q) (Route A). Isolated as a white solid (85%). 1H NMR (400 MHz, CDCl3): " 7.52 
(dt, J = 7.6, 1.8 Hz, 0.3H), 7.42 (dt, J = 7.6, 1.8 Hz, 0.7H), 7.19-7.01 (m, 3.3H), 6.90 
(dd, J = 8.7, 1.8 Hz, 0.3H), 6.84-6.77 (m, 1H), 6.57 (dd, J = 8.7, 2.8 Hz, 0.7H), 6.36 
(d, J = 8.7 Hz, 0.7H), 5.70-5.58 (m, 1H), 5.00-4.86 (m, 2H), 3.91 (t, J = 7.5 Hz, 
0.3H), 3.80 (s, 0.9H), 3.78 (s, 2.1H), 3.66 (t, J = 7.5 Hz, 0.7H), 2.81-2.74 (m, 1H), 
2.40-2.30 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 172.68, 172.67, 172.55, 172.53, 
161.62, 161.30, 159.90, 159.86, 159.19, 158.86, 135.93, 135.74, 134.92, 134.58, 
130.72, 130.65, 129.99, 129.84, 129.09, 129.05, 128.56, 128.50, 128.48, 128.42, 
127.20, 127.05, 126.15, 126.00, 124.51, 124.48, 124.42, 124.38, 123.92, 118.84, 
118.49, 117.13, 116.88, 115.19, 115.02, 114.97, 114.79, 114.63, 114.48, 55.98, 55.97, 
41.54, 41.52, 40.03, 40.00, 38.91, 38.55, 36.55. HRMS (EI) m/z calculated for 
C19H19BrNO2F [M]+ 391.0583, observed 391.0578. 
N-(2-Bromo-4-methoxyl-phenyl)-N-methyl-2-methyl-pent-4-enamide (2r) (Route 
B). Isolated as a white solid (88%). 1H NMR (400 MHz, CDCl3): " 7.58-7.54 (m, 
1H), 7.46-6.22 (m, 6H), 7.11-7.09 (m, 1H), 7.06-7.04 (m, 1.3H), 6.94 (dd, J = 8.7, 2.8 
Hz, 0.3H), 6.66 (dd, J = 8.7, 2.8 Hz, 0.7H), 6.56 (d, J = 8.7 Hz, 0.7H), 5.73-5.63 (m, 
1H), 5.06-4.90 (m, 2H), 3.83 (s, 0.9H), 3.81 (s, 2.1H), 3.50 (t, J = 7.5 Hz, 0.3H), 3.30 
(t, J = 7.5 Hz, 0.7H), 3.17 (s, 0.9H), 3.14 (s, 2.1H), 2.95-2.85 (m, 1H), 2.47-2.40 (m, 
1H). 13C NMR (CDCl3, 100 MHz): " 173.02, 172.98, 159.84, 159.81, 141.13, 140.82, 
139.82, 139.75, 138.79, 137.98, 136.42, 136.18, 135.26, 134.92, 1321.43, 130.91, 
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129.02, 128.88, 128.80, 128.63, 127.35, 127.20, 27.12, 127.10, 127.05, 127.01, 
124.88, 123.97, 118.81, 118.52, 116.86, 116.63, 114.50, 114.17, 55.94, 55.92, 49.92, 
48.96, 39.53, 39.30, 36.49. HRMS (EI) m/z calculated for C25H24BrNO2 [M]+ 
449.0990, observed 449.0980. 
N-(2-Bromo-3-methyl-phenyl)-N-methyl-2-(o-fluorophenyl)-pent-4-enamide (2s) 
(Route B). Isolated as a colorless oil (73%). 1H NMR (400 MHz, CDCl3): " 7.52-7.42 
(m, 1H), 7.27-7.00 (m, 3.6H), 6.94 (t, J = 8.6 Hz, 0.7H), 6.77 (dt, J = 7.8, 1.3 Hz, 
1H), 6.31 (d, J = 8.2 Hz, 0.7H), 5.69-5.58 (m, 1H), 5.00-4.85 (m, 2H), 3.87 (t, J = 7.5 
Hz, 0.3H), 3.63 (t, J = 7.5 Hz, 0.7H), 3.17 (s, 0.9H), 3.14 (s, 2.1H), 2.81-2.74 (m, 
1H), 2.47 (s, 2.1H), 2.42-2.33 (m, 1H), 2.31 (s, 0.9H). 13C NMR (CDCl3, 100 MHz): 
" 172.24, 172.07, 161.62, 161.26, 159.18, 158.81, 142.32, 142.01, 140.74, 140.44, 
135.93, 135.71, 130.68, 130.57, 129.95, 129.92, 129.09, 129.05, 128.56, 128.48, 
128.40, 128.06, 127.79, 127.62, 127.25, 127.10, 126.78, 126.10, 126.00, 125.96, 
124.51, 124.48, 124.39, 124.36, 117.09, 116.87, 115.16, 114.94, 114.85, 114.62, 
41.62, 41.60, 40.16, 40.14, 38.86, 38.64, 36.30, 36.25, 23.94, 23.77. HRMS (EI) m/z 
calculated for C19H19BrNOF [M]+ 375.0634, observed 375.0628. 
N-(2-Bromophenyl)-N-methyl-2-(1-methyl-1H-indol-3-yl)-pent-4-enamide (2t) 
(Route B). Isolated as a colorless oil (78%). 1H NMR (400 MHz, CDCl3): " 7.70 (dd, 
J = 8.0, 1.4 Hz, 0.7H), 7.44-7.35 (m, 0.9H), 7.24-7.10 (m, 3H), 7.03-6.88 (m, 3.7H), 
6.60 (dd, J = 7.7, 1.6 Hz, 0.7H), 5.75-5.64 (m, 1H), 5.06-4.85 (m, 2H), 3.76 (t, J = 7.5 
Hz, 0.3H), 3.71 (s, 2.1H), 3.69 (s, 0.9H), 3.52 (t, J = 7.5 Hz, 0.7H), 3.19 (s, 0.9H), 
3.17 (s, 2.1H), 2.89-2.82 (m, 1H), 2.57-2.49 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 
173.76, 173.53, 142.78, 142.48, 136.96, 136.75, 136.72, 134.09, 133.67, 130.86, 
130.63, 129.70, 129.63, 128.65, 128.61, 127.72, 127.54, 127.42, 126.83, 124.31, 
123.38, 121.53, 121.30, 119.12, 118.87, 118.84, 118.69, 116.45, 116.23, 112.98, 
112.07, 109.15, 109.03, 41.04, 40.32, 39.72, 39.49, 36.16, 36.13, 32.86, 32.82. 
HRMS (EI) m/z calculated for C21H21BrN2O [M]+ 396.0837, observed 396.0840. 
N-(2-Bromo-4-methoxyl-phenyl)-N-methyl-2-methyl-pent-4-enamide (2u) (Route 
B). Isolated as a colorless oil (92%). 1H NMR (400 MHz, CDCl3): " 7.17-7.10 (m, 
2H), 6.87-6.84 (m, 1H), 5.70-5.52 (m, 1H), 4.99-4.90 (m, 2H), 3.80 (s, 3H), 3.13 (s, 
1.6H), 3.12 (s, 1.4H), 2.45-1.95 (m, 3H), 1.05 (d, J = 6.6 Hz, 1.6H), 0.97 (d, J = 6.6 
Hz, 1.4H). 13C NMR (CDCl3, 100 MHz): " 176.87, 176.63, 159.76, 159.73, 136.67, 
136.21, 135.70, 135.68, 130.79, 130.12, 124.07, 123.99, 118.94, 118.79, 116.78, 
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116.62, 114.70, 114.63, 55.97, 39.05, 38.26, 37.14, 36.99, 36.31, 36.28, 17.62. 
HRMS (EI) m/z calculated for C14H18BrNO2 [M]+ 311.0521, observed 311.0516. 
N-(2-Bromophenyl)-N-methyl-2-(3,5-dimethylphenyl)-pent-4-enamide (2v) 
(Route A). Isolated as a colorless oil (66%). 1H NMR (400 MHz, CDCl3): " 7.68 (dd, 
J = 8.0, 1.4 Hz, 0.7H), 7.53 (dd, J = 8.0, 1.4 Hz, 0.3H), 7.39 (dt, J = 7.6, 1.4 Hz, 
0.3H), 7.29 (dd, J = 7.8, 1.7 Hz, 0.3H), 7.25-7.15 (m, 1H), 7.10 (dt, J = 7.7, 1.5 Hz, 
0.7H), 6.79-6.77 (m, 1H), 6.59 (dd, J = 7.8, 1.6 Hz, 0.7H), 6.48 (s, 2H), 5.69-5.59 (m, 
1H), 5.03-4.87 (m, 2H), 3.36 (t, J = 7.5 Hz, 0.3H), 3.17 (s, 0.9H), 3.14 (s, 2.1H), 3.09 
(t, J = 7.5 Hz, 0.7H), 2.84-2.77 (m, 1H), 2.41-2.29 (m, 1H), 2.19 (s, 2.1H), 2.18 (s, 
0.9H). 13C NMR (CDCl3, 100 MHz): " 172.73, 142.58, 142.19, 139.47, 138.34, 
138.16, 137.86, 137.67, 136.71, 136.54, 134.01, 133.69, 131.63, 130.85, 129.81, 
129.76, 128.67, 128.64, 128.14, 126.37, 126.01, 124.71, 123.69, 116.59, 116.39, 
50.59, 49.53, 39.45, 38.93, 36.33, 36.30, 21.44, 21.42. HRMS (EI) m/z calculated for 
C20H22BrNO [M]+ 371.0885, observed 371.0883. 
4.5.4 Pd-Catalyzed asymmetric intramolecular !-arylation to give oxindoles: 
4.5.4.1 General procedure for catalytic reactions by using well-defined chiral 
palladium catalysts 
Catalyst (5 mol%) and base (1.5 eq.) were charged in a 20 mL vial in a 
glovebox. DME (2 mL) was added and the mixture was stirred for 5 min. The 
substrate (0.2 mmol, 1 eq.) was then added as a solution in 2 mL DME. The reaction 
was stirred at the indicated temperature, and monitored by GC-MS. After the required 
time, the reaction was treated with aq. NH4Cl (10 mL) and this phase was extracted 
with 2%10 mL ether. The combined organic phases were washed with brine and dried 
over MgSO4. Flash chromatography afforded the product oxindoles, and the 
enantiomeric purity of products was determined by chiral HPLC analysis. 
4.5.4.2 General procedure for catalytic reactions by using chiral phosphine ligands 
Pd(dba)2 (5 mol%), chiral phosphine ligand (5.5 mol%) and base (1.5 eq.) 
were charged in a 20 mL vial in a glovebox. DME (2 mL) was added and the mixture 
was stirred for 5 min. The substrate 2a (0.2 mmol, 1 eq.) was then added as a solution 
in 2 mL DME. The reaction was stirred at 50 ºC for  24h, and then the reaction was 
treated with aq. NH4Cl (10 mL) and this aqueous phase was extracted with 2%10 mL 
ether. The combined organic phases were washed with brine and dried over MgSO4. 
The conversions and the ratio 3a/4a were determined by 1H NMR of the crude 
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mixture. The enantiomeric purity of products was determined by chiral HPLC 
analysis. 
Table S1. Catalytic results with chiral phosphine ligands. 
Br
N
Me
O
Ph
Pd(dba)2 (5 mol %)
Ligand (5.5 mol %)
DME, 50ºC, 24h N
O
Me
Ph
N O
Ph
Me
+
2a 3a 4a
1.5 eq. NaOtBu
 
Entry Ligand[a] Conversion (%)[b] 3a/4a[c] ee (%)[d] 
1 (S)-BINAP 48 5:1 -29 (S) 
2 (S)-BIPHEMP 50 6:1 -24 (S) 
3 (R)-MeO-MOP >99 5:1 0 
[a] (S)-BINAP: (S)-2,2$-Bis(diphenylphosphino)-1,1$-binaphthalene; (S)-BIPHEMP: 
(S)-(6,6$-dimethyl-1,1$-biphenyl-2,2$-diyl)bis(diphenylphosphine); (R)-MeO-MOP: 
(R)-2-(diphenylphosphino)-2$-methoxy-1,1$-binaphthalene. [b-c] Determined by 
analysis of 1H NMR spectra of product mixtures prior to purification. [d] Determined 
by chiral HPLC for 3a. 
4.5.4.3 General procedure for preparing authentic racemic samples for HPLC 
analyses 
Pd(dba)2 (5 mol%), SIPrNap•HBF4 (5.5 mol%) and base (1.5 eq.) were 
charged in a 20 mL vial in a glovebox. DME (2 mL) was added and the mixture was 
stirred for 5 min. The substrate (0.2 mmol, 1 eq.) was then added as a solution in 2 
mL DME. The reaction was stirred at 50 ºC for 16h, and then the reaction was treated 
with aq. NH4Cl (10 mL) and extracted with 2%10 mL ether. The combined organic 
phases were washed with brine and dried over MgSO4. Flash chromatography 
afforded the product oxindoles, and the enantiomeric purity of products was 
determined by chiral HPLC analysis. 
 (R)-3-Allyl-1-methyl-3-phenyl-1,3-dihydro-indol-2-one (3a).4a  Colorless oil, 96% 
yield. [!]27D = 118.26 (c = 1, CHCl3), 81% ee [Chiralpak IB column, n-hexane/i-
PrOH = 99:1, 0.5 mL/min, tR = 25.09 min (minor) and 26.16 min (major)].  1H NMR 
(400 MHz, CDCl3): " 7.38-7.20 (m, 7H), 7.10 (dt, J = 7.6, 1.0 Hz, 1H), 6.88 (d, J = 
7.8 Hz, 1H), 5.43-5.33 (m, 1H), 5.04-4.89 (m, 2H), 3.19 (s, 3H), 3.01 (d, J = 7.2 Hz, 
2H). 13C NMR (CDCl3, 100 MHz): " 178.18, 144.06, 139.72, 132.63, 131.89, 128.73, 
128.42, 127.53, 125.39, 122.65, 119.34, 108.39, 56.60, 42.20, 26.55. HRMS (EI) m/z 
calculated for C18H17NO [M]+ 263.1310, observed 263.1309. 
(±)-1-Methyl-5-methylidene-3-phenyl-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one 
(4a). Colorless oil.  1H NMR (400 MHz, CDCl3): " 7.40-7.36 (m, 1H), 7.31-7.18 (m, 
8H), 5.28-5.25 (m, 1H), 5.10-5.09 (m, 1H), 3.97 (dd, J = 13.1, 6.0 Hz, 1H), 3.36-3.29 
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(m, 1H), 3.31 (s, 3H), 3.14-3.04 (m, 1H). 13C NMR (CDCl3, 100 MHz): " 173.00, 
145.02, 142.25, 138.47, 137.40, 129.48, 129.07, 129.03, 128.33, 127.34, 126.58, 
122.96, 116.07, 47.24, 44.44, 36.31. HRMS (EI) m/z calculated for C18H17NO [M]+ 
263.1310, observed 263.1309. 
(R)-3-Allyl-1-methyl-3-(1-naphthyl)-indolin-2-one (3b). Colorless oil, 98% yield. 
[!]27D = -17.02 (c = 0.5, CHCl3), 87% ee [Chiralpak IB column, n-hexane/i-PrOH = 
95:5, 1 mL/min, tR = 13.55 min (minor) and 27.96 min (major)]. 1H NMR (400 MHz, 
CDCl3): " 7.85 (d, J = 7.4 Hz, 1H), 7.80 (d, J = 8.4 Hz, 1H), 7.77 (d, J = 9.3 Hz, 1H), 
7.51 (t, J = 7.8 Hz, 1H), 7.32-7.27 (m, 2H), 7.15-7.11 (m, 1H), 7.03-6.91 (m, 3H), 
6.82 (d, J = 7.3 Hz, 1H), 5.39-5.29 (m, 1H), 5.04-4.92 (m, 2H), 3.35 (s, 3H), 3.22-
3.12 (m, 2H). 13C NMR (CDCl3, 100 MHz): " 178.99, 143.43, 135.22, 134.72, 
134.42, 131.79, 129.36, 128.30, 126.47, 126.32, 125.48, 125.25, 123.73, 123.61, 
123.21, 119.72, 108.37, 56.60, 43.47, 26.53. HRMS (EI) m/z calculated for C22H19NO 
[M]+ 313.1467, observed 313.1461. 
Table S2. Asymmetric intramolecular !-arylation of amide 2b with 1a-d. 
Br
N
Me
O 1 (5 mol %)
DME, 16h
N
O
Me
N OMe
+
2b 3b 4b
1.5 eq. NaOtBu
 
Entry NHC•Pd T (°C) Conversion (%)[a] 3b/4b[b] ee (%)[c] 
1 Ra,Ra-1a 50 >99 10:1 -21 (S) 
2 Ra,Sa-1a 50 >99 8:1 -14 (S) 
3 Sa,Sa-1a 50 >99 9:1 10 (R) 
4 Ra,Ra-1b 50 >99 9:1 33 (R) 
5 Ra,Sa-1b 50 >99 6:1 10 (R) 
6 Ra,Ra-1c 50 >99 8:1 59 (R) 
7 Ra,Sa-1c 50 >99 6:1 32 (R) 
8 Ra,Ra-1d 23 >99 1:0 87 (R) 
9 Ra,Sa-1d 23 >99 17:1 39 (R) 
10 Sa,Sa-1d 23 >99 19:1 53 (R) 
[a-b] Determined by analysis of 1H NMR spectra of product mixtures prior to purification. 
[c] Determined by chiral HPLC for 3b. 
 
(R)-3-Allyl-1-methyl-3-(2-naphthyl)-indolin-2-one (3c). Colorless oil, 94% yield. 
[!]27D = 126.80 (c = 0.5, CHCl3), 85% ee [Chiralpak IB column, n-hexane/i-PrOH = 
95:5, 0.5 mL/min, tR = 16.07 min (minor) and 17.39 min (major)]. 1H NMR (400 
MHz, CDCl3): " 7.78-7.73 (m, 4H), 7.52 (dd, J = 8.2, 1.0 Hz, 1H), 7.44-7.40 (m, 2H), 
7.35 (dt, J = 8.0, 1.2 Hz, 1H), 7.30 (d, J = 7.9Hz, 1H), 7.13 (dt, J = 8.0, 1.2 Hz, 1H), 
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6.91 (d, J = 7.9Hz, 1H), 5.48-5.38 (m, 1H), 5.08-4.91 (m, 2H), 3.22 (s, 3H), 3.13 (d, J 
= 7.2 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 178.16, 144.14, 137.15, 133.42, 
132.79, 132.6, 132.00, 128.53, 127.65, 126.27, 126.26, 126.13, 125.47, 125.36, 
122.76, 119.45, 108.49, 56.74, 42.08, 26.60. HRMS (EI) m/z calculated for C22H19NO 
[M]+ 313.1467, observed 313.1461. 
Table S3. Asymmetric intramolecular !-arylation of amide 2c with 1a-d. 
Br
N
Me
O 1 (5 mol %)
DME, 16h
N
O
Me
N OMe
+
2c 3c 4c
1.5 eq. NaOtBu
 
Entry NHC•Pd T (°C) Conversion (%)[a] 3c/4c[b] ee (%)[c] 
1 Ra,Ra-1a 50 >99 7:1 -21 (S) 
2 Ra,Sa-1a 50 >99 5:1 55 (R) 
3 Sa,Sa-1a 50 >99 6:1 33 (R) 
4 Ra,Ra-1b 50 >99 6:1 31 (R) 
5 Ra,Sa-1b 50 >99 5:1 57 (R) 
6 Ra,Ra-1c 50 >99 7:1 42 (R) 
7 Ra,Sa-1c 50 >99 6:1 69 (R) 
8 Ra,Ra-1d 23 >99 1:0 82 (R) 
9 Ra,Sa-1d 23 >99 18:1 85 (R) 
10 Sa,Sa-1d 23 >99 1:0 56 (R) 
[a-b] Determined by analysis of 1H NMR spectra of product mixtures prior to purification. 
[c] Determined by chiral HPLC for 3c. 
 
(R)-3-Allyl-1-benzyl-3-phenylindolin-2-one (3d).4a Colorless oil, 89% yield. [!]27D 
= 87.29 (c = 0.5, CHCl3), 81% ee [Chiralpak IB column, n-hexane/i-PrOH = 97:3, 1 
mL/min, tR = 7.84 min (minor) and 8.42 min (major)].  1H NMR (400 MHz, CDCl3): 
" 7.40-7.17 (m, 12H), 7.06 (dt, J = 7.6, 1.0 Hz, 1H), 6.75 (d, J = 7.8 Hz, 1H), 5.47-
5.36 (m, 1H), 5.10-4.81 (m, 4H), 3.16-3.03 (m, 2H). 13C NMR (CDCl3, 100 MHz): " 
178.27, 143.21, 139.96, 136.11, 132.70, 131.99, 128.87, 128.82, 128.33, 127.74, 
127.60, 127.57, 127.24, 125.36, 122.72, 119.61, 109.53, 5.62, 44.14, 42.16. HRMS 
(EI) m/z calculated for C14H21NO [M]+ 339.1623, observed 339.1620. 
Note: the absolute stereochemistry of compound 3d was assigned by comparison of 
both optical rotation and HPLC analysis (AD-H chiral column) with the know 
enantiomer.10 
(R)-3-Allyl-1-methyl-3-o-tolylindolin-2-one (3e).4a White solid, 98% yield. [!]27D = 
-78.83 (c = 1, CHCl3), 85% ee [Chiralpak IB column, n-hexane/i-PrOH = 98:2, 1 
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mL/min, tR = 10.69 min (minor) and 14.63 min (major)]. 1H NMR (400 MHz, 
CDCl3): " 7.63 (d, J = 7.6 Hz, 1H), 7.28-7.26 (m, 2H), 7.17 (dt, J = 7.4, 1.2 Hz, 1H), 
7.01 (d, J = 7.4 Hz, 1H), 6.98 (dt, J = 7.6, 10.8 Hz, 1H), 6.86-6.83 (m, 2H), 5.35-5.25 
(m, 1H), 5.00-4.87 (m, 2H), 3.24 (s, 3H), 3.09-2.99 (m, 2H), 1.62 (2, 3H). 13C NMR 
(CDCl3, 100 MHz): " 178.45, 144.14, 138.04, 137.32, 132.75, 132.19, 131.83, 
128.15, 127.76, 127.53, 126.19, 123.55, 123.06, 119.52, 107.83, 56.44, 42.60, 26.30, 
19.62. HRMS (EI) m/z calculated for C19H19NO [M]+ 277.1467, observed 277.1467. 
(S)-3-Allyl-3-(2-fluorophenyl)-1-methylindolin-2-one (3f). Colorless oil, 94% yield. 
[!]27D = -111.08 (c = 1, CHCl3), 91% ee [Chiralpak IB column, n-hexane/i-PrOH = 
98:2, 1 mL/min, tR = 14.69 min (major) and 16.87 min (minor)]. 1H NMR (400 MHz, 
CDCl3): " 7.51 (dt, J = 7.8, 1.6 Hz, 1H), 7.28-7.20 (m, 2H), 7.03-6.88 (m, 3H), 6.85 
(d, J = 7.8 Hz, 1H), 5.39-5.27 (m, 1H), 5.05-4.90 (m, 2H), 3.26 (s, 3H), 3.10-3.00 (m, 
2H). 13C NMR (CDCl3, 100 MHz): " 177.98, 162.13, 159.66, 144.03, 132.43, 131.47, 
129.44, 129.36, 128.53, 128.49, 128.34, 124.42, 124.38, 123.55, 123.53, 122.82, 
119.79, 116.45, 116.22, 108.06, 53.7, 40.22, 26.51. HRMS (EI) m/z calculated for 
C18H16NOF [M]+ 281.1216, observed 281.1216. 
(S)-3-Allyl-3-(2-methoxyphenyl)-1-methylindolin-2-one (3g).4a Colorless oil, 94% 
yield. [!]27D = -86.76 (c = 1, CHCl3), 83% ee [Chiralpak IB column, n-hexane/i-PrOH 
= 95:5, 1 mL/min, tR = 11.34 min (minor) and 15.50 min (major)]. 1H NMR (400 
MHz, CDCl3): " 7.56 (dd, J = 7.8, 1.5 Hz, 1H), 7.25-7.18 (m, 2H), 7.01 (dt, J = 7.7, 
1.1 Hz, 1H), 6.91 (dt, J = 7.4, 1.0 Hz, 1H), 6.85 (dd, J = 7.3, 1.0 Hz, 1H), 6.80 (d, J = 
7.7 Hz, 1H), 6.74 (dd J = 8.2, 1.0 Hz, 1H), 5.39-5.27 (m, 1H), 5.00-4.86 (m, 2H), 3.39 
(s, 3H), 3.25 (s, 3H), 2.98 (d, J = 7.1 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 
179.43, 157.37, 144.62, 133.48, 131.95, 129.90, 128.85, 127.73, 127.64, 122.78, 
122.28, 121.11, 119.22, 112.53, 107.22, 56.12, 53.96, 40.73, 26.35. HRMS (EI) m/z 
calculated for C19H19NO2 [M]+ 293.1416, observed 293.1415. 
(R)-3-Allyl-1-methyl-3-m-tolylindolin-2-one (3h).4a Colorless oil, 91% yield. [!]26D 
= -120.39 (c = 1, CHCl3), 83% ee [Chiralcel OJ-H column, n-hexane/i-PrOH = 95:5, 
1 mL/min, tR = 8.70 min (minor) and 22.44 min (major)]. 1H NMR (400 MHz, 
CDCl3): " 7.31 (dt, J = 7.7, 1.0 Hz, 1H), 7.23 (d, J = 6.9 Hz, 1H), 7.18-7.03 (m, 5H), 
6.87 (d, J = 7.8 Hz, 1H), 5.42-5.32 (m, 1H), 5.03-4.88 (m, 2H), 3.19 (s, 3H), 3.00 (d, 
J = 7.1 Hz, 2H), 2.29 (2, 3H). 13C NMR (CDCl3, 100 MHz): " 178.28, 144.05, 
139.69, 138.35, 132.72, 132.12, 128.59, 128.35, 127.87, 125.33, 124.28, 122.65, 
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119.27, 108.35, 56.58, 42.13, 26.55, 21.81. HRMS (EI) m/z calculated for C19H19NO 
[M]+ 277.1467, observed 277.1467. 
(R)-3-Allyl-3-(3-fluorophenyl)-1-methylindolin-2-one (3i). Colorless oil, 97% 
yield. [!]26D = 126.19 (c = 1, CHCl3), 85% ee [Chiralcel OJ-H column, n-hexane/i-
PrOH = 95:5, 1 mL/min, tR = 9.13 min (minor) and 13.73 min (major)]. 1H NMR (400 
MHz, CDCl3): " 7.33 (dt, J = 7.8, 1.6 Hz, 1H), 7.27-7.06 (m, 5H), 6.95-6.88 (m, 2H), 
5.41-5.31 (m, 1H), 5.05-4.90 (m, 2H), 3.19 (s, 3H), 2.97 (d, J = 7.1 Hz, 2H). 13C 
NMR (CDCl3, 100 MHz): " 177.63, 164.28, 161.84, 144.00, 142.29, 142.22, 132.23, 
131.28, 130.16, 130.08, 128.72, 125.37, 123.01, 122.98, 122.83, 119.68, 114.75, 
114.60, 114.53, 114.39, 108.58, 56.36, 42.29, 26.61. HRMS (EI) m/z calculated for 
C18H16NOF [M]+ 281.1216, observed 281.1217. 
(R)-3-Allyl-3-(3-methoxyphenyl)-1-methylindolin-2-one (3j). Colorless oil, 90% 
yield. [!]27D = 100.31 (c = 0.5, CHCl3), 85% ee [Chiralcel OD-H column, n-hexane/i-
PrOH = 90:10, 0.5 mL/min, tR = 15.622 min (major) and 17.25 min (minor)]. 1H 
NMR (400 MHz, CDCl3): " 7.31 (dt, J = 7.7, 1.1 Hz, 1H), 7.25-7.22 (m, 1H), 7.09 (t, 
J = 7.5 Hz, 1H), 6.96-6.93 (m, 2H), 6.86 (d, J = 7.8 Hz, 1H), 6.77 (dd, J = 8.1, 1.5 Hz, 
1H), 5.43-5.32 (m, 1H), 5.03-4.88 (m, 2H), 3.75 (s, 3H), 3.18 (s, 3H), 2.99 (d, J = 7.0 
Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 178.04, 159.86, 144.03, 141.32, 132.65, 
131.83, 129.65, 128.44, 125.39, 122.68, 119.69, 119.35, 113.76, 112.46, 108.40, 
56.55, 55.41, 42.18, 26.56. HRMS (EI) m/z calculated for C19H19NO2 [M]+ 293.1416, 
observed 293.1413. 
(R)-3-Allyl-1-methyl-3-p-tolylindolin-2-one (3k).4a Colorless oil, 94% yield. [!]27D 
= 109.14 (c = 1, CHCl3), 82% ee [Chiralcel OD-H column, n-hexane/i-PrOH = 
99.3:0.7, 0.5 mL/min, tR = 35.09 min (major) and 39.06 min (minor)]. 1H NMR (400 
MHz, CDCl3): " 7.31 (dt, J = 7.7, 1.0 Hz, 1H), 7.26-7.22 (m, 3H), 7.11-7.07 (m, 3H), 
6.87 (d, J = 7.8 Hz, 1H), 5.44-5.33 (m, 1H), 5.03-4.88 (m, 2H), 3.18 (s, 3H), 2.99 (d, 
J = 7.1 Hz, 2H), 2.28 (2, 3H). 13C NMR (CDCl3, 100 MHz): " 178.33, 144.07, 
137.24, 136.74, 132.75, 132.08, 129.44, 128.34, 127.12, 125.33, 122.61, 119.25, 
108.34, 56.31, 42.13, 26.52, 21.15. HRMS (EI) m/z calculated for C19H19NO [M]+ 
277.1467, observed 277.1463. 
(R)-3-Allyl-3-(4-fluorophenyl)-1-methylindolin-2-one (3l).4a Colorless oil, 94% 
yield. [!]27D = 141.88 (c = 1, CHCl3), 83% ee [Chiralpak IB column, n-hexane/i-
PrOH = 98:2, 1 mL/min, tR = 7.26 min (minor) and 8.05 min (major)]. 1H NMR (400 
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MHz, CDCl3): " 7.36-7.30 (m, 3H), 7.24-7.22 (m, 1H), 7.11 (dt, J = 7.5, 1.0 Hz, 1H), 
7.98-6.94 (m, 2H), 6.88 (d, J = 7.8 Hz, 1H), 5.41-5.30 (m, 1H), 5.03-4.89 (m, 2H), 
3.18 (s, 3H), 2.96 (d, J = 7.1 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 178.04, 
163.51, 161.06, 144.01, 135.41, 135.38, 132.37, 131.56, 129.07, 128.99, 128.61, 
125.36, 122.5, 119.55, 115.61, 115.40, 108.55, 55.98, 42.50, 26.57. HRMS (EI) m/z 
calculated for C18H16NOF [M]+ 281.1216, observed 281.1216. 
(R)-3-Allyl-3-(4-methoxyphenyl)-1-methylindolin-2-one (3m). Colorless oil, 92% 
yield. [!]27D = 128.36 (c = 1, CHCl3), 77% ee [Chiralcel OD-H column, n-hexane/i-
PrOH = 99:1, 1 mL/min, tR = 29.00 min (major) and 32.42 min (minor)]. 1H NMR 
(400 MHz, CDCl3): " 7.33-7.23 (m, 4H), 7.09 (dt, J = 7.6, 1.0 Hz, 1H), 6.87 (d, J = 
7.6 Hz, 1H), 6.83-6.80 (m, 2H), 5.43-5.32 (m, 1H), 5.03-4.88 (m, 2H), 3.75 (s, 3H), 
3.17 (s, 3H), 2.97 (d, J = 7.1 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 178.46, 
159.02, 144.07, 132.76, 132.05, 131.76, 128.39, 128.37, 125.37, 122.61, 119.25, 
114.11, 108.38, 55.93, 55.47, 42.34, 26.53. HRMS (EI) m/z calculated for C19H19NO2 
[M]+ 293.1416, observed 293.1412. 
(R)-3-Allyl-1-methyl-3-(4-trifluorophenyl)-indolin-2-one (3n). Colorless oil, 97% 
yield. [!]27D = 124.51 (c = 0.5, CHCl3), 86% ee [Chiralpak IB column, n-hexane/i-
PrOH = 98:2, 1 mL/min, tR = 6.50 min (minor) and 7.62 min (major)]. 1H NMR (400 
MHz, CDCl3): " 7.55-7.49 (m, 4H), 7.35 (dt, J = 7.6, 1.0 Hz, 1H), 7.25-7.23 (m, 1H), 
7.12 (dt, J = 7.6, 1 Hz, 1H), 6.90 (d, J = 7.8 Hz, 1H), 5.42-5.31 (m, 1H), 5.05-4.91 
(m, 2H), 3.19 (s, 3H), 3.00 (d, J = 7.6 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 
177.47, 144.04, 143.68, 132.03, 131.04, 129.99, 129.67, 128.88, 127.83, 125.72, 
125.68, 125.65, 125.61, 125.41, 122.93, 119.90, 108.73, 56.56, 42.32, 26.67. HRMS 
(EI) m/z calculated for C19H16NOF3 [M]+ 331.1184, observed 331.1182. 
(R)-3-Allyl-3-(4-biphenyl)-1-methylindolin-2-one (3o).4a White solid, 95% yield. 
[!]27D = 107.04 (c = 1, CHCl3), 87% ee [Chiralpak IB column, n-hexane/i-PrOH = 
98:2, 1 mL/min, tR = 11.00 min (minor) and 13.08 min (major)]. 1H NMR (400 MHz, 
CDCl3): " 7.55-7.51 (m, 4H), 7.46-7.29 (m, 7H), 7.13 (dt, J = 7.5, 0.8 Hz, 1H), 6.91 
(d, J = 7.8 Hz, 1H), 5.48-5.38 (m, 1H), 5.08-4.92 (m, 2H), 3.21 (s, 3H), 3.06 (d, J = 
7.2 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 178.14, 144.07, 140.86, 140.45, 138.74, 
132.58, 131.80, 128.93, 128.49, 127.68, 126.48, 127.46, 127.26, 125.40, 122.71, 
119.43, 108.46, 56.42, 42.21, 26.58. HRMS (EI) m/z calculated for C24H21NO [M]+ 
339.1623, observed 339.1622. 
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(S)-3-Allyl-3-(2-fluorophenyl)-5-methoxyl-1-methylindolin-2-one (3q). Colorless 
oil, 90% yield. [!]22D = -86.04 (c = 0.5, CHCl3), 94% ee [Chiralcel OD-H column, n-
hexane/i-PrOH = 95:5, 1 mL/min, tR = 11.55 min (minor) and 13.53 min (major)]. 1H 
NMR (400 MHz, CDCl3): " 7.50 (dt, J = 7.8, 1.7 Hz, 1H), 7.26-7.20 (m, 1H), 7.15 
(dt, J = 7.6, 1.3 Hz, 1H), 6.91 (ddd, J =11.6, 8.1, 1.3 Hz, 1H), 6.79-6.73 (m, 2H), 6.64 
(d, J = 2.2 Hz, 1H), 5.42-5.30 (m, 1H), 5.06-4.90 (m, 2H), 3.71 (s, 3H), 3.23 (s, 3H), 
3.05-3.02 (m, 2H). 13C NMR (CDCl3, 100 MHz): " 177.61, 162.16, 159.70, 156.27, 
137.67, 133.79, 131.49, 129.48, 129.39, 128.54, 128.50, 127.95, 127.82, 124.43, 
124.40, 119.80, 116.48, 116.25, 112.29, 111.28, 111.26, 108.27, 55.94, 54.30, 40.26, 
26.61. HRMS (EI) m/z calculated for C19H18NOF [M]+ 311.1322, observed 311.1318. 
(R)-3-Allyl-3-(4-biphenyl)-1-methyl-5-methoxyl-indolin-2-one (3r). White solid, 
90% yield. [!]22D = 131.88 (c = 0.5, CHCl3), 86% ee [Chiralpak IB column, n-
hexane/i-PrOH = 95:5, 1 mL/min, tR = 10.71 min (minor) and 12.72 min (major)]. 1H 
NMR (400 MHz, CDCl3): " 7.54-7.49 (m, 4H), 7.45-7.38 (m, 4H), 7.33-7.29 (m, 1H), 
6.90-6.79 (m, 3H), 5.48-5.37 (m, 1H), 5.08-4.92 (m, 2H), 3.80 (s, 3H), 3.18 (s, 3H), 
3.00 (d, J = 7.7 Hz, 2H). 13C NMR (CDCl3, 100 MHz): " 177.85, 156.16, 140.91, 
140.49, 138.73, 137.70, 133.23, 132.39, 128.59, 127.68, 127.51, 127.50, 127.29, 
119.50, 112.91, 112.67, 108.69, 56.87, 56.06, 42.10, 26.69. HRMS (EI) m/z 
calculated for C25H23NO2 [M]+ 369.1729, observed 369.1724. 
(S)-3-Allyl-3-(2-fluorophenyl)-1,4-dimethylindolin-2-one (3s). White solid, 95% 
yield. [HPLC condition: Chiralpak IB, 2:98 (iPrOH/n-Hexane), 1 ml/min. 12.45 
(major), 20.76 (minor).] 1H NMR (400 MHz, CDCl3): " 7.58 (dt, J = 7.8, 0.8 Hz, 1H), 
7.26-7.15 (m, 3H), 7.12 (ddd, J = 11.4, 8.0, 1.4 Hz, 1H), 6.74 (d, J = 7.8 Hz, 1H), 
6.70 (d, J = 7.8 Hz, 1H), 5.39-5.19 (m, 1H), 5.06-4.86 (m, 2H), 3.24-3.19 (m, 2H), 
3.23 (s, 3H), 1.92 (s, 3H). 13C NMR (CDCl3, 100 MHz): " 177.91, 162.03, 159.56, 
144.46, 134.04, 131.33, 129.39, 129.31, 129.18, 128.93, 128.89, 128.25, 127.31, 
127.19, 125.15, 124.23, 124.19, 119.46, 116.34, 116.12, 105.76, 53.82, 37.49, 26.56, 
17.64. HRMS (EI) m/z calculated for C19H18NOF [M]+ 295.1372, observed 295.1372. 
(R)-3-Allyl-1,1'-dimethyl-3,3'-biindolin-2-one (3t). White solid, 94% yield. [!]27D = 
182.19 (c = 1, CHCl3), 86% ee [Chiralcel OD-H column, n-hexane/i-PrOH = 90:10, 
1.0 mL/min, tR = 11.26 min (minor) and 30.88 min (major)]. 1H NMR (400 MHz, 
CDCl3): " 7.32 (dt, J = 7.7, 1.3 Hz, 1H), 7.23-7.20 (m, 2H), 7.14-7.09 (m, 2H), 7.04 
(d, J = 7.5, 1.0 Hz, 1H), 6.98 (s, 1H), 6.93-6.89 (m, 2H), 5.51-5.40 (m, 1H), 5.06-4.90 
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(m, 2H), 3.71 (s, 3H), 3.24 (s, 3H), 3.19-3.06 (m, 2H). 13C NMR (CDCl3, 100 MHz): 
" 178.49, 144.02, 137.80, 132.64, 128.32, 127.71, 126.16, 124.78, 122.69, 121.93, 
120.76, 119.42, 119.18, 113.60, 109.54, 108.16, 52.71, 41.05, 33.02, 26.53. HRMS 
(EI) m/z calculated for C21H20N2O [M]+ 316.1576, observed 316.1578. 
(S)-3-Allyl-1,3-dimethyl-5-methoxyl-indole-2-one (3u).4c Colorless oil, 92% yield. 
[!]25D = -32.43 (c = 1, CHCl3), 70% ee [Chiralpak IB column, n-hexane/i-PrOH = 
98:2, 0.5 mL/min, tR = 19.02 min (major) and 24.06 min (minor)]. 1H NMR (400 
MHz, CDCl3): " 6.80-6.69 (m, 3H), 5.49-4.38 (m, 1H), 5.00-4.89 (m, 2H), 3.78 (s, 
3H), 3.15 (s, 3H), 2.53-2.43 (m, 2H), 1.34 (s, 3H). 13C NMR (CDCl3, 100 MHz): " 
180.04, 156.15, 136.98, 135.28, 132.76, 118.87, 111.84, 110.96, 108.27, 56.04, 48.88, 
42.65, 26.40, 22.99. HRMS (EI) m/z calculated for C14H17NO2 [M]+ 231.1259, 
observed 231.1258. 
(R)-3-Allyl-3-(3,5-dimethylphenyl)-1-methylindolin-2-one (3v). Colorless oil, 94% 
yield. [!]27D = 102.33 (c = 1, CHCl3), 84% ee [Chiralcel OD-H column, n-hexane/i-
PrOH = 98:2, 0.5 mL/min, tR = 16.24 min (major) and 17.77 min (minor)]. 1H NMR 
(400 MHz, CDCl3): " 7.31 (dt, J = 7.6, 1.0 Hz, 1H), 7.22 (d, J = 7.4 Hz, 1H), 7.09 (dt, 
J = 7.5, 1.0 Hz, 1H), 6.94 (s, 3H), 6.88-6.86 (m, 2H), 5.41-5.30 (m, 1H), 5.03-4.87 
(m, 2H), 3.19 (s, 3H), 3.00 (d, J = 6.5 Hz, 2H), 2.24 (s, 6H). 13C NMR (CDCl3, 100 
MHz): " 178.37, 144.05, 139.66, 138.18, 132.79, 132.31, 129.30, 128.27, 
125.28,124.94, 122.65, 119.19, 108.30, 56.55, 42.08, 26.54, 21.68. HRMS (EI) m/z 
calculated for C20H21NO [M]+ 291.1623, observed 291.1624. 
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